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ABSTRACT 
 
This is a study of copy number variations (CNVs) in the horse genome to gain 
knowledge about the role of CNVs in equine biology, and their contribution to complex 
diseases and disorders.  
We constructed a 400K whole-genome tiling array and applied it for the 
discovery of CNVs in 38 normal horses of 16 diverse breeds, and the Przewalski horse. 
Altogether, 258 CNV regions (CNVRs) were identified across all autosomes, chrX, and 
chrUn. The CNVRs comprised 1.3% of the horse genome with chr12 being most 
enriched. American Miniature Horses had the highest and American Quarter Horses the 
lowest number of CNVs in relation to Thoroughbred references. The Przewalski horse 
was similar to native ponies and draft breeds. About 20% of CNVRs were intergenic, 
while 80% involved 750 annotated genes with molecular functions predominantly in 
sensory perception, immunity, and reproduction.  
The findings were integrated with previous CNV studies in the horse to generate 
a composite genome-wide dataset of 1476 CNVRs. Of these, 301 CNVRs were shared 
between studies, while 1174 were novel and require further validation. Integrated data 
revealed that only 41 out of over 400 breeds of the domestic horse have been analyzed 
for CNVs, whereas this study added 11 new breeds.  
The composite CNV dataset served as a foundation for the discovery of variants 
contributing to Recurrent Airway Obstruction (RAO) and XY disorders of sexual 
development (DSDs), such as cryptorchidism and XY sex reversal. In 16 RAO affected 
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horses 363 CNVRs were identified, of which 31 were novel and not found in healthy 
horses. A deletion in SPI2 and SERPINA1 was studied in detail because the genes are 
involved in respiratory diseases in human. In horses with XY DSDs, over 50 novel 
CNVRs were identified including deletions of functional interest in the pseudoautosomal 
region and the ATRX gene. A potentially causative homozygous deletion in chr29 
disrupting AKR1C genes with functions in sex hormone metabolism was shared between 
a cryptorchid and two sex reversal horses.  
The findings effectively improved the knowledge about CNVs in horses, in 
health and disease, and generated resources for future studies. 
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CNVR Copy Number Variable Region 
aCGH array Comparative Genomic Hybridization 
qPCR quantitative PCR 
FISH Fluorescent in situ Hybridization  
RAO Recurrent Airway Obstruction 
DSD Disorder of Sexual Development 
CO Cryptorchids 
 
 vi 
 
TABLE OF CONTENTS 
 
 Page 
ABSTRACT .......................................................................................................................ii 
ACKNOWLEDGEMENTS .............................................................................................. iv 
NOMENCLATURE ........................................................................................................... v 
TABLE OF CONTENTS .................................................................................................. vi 
LIST OF FIGURES ........................................................................................................ viii 
LIST OF TABLES ............................................................................................................. x 
CHAPTER I  INTRODUCTION AND LITERATURE REVIEW ................................... 1 
The horse: domestication, breeds, importance ............................................................... 1 
The horse genome .......................................................................................................... 2 
Horse genome mapping .................................................................................................. 3 
The genome sequence of the domestic horse ................................................................. 6 
The development and application of advanced genome analysis tools ........................ 10 
Genomics of equine diseases and traits ........................................................................ 16 
Genomic Copy Number Variation (CNV) ................................................................... 20 
Present status of CNV research in the horse ................................................................ 46 
Prospective equine complex traits for CNV research .................................................. 49 
Goals of this study ........................................................................................................ 70 
CHAPTER II GENOMIC COPY NUMBER VARIATION IN EQUINE 
POPULATIONS ............................................................................................................... 72 
Introduction .................................................................................................................. 72 
Material and methods ................................................................................................... 75 
Results  ....................................................................................................................... 89 
Discussion .................................................................................................................. 108 
CHAPTER III ANALYSIS OF GENOMIC COPY NUMBER VARIATION IN 
EQUINE RECURRENT AIRWAY OBSTRUCTION .................................................. 121 
Introduction ................................................................................................................ 121 
Material and methods ................................................................................................. 124 
Results  ..................................................................................................................... 133 
 vii 
 
Page 
 
Discussion .................................................................................................................. 148 
CHAPTER IV IDENTIFICATION OF CNVS IN EQUINE DISORDERS OF 
SEXUAL DEVELOPMENT (DSDS) – CRYPTORCHIDISM AND XY SRY-
POSITIVE SEX REVERSAL ........................................................................................ 153 
Introduction ................................................................................................................ 153 
Material and methods ................................................................................................. 156 
Results  ..................................................................................................................... 164 
Discussion .................................................................................................................. 181 
CHAPTER V CONCLUSIONS AND FUTURE WORK ............................................. 187 
REFERENCES ............................................................................................................... 190 
APPENDIX .................................................................................................................... 284 
 
 viii 
 
LIST OF FIGURES 
 Page 
Figure 1. Different mechanisms of CNV formation. ....................................................... 23 
Figure 2: The molecular and genetic events in mammalian sex determination. .............. 58 
Figure 3: Synthesis of dihydrotestosterone via the classic and alternative pathways. ..... 60 
Figure 4: Genome-wide distribution of CNVs in self-to-self hybridization. ................... 90 
Figure 5: Male-to-female aCGH for the X chromosome. ................................................ 91 
Figure 6: Comparative DLRSD values. ........................................................................... 91 
Figure 7: A CNVR map of the horse genome. ................................................................. 93 
Figure 8: Confirmation of homozygous deletion CNVs by qualitative PCR. .................. 98 
Figure 9: Chromosome-wise distribution of CNVRs in the horse genome. .................... 99 
Figure10: GO classifications of copy number variable genes in horses. ....................... 100 
Figure 11: A summary diagram for the CNVs identified in the horse genome. ............ 102 
Figure 12: Validation of CNVRs by qPCR. ................................................................... 106 
Figure 13: Validation of a copy number gain in chr1 (114.0 Mb) by FISH. ................. 107 
Figure 14: Chromosomal assignment and validation of a CNVR. ................................. 108 
Figure 15. Genetic relationships of the horse breeds studied for CNVs. ....................... 119 
Figure 16: Schematic diagram of a region in chr24. ...................................................... 143 
Figure 17: Validation of the deletion in chr24 by qPCR. ............................................... 143 
Figure 18: CNV analysis in chr24 by qPCR using array probe specific primers. .......... 144 
Figure 19: Regular (qualitative) PCR with SPI2 exon 1 primers. .................................. 145 
 
 ix 
 
Page 
Figure 20: Analysis of CNV in SPI2 exon 1. ................................................................. 146 
Figure 21: Quantitative PCR with SPI2 and SERPINA1 exon primers. ......................... 147 
Figure 22: Ensembl output for chrX:2 03-366,729. ....................................................... 173 
Figure 23: Validation of the CNVR in the PAR of H252 by qPCR. .............................. 174 
Figure 24: Quantitative PCR to validate shared CNVRs. .............................................. 176 
Figure 25: Schematic of the homozygous deletion in chr29 in DSD horses. ................. 178 
Figure 26: Breakpoint analysis for the homozygous deletion in chr29. ......................... 180 
 
 x 
 
LIST OF TABLES 
 Page 
 
Table 1: Summary of GWAS studies using Equine SNP50 Beadchip. ........................... 14 
Table 2: Summary of genetic test available for 14 coat colors in horses. ........................ 18 
Table 3:  List of conditions in horses where diagnostic tests are available to detect. ...... 19 
Table 4: An overall summary of the DGV database. ....................................................... 27 
Table 5:  A summary of CNV studies in domestic species. ............................................. 39 
Table 6: Horse breeds (n=16) and individuals (n=38) used in this study. ....................... 80 
Table 7: Breed- and individual-wise summary of CNVRs in horses. .............................. 92 
Table 8: Chromosome-wise CNVR statistics for the horse genome. ............................... 94 
Table 9: Tentative breed-specific CNVRs ....................................................................... 96 
Table 10: Equine copy number variable genes with known mammalian phenotypes. .. 104 
Table 11:  Summary statistics of all CNV studies in horses .......................................... 115 
Table 12: List of horse breeds studied for CNVs ........................................................... 118 
Table 13:  Details about the RAO study cohort. ............................................................ 125 
Table 14: Primers for qualitative and qPCR to analyze a CNVR in chr24. ................... 131 
Table 15: Summary of CNV calls in RAO cases and controls. ..................................... 135 
Table 16: Summary information for the 30 “RAO specific” CNVRs. ........................... 138 
Table 17: List of bilateral cryptorchid horses used for the study. .................................. 156 
Table 18: List of SRY-positive sex- reversal horses used for array CGH. ..................... 158 
Table 19: Primers for qualitative and quantitative PCR. ............................................... 162 
 
 xi 
 
Page 
Table 20: Summary of CNVs in the 12 bilateral cryptorchid horses. ............................ 165 
Table 21: Novel CNVRs in bilateral cryptorchid horses. .............................................. 167 
Table 22: Summary of CNVs in the 8 sex reversal horses. ............................................ 169 
Table 23: Summary of genes involved in the 41 novel CNVRs in sex reversal horses. 170 
Table 24: Novel CNVRs present in sex-reversal and bilateral cryptorchid horses. ....... 175 
 
 
 
 1 
 
CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
The horse: domestication, breeds, importance 
 
Horses were domesticated over 5500 years ago (Vila et al. 2001; Levine 2005; 
Outram et al. 2009; Orlando et al. 2013) and occupy a special place amongst domestic 
species. Unlike cattle, pigs, sheep, goats and poultry which are mostly used as a source 
of food (milk, meat and eggs), horses have been used as a source of power and transport. 
Thanks to natural athleticism and endurance for physical activities even in rough 
environmental conditions with scarce resources, horses were valuable for transportation 
in older times. Today, they are mainly used for racing and leisure industry, and as 
companion animals. Since domestication, humans have bred horses for several different 
purposes, resulting in over 400 horse and pony breeds (Hendricks 1995) which can be 
divided into three big groups: warmblood horses for racing and riding, coldblood horses 
for draft and heavy duty jobs, and native ponies, which are often adapted to local 
specific environmental and climatic conditions (Austen et al. 2008).  
Horses have a great impact on the economy of the U.S.A. and throughout the 
world; the revenue of the US equine industry in 2010 was $1.6 billion as per IBIS-World 
Industry Report 2013. As per 2005 American Horse Council study, in the United States, 
the horse industry directly produces goods and services in excess of $39 billion and has a 
total impact of $102 billion on U.S. GDP.  
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Direct employment and additional jobs generated through spending, leads to a 
total employment impact of 1.4 million FTE jobs. Approximately 34% of horse owners 
have a household annual income of less than $50,000, and over 70% of horse owners 
live in communities with <50,000 population. Thus the equine industry has a strong 
impact on the rural economy and supports a considerable proportion of people in the 
relatively lower income group.  
Being a species with great economic importance, good health and performance of 
horses are of high priority to the owners, breeders and the equine industry. Therefore, the 
primary goal of genome analysis in horses is to identify genetic factors governing equine 
diseases, congenital disorders and traits of biological importance (e.g., disease 
resistance) and of human interest (e.g., coat color, athletic performance), so that 
molecular tools can be developed for the improvement of equine health and 
performance.  
 
The horse genome 
 
The nuclear genome of the horse is packaged into 64 chromosomes (2n=64) - 31 
pairs of autosomes and one pair of sex chromosomes (XX in females and XY in males). 
In 1997 an International System for Chromosome Nomenclature of the Domestic Horse 
(ISCNH 1997) was developed. This System determined the arrangement of horse 
chromosomes into a standard karyotype and established a banding nomenclature for 
chromosome identification. 
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The size of the horse genome is about 2.7 billion DNA base pairs with at least 
20,449 protein-coding genes as revealed by the current horse genome sequence 
assembly, EquCab2, which is based on the genome of a Thoroughbred mare (Wade et al. 
2009).  
The mitochondrial genome of the horse is 16.6 kilo base pairs (kb) in size and 
consists of 13 protein-coding genes, 22 tRNA genes (transfer RNA) and 2 rRNA genes 
(ribosomal RNA) (Xu and Arnason 1994). Similarly to other mammals, the 
mitochondrial genome of the horse is maternally inherited. Thus, horses of the same 
maternal ancestry share similar mitochondrial sequences (Bower et al. 2013). Studies of 
mitochondrial DNA have been widely used to explore the origins and relationships of 
horse breeds and populations (Hill et al. 2002; Cieslak et al. 2010; Khanshour and 
Cothran 2013). 
 
Horse genome mapping 
 
Until whole genome sequencing, the primary sources of information about the 
molecular organization of the horse genome have been various types of maps 
(Chowdhary et al. 2008; Chowdhary and Raudsepp 2008; Raudsepp et al. 2012; 
Raudsepp and Chowdhary 2013). Gene mapping in horses started with linkage analysis 
which is based on meiotic recombination and linkage maps show linear order and 
relative distance between markers.  
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The first linkage mapped gene was G6PD (Glucose 6 Phosphate Dehydrogenase) 
which was assigned to the X-chromosome almost 5 decades ago (Trujillo et al. 1965; 
Mathai et al. 1966). Thereafter linkage maps were constructed for autosomal regions 
(Sandberg 1974; Andersson and Sandberg 1984; Sandberg and Andersson 1984) and for 
the whole genome (Lindgren et al. 1998; Guerin et al. 1999; Swinburne et al. 2000; 
Penedo et al. 2005; Swinburne et al. 2006). 
The first physical chromosome maps for the horse were constructed by synteny 
mapping (Lear et al. 1992; Williams et al. 1993; Bailey et al. 1995; Raney et al. 1998; 
Shiue et al. 1999). The method is based on somatic cell hybrid technology and assigns 
genes and markers into synteny groups. However, in the early years of gene mapping, 
neither linkage nor synteny maps were able to anchor markers to specific chromosomes 
or chromosomal regions. This limitation was overcome by another physical mapping 
technique - cytogenetic mapping, also known as in situ hybridization (ISH) or 
fluorescence in situ hybridization (FISH).  
The first ISH mapped loci were the equine major histocompatibility complex 
(ELA) (Ansari et al. 1988; Makinen et al. 1989) and glucose phosphate isomerase (GPI) 
(Harbitz et al. 1990), while hemoglobin alpha (HBA) was the first gene mapped by FISH 
(Oakenfull et al. 1993). Currently, over 1000 genes and markers have been mapped in 
the horse genome by FISH (Raudsepp et al. 2008). 
In the early 2000s, another somatic cell hybrid based technique - radiation hybrid 
(RH) mapping - was adopted for the horse (Chowdhary et al. 2002) resulting in the 
development of high-resolution physical maps for individual chromosomes (Lee et al. 
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2004; Raudsepp et al. 2004a; Raudsepp et al. 2004b; Gustafson-Seabury et al. 2005; Goh 
et al. 2007), as well as for the whole genome (Chowdhary et al. 2003; Raudsepp et al. 
2008). The most comprehensive of these is one 4000 marker containing 2
nd
 generation 
RH map (Raudsepp et al. 2008) which integrates all linkage and cytogenetic maps, and 
aligns about 2000 loci with the human genome. 
Another type of high-resolution maps were based on contigs of Bacterial 
Artificial Chromosome (BAC) clones and were constructed for selected genomic 
regions, such as the major histocompatibility complex, MHC (Gustafson et al. 2003), 
pseudoautosomal region, PAR (Raudsepp and Chowdhary 2008b), and a small region in 
chromosome 21 (Brinkmeyer-Langford et al. 2008). Attempts were also made to 
construct a WG BAC fingerprint map (Leeb et al. 2006) with the aim to guide and 
validate the horse WG sequence assembly (Wade et al. 2009). 
An integral part of constructing various maps was the development of mapping 
resources, such as pedigree material (Lindgren et al. 1998; Guerin et al. 1999; Penedo et 
al. 2005), polymorphic microsatellite markers for linkage mapping (Lindgren et al. 1998; 
Guerin et al. 1999; Mittmann et al. 2010a), markers for PCR-based synteny and RH 
mapping (Chowdhary et al. 2003; Swinburne et al. 2006; Raudsepp et al. 2008), and 
large insert clone libraries for cytogenetic and BAC-based mapping. The latter include 
one cosmid library (Breen et al. 1997) and three male genomic BAC libraries: INRA 
(Milenkovic et al. 2002), CHORI-241 BAC library, and TAMU BAC library (Rubes et 
al. 2009).  
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All these maps have served as valuable tools for the isolation of genes and 
markers associated with equine diseases and economically important traits. Besides, the 
linkage (Penedo et al. 2005; Swinburne et al. 2006), radiation hybrid (RH) and 
cytogenetic maps (Raudsepp et al. 2008) have been instrumental for anchoring and 
orienting WG sequence contigs and scaffolds on horse chromosomes (Wade et al. 
2009). The need for good maps will be even more pronounced in re-sequencing projects 
to assemble millions of short reads produced by next generation sequencing 
technologies (NGS) (Mardis 2008; Huddleston et al. 2014). The whole genome maps 
remain to offer a well-tested resource for the analysis of genome architecture, function, 
and evolution. 
 
The genome sequence of the domestic horse 
 
Sequencing and assembly of the genome of a Thoroughbred mare Twilight in 
2009 (Wade et al. 2009) marked the start of a new era in equine genomics. The assembly 
of 2.4 billion DNA base-pairs provided the first detailed characterization of the horse 
genome and serves currently as a reference for all other horse genome sequencing 
projects.  
The horse genome was sequenced with coverage of 6.97X. Although the total 
length of the assembly is 2.43 billion base pairs, with gaps the size of the horse genome 
is estimated to be 2.7 billion base pairs (Wade et al. 2009). Using gene predictions from 
mammalian and non-mammalian vertebrates, 20,449 protein-coding genes, 2142 non-
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coding genes, and 4400 pseudogenes and retrotransposed genes were annotated. Gene 
annotation showed that among 20,322 equine genes, 16,617 have orthologs in humans, 
17,106 in mouse, and 16,159 in dogs. Besides determining the DNA sequence for the 
horse, the project provided data regarding the functions and evolution of the genome, 
and the genomics of equine populations (Wade et al. 2009). Comparison of the horse 
genome with the human showed that horse chromosomes have undergone few 
evolutionary rearrangements: 53% of equine chromosomes show conserved synteny to a 
single human chromosome. There are a total of 403 syntenic segments between human 
and horse (Wade et al. 2009).  
About 95% of the genome sequences are assigned to the 31 autosomes and the X 
chromosome. The remaining 5% are not assigned to any chromosomes and considered as 
unassigned chromosome, “chrUn”. The horse genome is relatively repetitive but has 
little segmental duplications. About 46% of the horse genome comprises repetitive 
elements of which 19% are long interspersed elements (LINEs), 7% are short 
interspersed elements (SINEs) and the remaining are novel equine repetitive elements. 
Detailed analysis of equine repetitive elements showed that besides typical eutherian 
mammalian repeats, the horse genome also contains a significant number of hybrid 
repeats and clade-specific LINEs (Adelson et al. 2010).  
A novel feature of the horse genome was the discovery of an evolutionarily new 
centromere in ECA11. As this functional centromere did not contain any major horse 
satellite sequences, it was concluded that centromeric satellite DNA is not obligatory for 
centromere functions. 
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Importantly, the horse genome sequencing project also determined DNA 
sequence variation across horses by identifying 1,154,177 short variants - single 
nucleotide polymorphisms (SNPs) and indels. Single nucleotide polymorphisms are the 
most common types of genetic variations in mammalian populations and typically 
involve an alteration in a single nucleotide. For example, in humans, SNPs occur once in 
every 300 nucleotides suggesting that there are approximately 10 million SNPs in the 
human genome (NCBI). Most SNPs have no effect on health or development, however, 
when SNPs occur within a gene or in a regulatory region, they may affect phenotype 
more directly. The discovery of SNPs in horses was based on 7 horses of diverse breeds 
and “Twilight”. These 7 horses are breeds Akhal-Teke, Andulasian, Arabian, Icelandic 
horse, Quarter Horse, Standardbred, and a second Thoroughbred. On average, there is 
one SNP per 2000 nucleotides in horses, suggesting the presence of over one million 
SNPs in the genome. Indeed, since then, over 3 million SNPs have been discovered by 
sequencing additional genomes of individual horses (Orlando et al. 2011; Doan et al. 
2012b; Orlando et al. 2013).  
Besides SNPs, the horse genome sequence draft assembly showed that segmental 
duplications make up about 0.5 % of the equine genome and are most abundant in 
chromosome 25 (Wade et al. 2009). Segmentally duplicated areas are known as hotspots 
for non-allelic homologous recombination (NAHR), which is one of the main causes for 
the formation of copy number variable (CNV) regions (Hurles and Lupski 2006). These 
are stretches of DNA larger than 1 kb, although smaller CNVs are also common (Mills 
et al. 2011; Xu et al. 2011) that are involved in large scale genomic rearrangements, such 
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as deletions, insertions, duplications, inversions, translocations and mobile element 
transposition.  
These rearrangements result in structural differences between genomes 
generating the genetic basis for normal phenotypic variations. At the time of the draft 
assembly of the horse genome in 2009, it was known that gray coat color is caused by a 
CNV in STX17 (syntaxin-17) gene (Rosengren Pielberg et al. 2008). Thus, in the study 
by Wade and colleagues (2009) a breed wise CNV analysis was performed in horses of 
different coat colors as a proof of the principle. Since CNVs and their biological 
importance is the central theme of this dissertation, detailed description of CNV research 
in horses and other mammals will be provided later in “Genomic Copy Number 
Variation (CNV)” and “Present status of CNV research in the horse”.   
The current horse reference genome sequence assembly draft was produced by 
shotgun sequencing of the genome of a Thoroughbred mare “Twilight” using Sanger 
technology. During the recent years, taking advantage of various next generation 
sequencing (NGS) platforms, whole genomes of several more horses have been 
sequenced. The first was sequencing a Quarter Horse mare using Illumina platform 
(Doan et al. 2012b). Very recently single molecule sequencing technology (Helicos 
HeliScope and Illumina GAIIX) was applied of two ancient horses - a 700,000 years old 
early middle Pleistocene horse and a 43,000 years old pre-domestication late-Pleistocene 
horse, 5 modern horses (Arabian, Icelandic, Norwegian Fjord, Standardbred and 
Thoroughbred), a Przewalski’s horse and a donkey (Orlando et al. 2011; Doan et al. 
2012b; Orlando et al. 2013). Analysis of WG sequences of additional horses, by PacBio 
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and Illumina, is in progress. Altogether, these data are aimed to improve the current 
EcuCab2 assembly and upgrade it into version EcuCab3 (Kalbfleisch et al. 2013).  
 
The development and application of advanced genome analysis tools 
 
Achievements in horse genomics, in particular the availability of the reference 
sequence EcuCab2 and additional WG or partial sequences from multiple individuals, 
lay the foundation for the development of advanced tools for further analysis of the 
organization and function of the horse genome. These include a variety of array-based 
platforms and improved panels of polymorphic markers for WG scan. 
 
Studies of genome function 
 
The first gene expression arrays for the horse were constructed even before the 
whole genome was sequenced and were based on the sequence information of cDNA 
libraries and ESTs (Gu and Bertone 2004; Smith et al. 2006; Huang et al. 2008). The 
availability of the reference genome with over 20,000 annotated protein coding genes 
(Wade et al. 2009), essentially improved the production of whole genome cDNA and 
oligoarrays (Bright et al. 2009; Glaser et al. 2009; Mienaltowski et al. 2009; Noschka et 
al. 2009). These platforms have been used to study the dynamics of gene expression in 
normal equine cells and tissues: synoviocytes (Gu and Bertone 2004), cartilage (Huang 
et al. 2008), testes and sperm (Das et al. 2013a), and endometrium (Gebhardt et al. 2012; 
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Kamm et al. 2013; Moyo et al. 2013). Also, the arrays have been critical for the 
discovery of gene expression changes in pathologies: osteoarthritis (Smith et al. 2006), 
chondrocyte surface lesions (Mienaltowski et al. 2009), early stages of laminitis 
(Noschka et al. 2009), and expression of Rhodococcus equi in neonatal foals (Kachroo et 
al. 2013). However today, gene expression arrays have been largely replaced by RNA-
seq technology which is cost efficient and provides most comprehensive information 
about the expression profile of any tissue or cell type (Coleman et al. 2013). Most 
importantly, RNA-seq data from adult and embryonic equine tissues is a valuable 
resource for improving functional annotation of the horse genome and for the discovery 
of novel protein coding and regulatory RNA genes. 
 
Studies of the genome structure 
 
Even although there is just one reference genome for the horse, genomic DNA 
sequences of individual horses vary in multifarious ways. These variants include 
polymorphisms of single nucleotides (SNPs and indels) and short-tandem repeats 
(microsatellites), segmental duplications and copy number variants. Such inter-
individual DNA sequence differences can be used for genome wide association studies 
(GWAS) for detecting genotype-phenotype associations and discovering mutations 
underlying genetic diseases/disorders and traits of interest. Thus, development of cutting 
edge tools for the discovery of these associations has been an important part of equine 
genomics during the past years. 
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SNP arrays  
Single nucleotide polymorphisms in the horse genome are considered as the next 
generation markers for parentage testing, breed diversity analysis, and GWAS of 
Mendelian and complex traits (Swinburne et al. 2009; Wade et al. 2009). In the past, 
candidate genes for equine genetic disorders (Tryon et al. 2007; Young et al. 2007) or 
traits of interest, like fertility (Hamann et al. 2007) or athletic performance (Schroder et 
al. 2011; McGivney et al. 2012) were directly analyzed for SNPs to discover causative 
associations. However, this approach requires previous knowledge about the genes and 
is laborious. Therefore, one of the most awaited by-products of the genome sequencing 
was the discovery of over million SNPs (Wade et al. 2009)  and the construction of the 
first generation SNP chip, known as Illumina Equine SNP50 BeadChip (McCue 2009; 
McCue et al. 2012). The chip comprises 54,602 highly informative (polymorphic in 
many breeds) SNPs uniformly distributed across the equine genome. The mean inter-
SNP distance across the genome is about 43 kb, and 95% of informative SNPs are apart 
less than 150 kb. The SNP50 chip was successfully used for the proof of principle 
mapping of chestnut (MC1R) and black (ASIP) coat color loci detecting a ~350 kb and 
~200 kb conserved across-breeds haplotypes, respectively (McCue 2009). Since then, 
the SNP50 Beadchip has been extensively used for a variety of studies that can be 
broadly grouped into two: i) populations studies searching for similarities, differences 
and relationships between different horse breeds, and for signatures of domestication 
(Petersen et al. 2013a; Petersen et al. 2013b), and ii) studies looking for candidate genes 
and mutations underlying equine diseases/disorders and traits of interest (see Table 1 
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below). For example, a population study with 814 horses of 36 different breeds 
discovered candidate regions for selection during horse domestication. These included a 
5.5Mb region in ECA18 with the myostatin (MSTN) gene showing highest selection in 
Paint and Quarter Horse breeds; a shared, 186 kb haplotype in ECA23with DMRT2 and 
DMRT3 genes; and a locus at ECA11 possibly responsible for size in Draft breeds and 
Miniature horses (Petersen et al. 2013b).  
Despite of this success, it was soon recognized that the number and 
representation of SNPs on the chip needed improvement. Thus, in 2011 the SNP50 
Beadchip was modified by adding new SNPs, removing less informative ones and 
enhancing the coverage of ECAX, regions involved in coat colors, and the MHC in 
ECA20 (Brooks and Bellone 2013; McCue and Mickelson 2013; McCue 2013). The 
SNP70 Beadchip was produced by Illumina and is currently available for researchers. 
Further, work is in progress to develop a high density SNP chip with about 600,000 
probes. This is an international effort and started with identifying 20-30 million SNPS 
from WG sequences of a diverse set of horses.  
Based on WG sequence data of 166 horses representing 32 diverse breeds, 5 
million SNPs have been selected and sent to Affymetrix for quality control. It is 
expected that there will be 2 million SNPs suitable for the production of a test array. The 
final goal is to construct a chip with 640,000 SNPs for research. With such a SNP array 
in place, horse genomics will have high throughput genome analysis tools comparable to 
those available for humans and cattle. 
 
 14 
 
Table 1: Summary of GWAS studies using Equine SNP50 Beadchip.  
 
Condition Breeds Genes/mutations/associations Reference 
Negative effects on fitness Thoroughbred Inbreeding increased post-1996 and 
coincides with the introduction of 
stallions covering larger numbers 
of mares. 
(Binns et al. 2012) 
Athletic performance (racing 
distance) 
Thoroughbred MSTN in ECA18 (Binns et al. 2010; Hill et al. 
2010)  
Body size Many breeds ECA1, 8, 9 (Metzger et al. 2013a) 
Dwarfism Friesian 2 Mb in ECA14 (Orr et al. 2010) 
   Foal Immunodeficiency 
Syndrome;  Fell Pony 
Syndrome 
Fell Pony SLC5A3 in ECA26, causative 
mutation 
(Fox-Clipsham et al. 2011a; 
Fox-Clipsham et al. 2011b) 
Fracture risk Thoroughbred ECA1, 18 (Blott et al. 2014) 
Guttural pouch tympany Arabian, 
German Warmblood 
ECA15 – Arabian;  
ECA3- German Warmblood 
(Metzger et al. 2012) 
Height Hanoverian, 42 other 
breeds 
LCORL – ECA3 a candidate locus (Metzger et al. 2013b) 
Impaired acrosome reaction Thoroughbred FKBP6 - ECA13 a susceptibility 
locus  
(Raudsepp et al. 2012) 
Insect bite hypersensitivity Icelandic horse 
Exmoor pony 
ELA class II  (Andersson et al. 2012b) 
Lavender Foal Syndrome, LFS Arabian Causative mutation in MYO5A 
ECA1 
(Brooks et al. 2010) 
Locomotion, gait Icelandic horse, 
Trotters, 
Gaited breeds 
Causative mutation in DMRT3 – 
ECA23 
(Andersson et al. 2012a) 
Maxillary Prognathism Various breeds ECA13. (Signer-Hasler et al. 2014) 
Osteochondritis dissecans Thoroughbred ECA3 (Corbin et al. 2012) 
Osteochondrosis Standardbred ECA5, 10, 27, 28  (Lykkjen et al. 2010) 
Osteochondrosis French trotter ECA1, 2, 3, 13, 14, 15 (Teyssedre et al. 2012) 
Plantar osteochondral 
fragments 
Standardbred  ECA1, 2, 7, 9, 11,27, 31, X (Lykkjen et al. 2013) 
Recurrent exertional 
rhabdomyolysis, RER 
Thoroughbred 13 Mb in ECA16  (Fritz et al. 2012) 
Recurrent laryngeal neuropathy Warmblood, 
Trotter, 
Thoroughbred, 
Draft 
ECA21 and 31 (Dupuis et al. 2011) 
Recurrent laryngeal neuropathy Various breeds Duplication in ECA10  (Dupuis et al. 2013) 
Recurrent uveitis German Warmblood ECA20,18 (Kulbrock et al. 2013) 
Recurrent uveitis Appaloosa ECA1 and ELA (ECA20) (Fritz et al. 2014) 
Show-jumping Hanoverian  ECA1, 3, 8, 9, 11, 17, 21 (Schroder et al. 2012) 
Susceptibility to equine arteritis 
virus 
Thoroughbred, 
American Saddlebred, 
Standardbred, Quarter 
Horse  
ECA11 (Go et al. 2011) 
Trisomies Friesian 
Welsh Pony 
ECA27, 30 (Holl et al. 2013) 
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WG scanning panels 
Polymorphic microsatellites have, for years, been the markers of choice for 
linkage studies and whole genome scans. The success of these studies depends largely 
on the quality of panels made of informative microsatellite markers, strategically 
positioned over the genome. The available sequence assembly significantly improved 
these panels. For example, in silico analysis of EcuCab2.0 identified 21,781 
microsatellite sequences (Mittmann et al. 2010c). Of these 72% are di-, 3.8 % tri-, 17.6 
% tetra-, and 1.6% pentanucleotide repeats. The mean distance between these 
microsatellites in the horse genome is 112 kb. This collection of sequences was used to 
establish a highly polymorphic minimal microsatellite set for whole genome scans in 
warm- and coldblood horse breeds (Mittmann et al. 2010a). Markers from this panel 
have been used in whole genome scan for chronic pastern dermatitis in German draft 
horses (Mittmann et al. 2010b) and guttural pouch tympany in Arabian and German 
warmblood horses (Zeitz et al. 2009; Metzger et al. 2012). 
 
Tiling arrays   
In the past few years, specialized tiling arrays have been constructed for the 
study of CNVs in the horse genome. The first such array comprised 418,000 60 bp 
oligonucleotides representing exons and UTRs of ~21,000 annotated horse protein 
coding genes RNA genes, pseudogenes, transposons, and retrotransposons. The array 
was produced by Illumina and has so far been used in one study (Doan et al. 2012a). 
Very recently, Wang and colleagues reported about the production of a NimbleGen WG 
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tiling array with 1.4 million probes. The array was used to study CNVs in 6 indigenous 
horse breeds from China and Mongolia (Wang et al. 2014b). Overall, tiling arrays are 
‘newcomers’ in equine genomics and have, as yet, found limited application. This topic 
will be discussed in more detail in the following section “Present status of CNV research 
in the horse”. 
 
Genomics of equine diseases and traits 
 
The goals of equine genomics worldwide are to identify mutations responsible 
for genetic disorders, and discover genes associated with simple (coat color) and 
complex (athletic performance, reproduction) traits. This will allow the improvement of 
breeding practices and the development of better tests for diagnostics (Chowdhary et al. 
2008; Chowdhary and Raudsepp 2008; Finno et al. 2009; Swinburne et al. 2009). Before 
‘genome sequencing era’ causative genes and mutations for a handful of monogenic 
equine traits (Finno et al. 2009) were discovered using gene maps, comparative 
approaches and pedigree analyses. Genetic tests are currently available for 14 coat colors 
(see Table 2 below), 9 monogenic disorders (see Table 3 below) and for the recently 
discovered gait-mutation in DMRT3 (Andersson et al. 2012a).  However, given that there 
over 200 equine traits and disorders listed in the database of Online Mendelian 
Inheritance in Animals (OMIA), much more work needs to be done. Furthermore, a 
large proportion of the traits important to the equine industry are complex being 
controlled by multiple genes and environmental factors. Examples of such conditions are 
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recurrent airway obstruction (RAO) and other respiratory and allergic disorders, 
osteochondrosis, laminitis, reproductive and behavioral disorders. The availability of 
horse genome reference sequence and new cutting edge pan-genomic analysis tools have 
made a breakthrough in the study of these conditions facilitating hypothesis free 
genome-wide discovery of associated genes or genomic regions. Genome wide SNP 
association studies have been conducted for about 20 equine conditions and disorders. 
Although, causative mutations have been found for just a few - Lavender Foal Syndrome 
(Brooks et al. 2010), Fell Pony Syndrome (Fox-Clipsham et al. 2011a; Fox-Clipsham et 
al. 2011b) and gait (Andersson et al. 2012a). Additionally, likely candidate/contributing 
genes have been proposed for some complex disorders – MSTN for racing distance (Hill 
et al. 2012; McGivney et al. 2012), FKBP6 for impaired acrosome reaction (Raudsepp et 
al. 2012), and MHC Class II for insect bite hypersensitivity (Andersson et al. 2012b) 
(Table 3). For others, GWAS has identified one or more potentially associated genomic 
regions where the search for candidate genes will require additional efforts.  
Taken together, despite the rapid and qualitative progress in equine disease and 
trait genomics, contributing molecular factors for many economically important complex 
traits and conditions remain unknown. This justifies the launch of alternative directions 
in research, taking advantage of other forms of inter-individual genome variation, such 
as copy number variants (CNVs).  
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Table 2: Summary of genetic test available for 14 coat colors in horses. 
 
 
 
 
 
Coat Color Mode of inheritance Mutation References 
Red Factor/Black Factor 
(Extension) 
Autosomal recessive   
epistatic over black, 
Missense mutation and loss-of-
function mutation on MCIR gene 
in ECA 3 
(Rieder et al. 
2001) 
Agouti (Bay) Autosomal dominant Allele combinations in MC1R in 
ECA 3, and in ASIP in ECA 22 
(Rieder et al. 
2001) 
Agouti (Black) Autosomal recessive 11bp deletion at position 2174–
2184; frameshift loss-of-function 
mutation in ASIP in ECA 22 
(Rieder et al. 
2001) 
Champagne Dilution Autosomal dominant Mutation in Exon 2 of SLC36A1 
in ECA 14 
(Cook et al. 
2008) 
Cream Dilution Autosomal codominant Mutation  in MATP gene in ECA 
21  
(Mariat et al. 
2003) 
Pearl Dilution,  Barlink 
Factor 
Autosomal recessive Mutation  in MATP gene in ECA 
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Silver Dilution Autosomal dominant Missense mutation PMEL17 gene 
in ECA 6 
(Brunberg et 
al. 2006) 
Silver Dilution Incomplete dominance, 
homozygous for disease 
allele  
SNP A>T and C>T at PMEL gene 
in ECA7 
(Andersson et 
al. 2013) 
Gray Autosomal dominant 4.6-kb duplication in intron 6 of 
STX17 gene in ECA 25 
(Rosengren 
Pielberg et al. 
2008) 
Appaloosa Coat Pattern / 
Leopard Print 
Autosomal – incompletely 
– dominant 
Autosomal dominant 1378 bp 
insertion in intron 1 of TRPM1 in 
ECA 1. 
(Bellone et al. 
2010; Bellone 
et al. 2013) 
Overo Lethal White Foal 
Syndrome (OWLS) 
Autosomal recessive. Point mutation that results in an 
isoleucine/lysine substitution at 
codon 118 of the EDNRB gene 
located in ECA 17. 
(Hultgren 
1982; 
McCabe et al. 
1990; 
Metallinos et 
al. 1998) 
Sabino 1 Autosomal dominant Single nucleotide polymorphism 
caused by a base substitution for 
T with A in intron 16 of KIT gene 
in ECA 3. 
(Brooks and 
Bailey 2005) 
Splashed White Overo  
(SW-1, SW-2, SW-3) 
Autosomal dominant Breed-specific mutations in KIT 
gene in ECA 3 
(Mau et al. 
2004) 
Tobiano Autosomal dominant A large chromosomal inversion in 
ECA 3 near the KIT gene of 
Tobiano horses. 
(Brooks et al. 
2007; Haase 
et al. 2008) 
Dominant White (W1-W11) Autosomal dominant Carries the specific KIT mutation 
in ECA 3 
(Haase et al. 
2007; Haase 
et al. 2009) 
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Table 3:  List of conditions in horses where diagnostic tests are available to detect.
  
 
 
 
Condition name Breeds Mode of 
inheritance 
Mutation Reference 
Hyperkalemic 
periodic paralysis 
(HYPP) 
Quarter horse Autosomal 
dominant 
A point mutation in SCN44 
gene in ECA17 
(Rudolph et al. 
1992) 
Glycogen Branching 
Enzyme Deficiency 
(GBED) 
Quarter horse Autosomal 
recessive 
A point mutation in exon 1 
changes a tyrosine to a 
premature stop codon in the 
GBE1 gene in ECA26.  
(Ward et al. 
2004) 
Polysaccharide 
Storage Myopathy 
(PSSM) 
Quarter horse, 
Belgians, Percherons, 
Morgans, Mustangs 
and some Warmblood 
breeds 
Autosomal 
dominant 
Point mutation that results in an 
arginine to histidine substitution 
in the GYS1 gene in ECA10. 
(McCue et al. 
2008) 
Malignant 
Hyperthermia (MH) 
Quarter horse Autosomal 
dominant 
Point mutation that results in an 
arginine to glycine substitution 
in the RYR1 gene in ECA10. 
(McCue et al. 
2009) 
Hereditary Equine 
Regional Dermal 
Asthenia (HERDA 
or HC) 
Quarter horse Autosomal 
recessive 
Point mutation that results in a 
glycine to arginine substitution 
in the equine cyclophilin B gene 
PPIB in ECA1. 
(Tryon et al. 
2007) 
Overo Lethal White 
Foal Syndrome 
(OWLS) 
American Paint horses Autosomal 
recessive 
Point mutation that results in an 
isoleucine/lysine substitution at 
codon 118 of the EDNRB gene 
located in ECA 17. 
(Hultgren 
1982; McCabe 
et al. 1990; 
Metallinos et 
al. 1998) 
Junctional 
Epidermolysis 
bullosa (JEB) 
Belgian Draft horses, 
Breton, Comtois, 
Vlaams Paard, 
Belgische, 
Koudbloed, Flander 
draft, American 
Saddlebreds. 
Autosomal 
recessive 
Drafts have a cytosine insertion 
(1368insC) creating a premature 
stop codon in the LAMC2 gene 
in ECA 5, Saddlebreds has a 
6589-bp deletion spanning 
exons 24-27 in the LAMA3 gene 
in ECA 8. 
(Spirito et al. 
2002) 
Cerebellar 
Abiotrophy (CA) 
Arabian horses 
Miniature horses, 
Gotland Pony, 
Oldenburg. 
  (Cavalleri et 
al. 2013) 
Appaloosa Coat 
Pattern / Leopard 
Print/  
Congenital 
Stationary Night 
Blindness (CSNB) 
Appaloosa Autosomal 
dominant 
1378 bp insertion in intron 1 of 
TRPM1 in ECA 1. 
(Bellone et al. 
2010; Bellone 
et al. 2013) 
Myotonia New Forest ponies Autosomal 
recessive 
A total of three polymorphisms 
were identified, two single 
nucleotide substitutions in 
CLCN1 exon 15 (c.1593A>G 
and c.1775A>C) and a three 
base pair insertion 
(c.2652_2653insCTT) in exon 
23 in ECA 4. 
(Wijnberg et 
al. 2012) 
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Table 3 continued. 
 
 
Genomic Copy Number Variation (CNV) 
 
Background  
 
Genomes of individuals of the same species differ from each other at many 
different levels – from single nucleotide and microsatellite polymorphism as discussed in 
previous paragraphs to large scale chromosomal variations which are studied by 
cytogenetics. There is also a type of structural variation which involves DNA segments 
of intermediate length, typically from 1 kilobase-pair (kb) to several megabase-pairs 
(Mb), although variants as small as 50 bp have been detected (Li et al. 2004; Feuk et al. 
2006; Redon et al. 2006; Conrad et al. 2010b). These DNA segments can be inserted or 
deleted giving rise to copy number gains or losses or complex rearrangements involving 
both. Collectively, these types of variants are known as copy number variants (CNVs). 
Condition name Breeds Mode of 
inheritance 
Mutation Reference 
Lavender Foal 
Syndrome (LFS) 
Arabian Autosomal 
recessive 
A single base deletion in exon 
30 of MYO5A in ECA 1 that 
changes the reading frame and 
introduces a premature stop 
codon. 
(Brooks et al. 
2010) 
Severe Combined 
Immunodeficiency 
(SCID) 
Arabian Autosomal 
recessive 
A 5-basepair deletion in the 
gene encoding DNA-protein 
kinase catalytic subunit DNA-
PK in ECA 9. 
(Shin et al. 
1997) 
Foal 
immunodeficiency 
syndrome (FIS) 
Fell and Dales ponies Autosomal 
recessive 
Mutation in the SLC5A3 gene, 
in ECA 26, this causes a P446L 
substitution in the protein. 
(Fox-Clipsham 
et al. 2011a; 
Fox-Clipsham 
et al. 2011b) 
Equine insect bite 
hypersensitivity 
(IBH) 
Icelandic horse 
Exmoor pony 
 SNPs associated with    IGHE, 
FCER1A, IL4, IL4R, IL10, 
IL1RA, and JAK2 genes 
(Andersson et 
al. 2012b) 
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Copy number variants in vertebrate genomes were first acknowledged by 
Susumu Ohno over 40 years ago in the book “Evolution by Gene Duplication” (Ohno 
1970). It was, however, only from 2004 onwards that the presence of CNVs across the 
genomes of mice (Li et al. 2004; She et al. 2008) and humans (Iafrate et al. 2004; Sebat 
et al. 2004; Tuzun et al. 2005; Feuk et al. 2006; Fiegler et al. 2006; Redon et al. 2006) 
was shown using contemporary molecular methods. Thereafter, CNVs have been studied 
in the genomes of primates (Cheng et al. 2005; Dumas et al. 2007; Perry et al. 2008), rat 
(Guryev et al. 2008) and more recently, in domestic species (Clop et al. 2012; Liu and 
Bickhart 2012).  
Comparison of CNVs with SNPs showed that CNVs constitute 5 to 12% of the 
mammalian genome (Redon et al. 2006; Pielberg and Andersson 2007; Kim et al. 2008; 
Hastings et al. 2009) and contribute approximately twice the amount of total genetic 
differences between individuals when compared to SNPs (Sharp 2009).  
 
Genomic distribution and mechanisms of formation of CNVs  
 
Studies in humans and animals show that CNVs are not randomly distributed in 
the genome (Hastings et al. 2009; Hall and Quinlan 2012). They are significantly 
enriched in regions with segmental duplications (SD), also known as low copy number 
repeats (Hastings et al. 2009; Stankiewicz and Lupski 2010; Bickhart et al. 2012; Du et 
al. 2012) transposable elements (Cordaux and Batzer 2009; Xing et al. 2009), and other 
regions with complex architectural features, such as subtelomeric regions (DeScipio et 
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al. 2008; Riethman 2008) and the Y chromosome (Skaletsky et al. 2003). Association of 
CNVs with structurally complex regions suggests that the formation of CNVs is caused 
by the same general mechanisms that can cause other structural changes in chromosomes 
– occurrence of chromosomal breaks followed by repair mechanisms using homologous 
and non-homologous recombination (Hastings et al. 2009). As follows, is a summary of 
possible mechanisms leading to CNV formation. 
 
Non-Allelic Homologous Recombination (NAHR) 
Typically occurs in regions enriched with low copy number repeats or segmental 
duplications. These are sequences larger than 1 kb that share over 95% sequence identity 
(Hurles and Lupski 2006; Hastings et al. 2009). Double stranded breaks in these regions 
can be repaired by different mechanisms involving both gene conversion and crossing 
over (Hurles and Lupski 2006) resulting in deletions, duplications, inversions or 
translocations. Examples of NAHR resulting in the formation of CNV are shown in 
Figure 1.  
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Figure 1. Different mechanisms of CNV formation. 
(a) Recurrent structural variants often result from non-allelic homologous recombination 
(NAHR) which involves recombination between long highly similar low-copy-number 
repeats (blue and orange segments). (b) Novel genomic insertions can involve mobile 
element insertion of transposable elements by retrotransposition. (c) DNA-replication-
associated template-switching events, involving the fork-stalling and template switching 
(FoSTeS) and microhomology-mediated break-induced replication (MMBIR) 
mechanisms. (d) Non-homologous end joining (NHEJ), which is a process that repairs 
DNA double-strand breaks in the absence of extensive sequence homology and is often 
accompanied by the addition or deletion of several nucleotides in the form of a 'repair-
scar' (small red bar). (e) Chromothripsis — which is a phenomenon that seems to involve 
chromosome shattering leading to numerous breakpoints, followed by error-prone DNA 
repair (Weischenfeldt et al. 2013). 
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Non-homologous recombination (NHR)  
It is a DNA break repair mechanism which uses very limited or no sequence 
homology and can lead to the formation of CNVs. NHRs can be divided into non-
replicative and replicative mechanisms (Hastings et al. 2009). The former are not related 
to DNA replication and include phenomena such as non-homologous end joining 
(NHEJ), microhomology-mediated end joining (MMEJ), and breakage–fusion–bridge 
cycle (Hastings et al. 2009). For example, in NHEJ, double stand breaks are repaired 
without sequence homology and can result in deletion, insertion or duplication of a small 
number of nucleotides (1-4 bp), termed as replication scar. Sources of free DNA that can 
be inserted are mitochondrial DNA and retrotransposons (LINEs). Suggested 
mechanisms of CNV formation that are due to events during DNA replication are 
replication slippage, fork stalling and template switching (FoSTeS), and 
microhomology-mediated break-induced replication (MMBIR) (Hurles and Lupski 
2006; Hastings et al. 2009). A recently discovered form of NHR is chromothripsis which 
is althought to involve both MMBIR and NHEJ, leading to the formation of multiple and 
massive structural rearrangements in a very short time which is typically observed in 
cancers (Stephens et al. 2011; Liu and Bickhart 2012). It has been observed that small 
CNVs usually originate from mobile element insertion and NHEJ, whereas large CNVs 
are caused by NAHR (Conrad et al. 2010a).  
Taken together, even although some mechanisms of CNV formation are 
understood, the overall mechanistic aspects leading to CNVs are not completely clear 
and require further research. The study of CNVs is further complicated by possible 
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somatic mosaicism where CNVs are formed in some but not in other somatic cells or 
tissues (Hall and Quinlan 2012). 
 
Methods for CNV discovery and analysis 
 
Several tools and approaches have been used to examine CNVs. These include 
arrays of large genomic clones (Fiegler et al. 2006), SNP genotyping microarrays 
(Shaikh et al. 2009; Hou et al. 2012a; Yang et al. 2014), whole genome oligonucleotide 
tiling arrays (also known as comparative genomic hybridization or CGH arrays) (Carter 
2007; Gresham et al. 2008; Mitra et al. 2009; Conrad et al. 2010b; Ueno et al. 2012; 
Mizuno et al. 2014), and whole genome sequencing (Kidd et al. 2008; Alkan et al. 2009; 
Ni et al. 2013; Poultney et al. 2013; Iben and Maraia 2014; Tan et al. 2014). Although 
sequencing certainly provides the most comprehensive information about CNVs, array 
based CGH is currently the most widely used, efficient and relatively cost-effective way 
of detecting and measuring structural variations in the genome of humans (Carter 2007; 
Gresham et al. 2008; Mitra et al. 2009; Conrad et al. 2010b; McCarroll 2010) and 
animals (Liu et al. 2009; Fadista et al. 2010; Wang et al. 2010). The only prerequisite for 
designing a CGH array is the availability of whole genome sequence information for the 
species of interest. Once the arrays have been designed and produced, they are analyzed 
by array CGH. The method is based on co-hybridization of two differently fluorescently 
(usually with Cy3 and Cy5) labeled genomic DNA samples, of which one is always a 
reference and another, the sample of interest (case). The case/reference signal ratios are 
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measured and copy number variations are detected according to the ratio. Thereafter, the 
data can be analyzed using a variety of software packages, often provided by the 
companies producing the arrays: e.g., Agilent Technologies – Agilent Genomics 
Workbench, NimbleGen – NimbleGen SignalMap software and Affymetrix-
Chromosome Analysis Suite (ChAS) Software.  
In recent years, next generation sequencing (NGS) technology has been used 
widely to detect CNVs (Medvedev et al. 2009; Mills et al. 2011). CNVs identified by 
NGS are about 50 bp in size (Alkan et al. 2009). A new approach whole exome 
sequencing (WES), is also considered because in compare to NGS it is cost effective to 
study large population (Ng et al. 2009). WES focuses on protein-coding regions or 
exomes or customer defined target regions, which only encompass about 1% of the 
entire genome. 
 
CNV research in humans and primates 
 
Studies of CNVs in humans started a decade ago (Iafrate et al. 2004), first a small 
number of unrelated individuals (Iafrate et al. 2004; Feuk et al. 2006; Fiegler et al. 2006; 
Freeman et al. 2006; Redon et al. 2006), but soon expanding to larger cohorts 
representing specific human populations: European (Vogler et al. 2010), African 
(Matsuzaki et al. 2009), Japanese (Takahashi et al. 2008), Chinese (Lin et al. 2009), 
Korean (Moon et al. 2011). Additional information about human CNVs was provided by 
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the Human HapMap consortium and the 1000 Genome Sequence Project. The data are 
available from Ensembl and Database of Genomic Variants (DGV) (Table 4). 
The DGV shows that approximately half of the 109,863 human CNVs (July 
2013) fall into the size range from 1 to 10 kb; about 21% overlap with genomic regions 
listed in OMIM (Online Mendelian Inheritance in Human), and according to 
DECIPHER database (Firth et al. 2009), CNVs relate to 70 known human syndromes.  
 
 
Table 4: An overall summary of the DGV database. 
(July 2013 update, mapped to GRCh37 assembly) (MacDonald et al. 2014) 
 
Database content Number of entries 
Studies 55 
Unique samples 14316 
Variant regions 202431 
Deletion 77268 
Duplication 668 
Loss 64185 
Gain 24891 
Gain+loss 3850 
Insertion 24140 
Inversion 1149 
Complex 4090 
Unknown 2189 
Variant calls 2393718 
CNV 2391408 
Inversion 2310 
Filtered variants 3900253 
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CNVs formed in both genic and intergenic region. It was expected to find more 
CNVs in intergenic region as they contain large repeats, but most CNVs were present in 
gene containing region or inside known coding region (Iafrate et al. 2004; Perry et al. 
2006). CNVs present in intergenic region mostly containing non-coding RNAs which 
are responsible for regulation of normal gene expression as well as cause various 
diseases and disorders (Khalil et al. 2009; Huarte et al. 2010; Walker and Scherer 2013). 
Human CNV studies were performed to study various aspects of genomic 
variations and their effect on normal human population. Gene containing CNVs cause 
changes in gene dosage (Jaradat et al. 2013; Polan et al. 2014; Vittori et al. 2014), gene 
expression regulation (Haraksingh and Snyder 2013), and changes in recessive allele 
exposure (Boone et al. 2013) . Duplication and deletion of cis-regulatory elements have 
been shown to greatly influence phenotype, particularly developmental genes 
(Spielmann and Klopocki 2013). CNVs have great impact on genomic selection (Conrad 
et al. 2006; Redon et al. 2006; Itsara et al. 2010; Gokcumen et al. 2011; Stenberg and 
Larsson 2011), gene duplication and evolution (Popesco et al. 2006; Dumas et al. 2007; 
Nozawa et al. 2007; Hasin et al. 2008; Young et al. 2008; Waszak et al. 2010; Jarick et 
al. 2011; Shadravan 2013; Veerappa et al. 2013), and changes in innate and adaptive 
immunity (Kulski et al. 2002; She et al. 2008; Orange et al. 2011; Bergen et al. 2012; 
Lee et al. 2012; Llaurens et al. 2012).  From these outcomes a common CNV map was 
generated where most of the CNVs are associated with cell adhesion, sensory 
perception, neurophysiological processes, kinase- and phosphorylation-related 
categories, and cell signaling. 
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CNV studies were performed with primates to look for genome-wide structural 
microheterogeneity, breakpoints for chromosomal rearrangements between their 
genomes and humans. CNVs in primate genome might be indicative of the gaining of 
new functions and therefore of adaptive evolution. Comparative studies between human, 
chimpanzee (Kehrer-Sawatzki and Cooper 2007), gorilla (Wilson et al. 2006), orangutan 
genomes (Yohn et al. 2005) might help to determine the ancestral state of primate 
genome, thereby indicating the divergences between them.  
 
CNV research in mice 
 
The close association of CNVs with complex diseases and disorders 
(Weischenfeldt et al. 2013) identified several new structural mutations contributed to 
develop human disorders, and evolutionary drive of genes and species. It is important to 
generate accurate CNV maps not only in humans but in many different organisms and 
cellular contexts, so that the biological significances and molecular mechanism of CNV 
formation can be evaluated (Hall and Quinlan 2012). In this context CNV studies were 
performed in model mammalian animals; mouse, rat (Guryev et al. 2008; Charchar et al. 
2010) and dog (described later). CNV work in mouse was started in 2004 (Li et al. 
2004). CNV study in mouse was initiated by array CGH method (Li et al. 2004; 
Graubert et al. 2007; She et al. 2008) and later moved to NGS-based study (Quinlan et 
al. 2010; Yalcin et al. 2011). In mouse studies the genomic variation is more than human 
(7196 CNVs in single study) (Quinlan et al. 2010) because of the presence of high level 
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of transposable elements (Akagi et al. 2008) in mouse genome. Mouse and other 
mammalian studies showed that overall levels of structural variations are roughly 
similar. This information will help to analyze all species on a common CNV discovery 
platform in the future (Hall and Quinlan 2012). 
 
Phenotypes, genetic diseases, and disorders associated with CNVs 
 
The association of DNA copy number variation with phenotypic traits, 
adaptations and evolution was proposed over 40 years ago by Susumu Ohno in 
‘Evolution by Gene Duplication’ (Ohno 1970; Conant and Wolfe 2008) and has found 
compelling evidence from recent CNV studies. For example, comparison of humans and 
other primates has revealed several human lineage specific gene amplifications: copy 
number increase of the salivary amylase gene (AMY1) in some human populations gives 
an adaptive advantage in digesting starch-rich food (Perry et al. 2007); copy number 
expansion of aquaporin7 (AQP7) is thought to increase glycerol transport and endurance, 
or, CNVs in genes expressed specifically in neurons (DUF1220/NBPF) are thought to be 
related to cognition (Popesco et al. 2006; Lupski 2007b). The best known CNV related 
phenotypes in animals are coat colors, such as grey in horses (Rosengren Pielberg et al. 
2008), dominant white in pigs (Giuffra et al. 2002), agouti locus in goats (Fontanesi et 
al. 2009) or color sidedness in cattle (Durkin et al. 2012). 
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Microscopic CNVs  
Association of CNVs with diseases and disorders has been known for years since 
early cytogenetic studies. It is well known that chromosomal aneuploidies, as well as 
deletions and duplications which are large enough to be observed under light microscope 
are associated with diseases and disorders. The best known examples for aneuploidy in 
humans are the Down syndrome with trisomy of chromosome 21 and the Turner 
syndrome with X chromosome monosomy (Beckmann et al. 2008). Examples for large 
microscopic rearrangements are Smith-Magenis syndrome/ Potocki-Lupski syndrome 
associated with deletion/ duplication in Chr17p11.2 (Ricard et al. 2010); deletions in a 
complex imprinted region in Chr15q11-13 which causes Angelman syndrome if the 
deletion is maternal or Prader-Willi syndrome if deletion occurs on the paternal 
chromosome (Sanders et al. 2011; Rangasamy et al. 2013; Weischenfeldt et al. 2013); 
Thromcytopenia-absent radius (TAR) syndrome is caused by a deletion in Chr1q21.1, or 
Cri-du-Chat and Williams syndromes with large deletions in Chr5p and 7q, respectively 
(Sanders et al. 2011). Also, it is well established that multiple deletions in the AZF 
regions in the human Y chromosome are responsible for a spectrum of male fertility 
disorders (Lahn and Page 1997; Skaletsky et al. 2003; Rozen et al. 2012). 
 
Submicroscopic CNVs  
During the past decade tools have become available for the discovery and study 
of submicroscopic CNVs. This is directly attributed to the availability of whole genome 
sequence assemblies which have allowed the construction of tiling and SNP arrays for 
 32 
 
CNV discovery, whereas the resolution and sensitivity of these tools is gradually 
increasing, so that CNVs as small as 50 bp can be discovered (Conrad et al. 2010b). 
Even more developments in the field are accompanying the application of NGS. 
One of the central goals of CNV research is to determine their association with 
genome instability, genetic diseases, and congenital disorders. CNVs are considered as 
major sources of inter-individual genetic variation that could explain variable penetrance 
of Mendelian and polygenic diseases and variation in the phenotypic expression of 
complex traits (Beckmann et al. 2007; Beckmann et al. 2008). Human CNVs have been 
associated with a few rare conditions, such as CHARGE syndrome (Monfort et al. 2008) 
and many common diseases (Conrad and Antonarakis 2007; Hollox et al. 2008; Zhang et 
al. 2009; Choy et al. 2010; Fanciulli et al. 2010; Lee and Scherer 2010). Among the 
latter, most are complex and polygenic disorders affecting a broad range of processes of 
biomedical importance (Ermakova et al. 2011). Gene ontology analyses show that CNV 
regions are significantly enriched for genes involved in immune response and 
inflammation, cognition and perception, but also genes involved in reproduction, drug 
metabolism and other complex traits (Redon et al. 2006; Cooper et al. 2007). As follows 
is a summary of human biological systems and corresponding clinical conditions that 
have been shown to be influenced by or associated with CNVs.  
 
Immune and autoimmune disorders  
Because of the outstanding bias of CNVs in immunity-related genes, contribution 
of CNVs has been shown for several human infectious diseases (Choy et al. 2010), 
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autoimmune disorders, and allergies. For example, higher genomic copy number for 
beta-defensin genes has been associated with risk of psoriasis (Hollox et al. 2008); copy 
number of alpha-defensin genes is a strong risk factor for Crohn’s disease, HIV 
progression and multiple sclerosis (McCarroll et al. 2008a; Choy et al. 2010; Khan et al. 
2013) and deletion variants of RABGAP1L, 10q21.3, and cytochrome 4 (C4) are 
associated with the risk of systemic lupus erythematosus (Kim et al. 2013). Furthermore, 
21% of 270 candidate genes for asthma are residing near or within a CNV (Rogers et al. 
2013) 
 
Pharmacogenomics 
A relatively new field of CNV research is pharmacogenomics with a focus on 
genes that are responsible for the metabolism of drugs and pharmaceuticals or are 
involved in the genetics of pain and analgesia (He et al. 2011; Madian et al. 2012; Mogil 
2012). The aim to discover human genes and their variants that affect response to drugs 
with an ultimate goal to devise novel personalized pharmacological treatment strategies 
(Madian et al. 2012). Genes of interest include glutathione S-transferases (GSTs) which 
encode enzymes that catalyze the detoxification of carcinogens, therapeutic chemicals 
and environmental toxins (Hayes et al. 2005); cytochrome P450 2D6 (CYP2D6) which is 
predominantly expressed in human liver and metabolizes over 25% of drugs currently 
used in the clinic (Zhou 2009), and opioid receptors (Hayashida et al. 2008), to mention 
some.  
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Neuropsychiatric and behavioral disorders 
Among the most multifactorial traits affected by CNVs is human behavior. A 
number of CNVs have been associated with psychiatric and neurological disorders, 
mental retardation, autism and obsessive-compulsive disorders (Zhang et al. 2009), and 
are althought to be part of the development of cognition (Lupski 2007a). About 9.5% of 
patients with schizophrenia, bipolar or cognitive disorders have chromosomal 
abnormalities (van Karnebeek et al. 2005) including X chromosome aneuploidy and 
rearrangement in chromosome 9 (Ponnudurai et al. 2012), micro deletion in chromosome 
22 (Vassos et al. 2010) or rearrangements in chromosomes 1, 15 and 16 (Stefansson et 
al. 2008). There are multiple studies about the role of CNVs in various autism spectrum 
disorders (Sanders et al. 2011; Krumm et al. 2013; Poultney et al. 2013). For example, of 
300 kb exonic deletion in neurexin 1 gene (NRXN1) in chromosome 2 is associated with 
autism in some families (Grayton et al. 2012; Walker and Scherer 2013; Tansey et al. 
2014), while duplications in chromosomes 2 (Barbosa-Goncalves et al. 2008; Lo-Castro 
et al. 2009; Shim et al. 2014), 17 (Curry et al. 2013) and 22 (Marchani et al. 2012), in 
others. Further, CNVs have been associated with hyperactivity and attention deficit 
disorders (Elia et al. 2012), and vaiants in chromosomes 1, 15 and 16 with epilepsy 
(Mefford et al. 2010; Vassos et al. 2010). 
 
Metabolic and cardiovascular disorders 
CNV research is rapidly expanding in the study of complex metabolic and 
cardiovascular disorders (Fanciulli et al. 2010; Lee and Scherer 2010). Copy number 
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changes in GATA4 and NODAL have been identified as candidate loci for congenital 
heart disease (Warburton et al. 2014). Like in neurodevelopmental disorders, multiple 
regions in the human genome are associated with obesity: a 45 kb deletion near neuronal 
growth regulator gene (NEGR1) (Speliotes et al. 2010); a 25 kb deletion upstream of 
GPRC5B gene; a CNV in chromosomes 10, 11 and 16 (Sha et al. 2009; Willer et al. 
2009; Walters et al. 2010; Jarick et al. 2011; D'Angelo and Koiffmann 2012). CNVs 
involved in developmental delay or intellectual disabilities are also associated with 
obesity. The examples are Prader-Willi syndrome and Smith-Magenis syndrome 
(D'Angelo and Koiffmann 2012). CNVs in alpha-defensin genes are strong risk factors 
both for obesity and type I diabetes (Choy et al. 2010; Khan et al. 2013). Finally, 
transgenic mouse model with an extra copy of obesity candidate gene, G protein β3 
(GNB3), implicates GNB3 duplication in a childhood obesity syndrome and obesity-
related syndromes, such as type 2 diabetes, cardiovascular diseases, hypertension, and 
cancer (Goldlust et al. 2013).  
 
CNVs involved in cancer 
 Cancer genomes are characterized by multiple forms of genome instability, 
including genetic and epigenetic alterations which cumulatively trigger oncogenic 
processes (Lupski 2013). The diverse genetic changes include also CNVs and have been 
characterized in many different forms of cancer: breast cancer (Stephens et al. 2009), 
chronic lymphocytic leukemia (Puente et al. 2011), colorectal cancer (Bass et al. 2011; 
Stephens et al. 2011), lung cancer (Campbell et al. 2008; Stephens et al. 2011), 
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melanoma (Pleasance et al. 2010), pancreatic cancer (Campbell et al. 2010), prostate 
cancer (Berger et al. 2011), renal cancer (Stephens et al. 2011) and thyroid cancer 
(Stephens et al. 2011), to list a few.  
 
Disorders of sexual development and reproduction 
A number of studies associate CNVs with human disorders of sexual 
development (DSD) and reproduction. This is a diverse group of complex disorders 
which include urogenital abnormalities, sex reversal, hypospadias, cryptorchidism 
(Smyk et al. 2007; Ledig et al. 2010b; Tannour-Louet et al. 2010; Li et al. 2011; 
Tuttelmann et al. 2011; White et al. 2011), premature ovarian failure (Aboura et al. 
2009; Quilter et al. 2010), and male subfertility (Carrell and Aston 2011). Several of 
these conditions are regulated by dosage-sensitive genes, thus being particularly 
responsive to the effect of CNVs (Conrad and Antonarakis 2007; Sharp 2009; Tian et al. 
2009; Quilter et al. 2010). Gonadal dysgenesis has been associated with gains or losses 
in regions with known sex determining genes, such as DMRT1, DAX1 and SOX9 
(Tannour-Louet et al. 2010), with a 35 kb deletion that completely removes NEIL2 gene 
in human chromosome 8p (Ledig et al. 2006; Ledig et al. 2010b), and with deletions in 
the short arm of human chromosome 9 affecting KANK1, DOCK8 and DMRT1 genes 
(Tuttelmann et al. 2011).  
Besides, the studies have identified novel CNV genes, such as FGFR2 and ZEB2 
that are potentially associated with some DSD phenotypes (Ledig et al. 2010b). DSD-
associated CNVs have been identified also in non-coding regions of the genome. It has 
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been postulated that these regions harbor unidentified genes and non-coding RNAs that 
might be involved in sexual development and gonadal functions (White et al. 2011). 
While Y chromosome deletions are long known causes of spermatogenic failure in men 
(Lahn and Page 1997; Rozen et al. 2012), copy number variants in autosomal regions 
have also been associated with sperm abnormalities (Tuttelmann et al. 2011). Also, X 
chromosome aberrations are more frequent in azoospermic males compared to males 
with normal sperm count. Deletions and duplications in chromosomes 3, 6 and 12 and 
have been found in patients with severe oligozoospermia and Sertoli-cell-only-
syndrome. These regions contain EPHA3, ANKS1A and ASNKS1B –genes that are 
expressed in Sertoli cells or germ cells (Tannour-Louet et al. 2010).  
In summary, the list of human clinical conditions that are associated or althought 
to be associated with CNVs is long and the corresponding literature overwhelming. 
Although the exact functions of CNVs in most complex diseases and disorders remain 
elusive (Weischenfeldt et al. 2013), studies in humans have encouraged and paved way 
for initiating similar research in domestic species. 
 
CNV research in domestic animals 
 
Microscopically visible large scale genome variations in domestic animals have 
been known for years through extensive cytogenetic analysis (Chowdhary and Raudsepp 
2000; Ducos et al. 2008; Raudsepp and Chowdhary 2010). Many of these variants 
caught attention because of relationship with infertility, abnormal sexual development or 
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congenital defects (Fechheimer 1971; Ducos et al. 2008). However, with the 
development of approaches to identify submicroscopic variations between genomes, it 
became clear that only a fraction of CNVs might be associated with diseases and 
congenital abnormalities, while the majority of CNVs are neutral or contribute to normal 
phenotypic variation between individuals, populations, and breeds (Liu et al. 2010). 
Studies of sub-microscopic structural variations in animal genomes started when 
genome draft sequences (Ensembl, http://uswest.ensembl.org/index.html) became 
available. This allowed the design of suitable probes for whole genome tiling arrays and 
SNP beadchips, both of which can be used for the detection of CNVs. It was equally 
important to have a reference genome as a common platform to compare CNV findings 
among individuals and populations. To date, CNV research is ongoing or initiated in all 
main domestic species: cattle, pig, horse, sheep, goat, dog, and chicken; although, no 
CNV studies have yet been conducted in alpacas, camels, and cats. The current status of 
CNV research in domestic species is summarized in Table 5 and described in more detail 
in the following sections. 
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Table 5:  A summary of CNV studies in domestic species. 
 
Species; # 
studies 
Genome 
coverage 
Platform Method Reference 
Horse 
5 
Exons and 
UTRs 
2X400K Tiling array, Agilent aCGH (Doan et al. 2012a) 
WG Illumina NGS (Doan et al. 2012b) 
WG SNP50 Beadchip, Illumina Genotyping (Dupuis et al. 2013) 
WG SNP50 Beadchip, Illumina Genotyping (Metzger et al. 2013a) 
WG 1.3M Tiling array, NimbleGen aCGH (Wang et al. 2014b) 
Cattle 
14 
WG 385K tiling Array, Nimblegen aCGH (Liu et al. 2008) 
WG SNP50 BeadChip, Illumina Genotyping (Matukumalli et al. 2009) 
WG SNP50 BeadChip, Illumina Genotyping (Bae et al. 2010) 
WG 6.3M tiling array, NimbleGen aCGH (Fadista et al. 2010) 
WG 385K  tiling Array, Nimblegen aCGH (Liu et al. 2010) 
WG SNP50 BeadChip, Illumina Genotyping (Hou et al. 2011) 
WG Paired end sequencing, Illumina; High-
Density SNP BeadChip and SNP50 
BeadChip, Illumina; 6.3M tiling array, 
NimbleGen 
NGS, 
Genotyping, 
aCGH 
(Zhan et al. 2011) 
WG SOLiD 3 (ABI); Bovine HD SNP 
Beadchip, Illumina 
NGS, 
Genotyping 
(Stothard et al. 2011) 
WG GAIIx, Illumina NGS (Bickhart et al. 2012) 
WG SNP50 BeadChip, Illumina Genotyping (Jiang et al. 2012) 
WG 385K tiling Array, Nimblegen aCGH (Hou et al. 2012a) 
WG Applied Biosystems SOLiD System NGS (Choi et al. 2013) 
WG High-Density SNP BeadChip, Illumina Genotyping (Jiang et al. 2013) 
WG SNP50 BeadChip, Illumina Genotyping (Cicconardi et al. 2013) 
WG Illumina, Hiseq 2000 NGS (Shin et al. 2014) 
Pig 
11 
WG 385K tiling Array, Nimblegen aCGH (Fadista et al. 2008) 
WG SNP60 BeadChip, Illumina Genotyping (Ramayo-Caldas et al. 2010) 
WG SNP60 BeadChip, Illumina Genotyping (Chen et al. 2012) 
WG 3 × 720K tiling array, Nimblegen aCGH (Li et al. 2012) 
WG SNP60 BeadChip, Illumina Genotyping (Wang et al. 2012) 
WG Infinium II Multisample assay, Illumina  Genotyping (Wang et al. 2013a) 
WG SNP60 BeadChip, Illumina Genotyping (Wang et al. 2013b) 
WG SNP60 BeadChip, Illumina Genotyping (Fowler et al. 2013) 
WG HiSeq, Illumina NGS (Paudel et al. 2013) 
WG 2.1M tiling array, NimbleGen   aCGH (Wang et al. 2014a) 
WG SNP60 BeadChip, Illumina Genotyping (Fernandez et al. 2014) 
Dog 
8 
WG 385K  tiling array, Nimblegen aCGH (Chen et al. 2009) 
WG 2.1M tiling array, NimbleGen aCGH (Nicholas et al. 2009) 
WG HD BeadChip assay, Illumina Genotyping (Alvarez and Akey 2012) 
WG 2.1M array, NimbleGen aCGH (Berglund et al. 2012) 
WG v2 SNP Chip, Affymetrix Genotyping (Karyadi et al. 2013) 
WG 720K tiling array, NimbleGen Genotyping (Jung et al. 2013) 
WG HD BeadChip, Illumina Genotyping (Gurgul et al. 2014) 
WG HD Genotyping array Genotyping (Molin et al. 2014) 
Sheep 
2 
WG *Bovine 385K tiling Array, Nimblegen aCGH (Fontanesi et al. 2010a) 
WG SNP50 BeadChip array, Illumina Genotyping (Liu et al. 2013) 
Goat 
1 
WG *Bovine 385K tiling Array, Nimblegen aCGH (Fontanesi et al. 2010b) 
Chicken 
8 
WG 385K tiling Array, Nimblegen aCGH (Griffin et al. 2008) 
 WG 385K tiling Array, Nimblegen aCGH (Skinner et al. 2009) 
 WG 385K tiling Array, Nimblegen aCGH (Volker et al. 2010) 
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Table 5 continued. 
Species; # 
studies 
Genome 
coverage 
Platform Method Reference 
Chicken WG 385K tiling Array, Nimblegen aCGH (Wang et al. 2010) 
WG 60K SNP BeadChip, Illumina Genotyping (Jia et al. 2012) 
WG 4×180K tiling array, Agilent aCGH (Abe et al. 2013) 
WG 244K tiling array, Agilent aCGH (Crooijmans et al. 2013) 
WG 385K tiling Array, Nimblegen aCGH (Skinner et al. 2014) 
* The array platforms used for CNV discovery in different species were species-specific, with the exception of sheep 
and goat where bovine arrays were used. 
 
 
CNV research in the canine genome 
Dog is an important model species for biomedical research. This is probably why 
the first WG CNV studies in animals were carried out in dogs using a large insert clone 
(BAC) array to detect CNVs associated with canine cancers (Thomas et al. 2008). 
Thereafter, two studies used NimbleGen high-resolution ~380K custom tiling arrays to 
demonstrate that segmental duplications encompass about 4.21% of the canine genome 
and that many are breed or breed class specific (Chen et al. 2009; Nicholas et al. 2009). 
Interestingly, genomic imbalances in canine transmissible venereal tumors involve 
CNVs in centromeric and telomeric sequences (Chen et al. 2009), thus underscoring that 
genomic imbalances leading to disease are not necessarily located in genes. Prevalence 
of breed-specific CNVs in dogs has also been shown by two recent studies, one using a 
2.1 M NimbleGen canFam2 WG CGH array (Berglund et al. 2012), and another, a 
CanineHD 170 K SNP array (Molin et al. 2014). The latter analyzed 359 dogs from 30 
different breeds and with very stringent criteria identified 72 CNVRs of which 60% 
overlapped with previously reported CNVs in dogs. Notably, 15 CNVRs were defined as 
strictly breed specific among 12 different breeds. Altogether, over 400 CNV regions 
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have been found in the dog genome (Berglund et al. 2012; Molin et al. 2014)  and like in 
humans, many canine CNVs are related to phenotypic traits and diseases (Chen et al. 
2009; Molin et al. 2014).  
 
CNV research in the cattle genome  
Among domestic mammals, the cattle genome is probably the most extensively 
studied for CNVs. Since 2009, at least 14 studies report about WG CNV analysis in the 
cattle genome using array CGH, SNP beadchip genotyping, or NGS platforms (Table 5).  
The first CNV study in cattle was published in 2008, involved 3 animals and 
identified 25 CNVs (Liu et al. 2008). A year later, using bovine SNP50 Beadchip, 79 
deletion variants were detected in 556 animals of various breeds (Matukumalli et al. 
2009). However, the first systematic genome-wide CNV analysis using 385K Nimblegen 
array was reported by Liu and colleagues in 2010. The study included 90 animals 
representing taurine, indicine, and mixed breeds. Over 200 CNVs, covering 1.07% of 
cattle genome, were identified, whereas there were more CNVs in indicine breeds than 
in taurine breeds. These CNVs involved 400 annotated cattle genes and were 
significantly enriched with genes with functions in immunity, lactation, reproduction, 
and rumination. A strong association was observed between CNVs and evolutionary 
breakpoint regions (EBRs), whereas ~20% of cattle specific and ~52% of artiodactyl-
specific EBRs were significantly enriched with CNVs (Liu et al. 2010). This was a 
pioneering CNV study in cattle and domestic animals and established a foundation for 
further research. In the same year, Fadista and colleagues (2010) identified 304 CNVs in 
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20 animals of 4 breeds. Majority of CNV genes were involved in environmental 
response or were associated with human orthologs for known diseases and disorders. 
Importantly, over 50% of cattle CNVs have been associated with segmental duplications 
which are well known hotspots for CNV formation (Fadista et al. 2010; Liu et al. 2010).  
The most comprehensive information about CNVs in the cattle genome has been 
obtained by NGS. Bickhart and colleagues (2012) used WG sequence data for 5 taurine 
and one indicine cattle and identified 1265 CNVs of which 476 were novel. 
Interestingly, Nellore cattle showed copy number gain in genes responsible for pathogen 
and parasite resistance, while genes involved in lipid transport and metabolism were 
duplicated in taurine breeds of beef cattle (Bickhart et al. 2012). Thereafter, many more 
CNV studies have been conducted in different cattle breeds and populations from 
different parts of the World (Hou et al. 2012a; Jiang et al. 2012; Choi et al. 2013; 
Cicconardi et al. 2013; Jiang et al. 2013). Despite differences in methodology and 
animal cohorts, all studies agree that the bovine genome has hundreds of CNVs, many of 
which span known protein coding genes with functions in immune response and defense, 
sensory perception, reproduction, rumination and lactation. Interestingly, the absence of 
CNVs in housekeeping genes is thought to be an indication of strong refining selection 
(Liu and Bickhart 2012). 
 
CNV research in sheep and goat genomes  
CNV research in sheep and goat were initiated by cross-species hybridization to 
bovine WG 385K array (Fontanesi et al. 2010a; Fontanesi et al. 2010b). Analysis of 9 
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goats of 4 breeds identified 127 CNVs, while in 11 sheep of 6 breeds 135 CNVs were 
detected. Importantly, goat and sheep CNVs significantly overlapped with those 
previously known for cattle, suggesting that several chromosome regions might contain 
recurrent interspecies CNVs. Like in other mammals, goat and sheep CNVs affected 
genes with functions in immunity and disease resistance, environmental response, but 
also genes involved in lipid metabolism and behavior (Fontanesi et al. 2010a; Fontanesi 
et al. 2010b). More recently, an ovine SNP50 BeadChip was constructed and used for 
CNV analysis in 329 animals of 3 different sheep breeds (Liu et al. 2013). A total of 238 
CNVs were identified covering 2.27% of the sheep genome. Gene Ontology analysis 
showed significant relationship of CNVs with olfactory receptors, G-protein coupled 
receptor protein signaling pathway, signal transduction, and plasma membrane 
components (Liu et al. 2013). 
 
CNV research in the porcine genome  
The first snapshot of copy number variation in the pig genome was obtained by 
CGH analysis of 12 Duroc boars and one unrelated Hampshire boar on a custom made 
oligoarray for pig chromosomes 4, 7, 14 and 17 (Fadista et al. 2008). The authors 
identified 37 CNVRs of which some overlapped with known segmental duplications. 
This initial study has by now been followed by 10 WG CNV analyses in a variety of pig 
breeds and populations using CGH platforms, SNP Beadchip and NGS (Table 5). 
Studies relying on array based platforms, such as SNP60 BeadChip (Chen et al. 2012) or 
720K NimbleGen WG tiling array (Li et al. 2012), have identified hundreds of CNVs in 
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the porcine genome. In contrast, the recent NGS analysis of 16 animals from Europe and 
Asia, including wild boars, revealed over 3000 CNVs, 545 of which involved genes 
(Paudel et al. 2013). However, the large number of intergenic CNVs in the pig genome 
implies that the majority of variants are likely neutral. Observation that there are more 
CNVs in large porcine populations suggests that like SNPs and microsatellites, the 
CNVs reflect demographic history rather than phenotypic diversity (Paudel et al. 2013). 
Nevertheless, GO analysis of CNV genes indicates that, like in other species studied so 
far, copy number variable genes are related to sensory perception, various adaptations, 
and behavioral changes during domestication and, specific for pigs, to omnivorous 
lifestyle. A small number of CNVs are uniquely present in domestic pigs proposing their 
selection during domestication (Paudel et al. 2013). 
 
CNV research in avian genomes  
CNVs have been studied in several economically important poultry species, such 
as chicken (Table 5), turkey (Griffin et al. 2008), and Pekin duck (Skinner et al. 2009), 
and model species, like zebra finch (Volker et al. 2010). Very recently, CNV analysis 
was conducted in key avian clades including Galliformes, Anseriformes, Passeriformes, 
Gruiformes and Falconiformes (Skinner et al. 2014). The methodology involved a 
chicken WG 385 K tiling array (NimbleGen) and cross-species array CGH with the 
genomic DNA from 16 different species. The results, for the first time provide a global 
overview of the patterns of CNVs in birds. While avian genomes are approximately one 
third the size of a typical mammalian genome, the size and abundance of CNVs is 
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similar to that of mammals. Although, it is possible that in avian genomes there is 
slightly higher association between genes and CNVs than it is in mammals. Also, as the 
CNVs have an equal range of sizes across chromosomes, the proportion of a 
microchromosome affected by CNVs is greater than the comparable proportion of a 
macrochromosome. This explains why bird genomes are enriched with genic CNVs 
because about two thirds of avian genes are located in microchromosomes. Gene 
ontology analysis shows that, like in mammals, avian CNVs are predominantly 
associated with immune response and antigen presentation genes. Probably the most 
interesting finding was that 62% of all CNVRs were unique to individual species. For 
example, CNVs were associated with muscle activity and speed in falcons, migratory 
behavior in quails, brain development, and neuronal functions in turkey, and immune 
functions in the common quail and silver pheasant. Overall, this is the first broad survey 
of CNVs in avian species and establishes an important foundation for future research.  
 
Summary of CNV research in domestic species 
Taken together, CNV research in domestic species is rapidly gaining momentum 
and the attention of researchers worldwide. Recent methodological advances, such as 
high resolution array platforms and NGS, have essentially refined the existing data and 
facilitated the discovery of new CNVs. Despite this, the current research is restricted to 
the description of the genomic landscape and functional categories of CNVs in different 
species. At the same time, the discovery of variants that are associated with complex 
traits and disorders of biological and economic interest is, as yet, at a very initial stage. 
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Present status of CNV research in the horse 
 
Initial knowledge about the involvement of CNVs in equine biology dates back 
to 1970s when cytogenetic studies revealed that several developmental and reproductive 
disorders in horses are caused by chromosomal aneuploidies – gains or losses of whole 
chromosomes (Chowdhary and Raudsepp 2000). Here the best known are various sex 
chromosome aneuploidies (63,XO; 65,XXX; 65,XXY) and autosomal trisomies. 
Thereafter, gene mapping revealed traits and conditions that are caused by smaller CNVs 
in genes or genomic regions. For example, a 4.6-kb duplication in intron 6 of STX17 
(syntaxin-17) in ECA25 causes gray coat color (Swinburne et al. 2002; Rosengren 
Pielberg et al. 2008; Sundstrom et al. 2012); deletions in the male specific region of the 
Y (MSY) chromosome that involve the SRY gene, cause some forms of Y-linked male-
to-female sex reversal syndrome (Raudsepp et al. 2010); or duplication of the Y 
chromosome via the formation of a Y isochromosome causes abnormal sexual 
development (Das et al. 2012). However, genome-wide CNV research in horses started 
only after the horse whole genome draft assembly became available (Wade et al. 2009). 
The genome sequence showed that the horse genome is relatively poor for segmental 
duplications – genomic regions that have been frequently associated with CNVs in other 
species (Hastings et al. 2009; Stankiewicz and Lupski 2010; Bickhart et al. 2012; Du et 
al. 2012).  Segmental duplications make up only about 0.5% of the equine genome and 
are most abundant in ECA25 (Wade et al. 2009). 
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The first systematic CNV research in horses was conducted by array CGH using 
a custom-made tiling array which specifically targeted gene exons (Doan et al. 2012a). 
The study involved 16 horses of 15 different breeds and a donkey as an out group. 
Altogether, 775 CNVRs involving 1707 protein- and RNA-coding genes were identified, 
whereas 96.4% of genes in CNVs were protein coding. Functional categories of CNV 
genes included sensory perception, signal transduction, metabolism, regulating blood 
group antigens, fecundity, coat color, keratin formation, neuronal homeostasis, lactation, 
and height.  
This work was followed by the discovery of 282 CNVRs in the genome of a 
Quarter Horse mare by NGS (Doan et al. 2012b). Among the 282 CNVRs, 192 involved 
genes and 90 were located in intergenic regions. Similarly to CNV studies in other 
mammals (see above) and the previous study in horses (Doan et al. 2012a), most of the 
CNVs were enriched with genes involved in sensory perception, signal transduction, and 
immunity and defense pathways. 
Besides the contribution to the CNV research in horses, this was the second 
published horse WG sequence and the first genomic sequence of a Quarter Horse. The 
identified SNPs, INDELs and CNVs are a resource for future studies of genetic variation 
in horses (Doan et al. 2012b). 
The primary goal of the third CNV study in horses was to identify variants 
associated with recurrent laryngeal neuropathy (RLN), an important equine upper airway 
disease compromising performance (Dupuis et al. 2013). This genome-wide CNV study 
used genotyping on the Illumina Equine SNP50 BeadChip and involved 477 horses of 
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diverse breeds. The authors identified 2797 CNVs corresponding to 478 CNVRs. Of 
these, 67 common CNVRs were tested for association with RLN but no significant 
associations were found. Nevertheless, duplication in ECA10 was detected in 10 cases of 
3 breeds, but in none of the controls. Functional significance of this finding regarding 
RLN, however, remained unclear and requires further studies. 
The primary focus of the study by Metzger and colleagues (2013) was to 
compare the efficiency of different bioinformatics approaches and algorithms 
(CNVPartition, PennCNV and QuantiSNP) for CNV detection. The authors used the 
Illumina Equine SNP50 BeadChip and analyzed 717 horses of 17 breeds, the latter 
representing mainly various Thoroughbred-based European warmblood horses. 
Collectively, the three algorithms identified 50 common CNVs associated with 153 
genes. Like in earlier studies (Doan et al. 2012a; Doan et al. 2012b; Dupuis et al. 2013), 
the prevailing GO terms for CNV genes were sensory perception, signal transduction, 
and cellular components. Additionally, the authors carried out GWAS and identified 
significant losses in ECA1, 8, and 9 that could be related to body size in horses. Notably, 
homeologous regions to these CNVs in HSA1 and HSA9 have been associated with 
height in humans (Dauber et al. 2011). 
The most recent study analyzed CNVs in the genomes of indigenous Chinese 
horses using a custom made NimbleGen WG tiling array (Wang et al. 2014b). The array 
comprised 1,402,459 probes with 1.6 kb average distance between the probes. The 
horses were from five Chinese breeds: Mongolian, Abaga, Hequ, and Kazakh horses 
from the plateau, and the Debao horse from plains. The Thoroughbred was the reference.  
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A total of 353 CNVRs were identified across all autosomes. The size of CNVRs 
ranged from 6.1 kb to 1.45 Mb. The most interesting finding was the discovery of CNVs 
in 7 heme binding genes: CYP4A11, CYP4X1, EIF2AK1, CYP2C18, CYP4F22, NOS2, 
CYP4B1. These CNVs were present mainly in the Hequ horse and in some other plateau 
breeds but not in the plain horses. The authors theorize that CNVs in heme binding 
genes might be related to the adaption to the severe environment of the plateau. 
In summary, while the 5 above described studies set an important foundation for 
CNV research in horses, the current information is not adequate for efficient discovery 
of variants affecting equine health and disorders. This is because the studies have used 
different CNV discovery platforms, the number of breeds and individuals is very limited, 
and the majority of CNVs have not been validated by multiple independent studies. 
Also, the available information has not been integrated to facilitate the analysis of 
known and the discovery of new CNVs in the horse. 
 
Prospective equine complex traits for CNV research 
 
Growing knowledge about the association of CNVs with human complex traits 
(see section: “Phenotypes, genetic disease and disorders associated with CNVs”) 
justifies and guides the launch of similar research in the horse. As follows is an overview 
about biomedically and economically important equine traits that have a complex and 
likely polygenic genetic component, and share similarity with human conditions 
associated with CNVs. 
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Recurrent Airway Obstruction (RAO) 
 
Recurrent airway obstruction (RAO) or heaves is a common, lifelong, 
inflammatory disease of respiratory airways which predominantly affects middle-aged 
and older horses worldwide (Buechner-Maxwell et al. 1994; Robinson 2001). 
 
Characterization of RAO phenotype  
RAO is characterized by coughing and increased breathing effort due to 
cholinergic bronchospasm, and neutrophil and mucus accumulation in the airways as a 
result of hypersensitivity reactions to various inhaled allergens, in particular fungal 
spores (Art et al. 1999; Robinson 2001). Among the clinical symptoms are nasal 
discharge, flaring of the nostrils, labored expiratory effort, and abnormal respiratory 
sounds such as crackles and wheezes. Severely affected horses typically have higher 
neutrophil number in tracheobronchial secretion (TBS) and bronchoalveolar fluid 
(BALF), as well as airway hyper-responsiveness. Additionally, they may exhibit 
anorexia, weight loss, and dyspnea or shortness of breath (Armstrong et al. 1986; 
Robinson et al. 1996). As inflammation and obstruction lead to respiratory distress and 
exercise intolerance, the disease has a devastating impact on equine health and welfare, 
as well as to the economy of the equine industry. This is why American Association of 
Equine Practitioners has ranked RAO and other respiratory ailments as the second 
highest priority disorders (after laminitis) requiring research. 
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The phenotype of RAO can be determined by a standardized questionnaire or by 
detailed clinical tests. The questionnaire gathers information about the horse’s history of 
chronic coughing and includes data about gender, age, and signs of respiratory disease, 
i.e., coughing, nasal discharge, type of breathing and performance. Also, there are 
detailed questions on management and feeding, time spent outdoors, de-worming 
strategies and specific compounds, as well as other diseases and the use of the horse. 
This information is combined into a Horse Owner Assessed Respiratory Signs Index 
(HOARSI) (Ramseyer et al. 2007; Laumen et al. 2010). The HOARSI index scores from 
1 to 4 where HOARSI 1 denotes unaffected normal horses; HOARSI 2 denotes 
individuals with ambiguous phenotype, while HOARSI 3 and HOARSI 4 denote clearly 
RAO-affected horses (Laumen et al. 2010). However, the most accurate way for 
determining RAO phenotype is to document the pathophysiological changes by 
conducting a full clinical exam (Gerber et al. 2003; Gerber et al. 2004). This includes 
records on the respiratory and heart rate, coughing or nasal discharge, rectal temperature, 
the submandibular lymph nodes, the sensitivity of the pharynx/larynx area and the 
coughing reflex. The clinical test also involves estimation of lung functions by FOM 
(forced oscillation mechanics) (Ryhner et al. 2008), scoring of mucus accumulation by 
endoscopy (Gerber et al. 2004), and cytological analysis of tracheo-bronchial secretion 
(TBS) and bronchio-alveolar lavage fluid (BALF) by haemocytometer and light 
microscopy (Gerber et al. 2004; Ryhner et al. 2008). 
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Etiology of RAO  
RAO is a complex disease as both environmental and genetic factors are 
involved. While the environmental causes of RAO are established, little is known about 
the intrinsic factors and mechanisms in equine body that lead to RAO. The presence of a 
polygenic genetic component in equine RAO was postulated over 70 years ago 
(Schaeper 1939). More recent studies agree with this and suggest a complex inheritance 
mode (Schaeper 1939; Gerber et al. 2009). RAO has been studied using a combination 
of genomics approaches, such as microsatellite- and SNP-based GWAS (Swinburne et 
al. 2009; Shakhsi-Niaei et al. 2010; Klukowska-Rotzler et al. 2012a; Shakhsi-Niaei et al. 
2012) and candidate gene and WG gene expression profiling (Kachroo et al. 2010; 
Venugopal et al. 2010; Cote et al. 2012; Klukowska-Rotzler et al. 2012b; Lanz et al. 
2013). In one study pathways analysis of candidate genes was combined with proteomic 
data from bronchoalveolar lavage fluid of affected and control horses (Racine et al. 
2011). While the findings provide some insight into the multi-genic and complex nature 
of the condition and show the likely involvement of interleukins and other innate 
immunity related genes (Swinburne et al. 2009; Shakhsi-Niaei et al. 2010; Klukowska-
Rotzler et al. 2012b; Shakhsi-Niaei et al. 2012), little is known about the genetic 
predisposition of horses to RAO, and molecular genetic mechanisms modulating 
pathogenesis of the disease. 
Several studies have been conducted for the search of candidate genes and/or 
genomic regions responsible for RAO. Mucin glycoprotein alteration and mucus 
accumulation during RAO suggests elevated expression of mucin genes in affected 
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horses. Expression analysis of MUC5AC and MUC2 showed upregulation of MUC5AC, 
while no relation between MUC2 and RAO was detected (Gerber et al. 2003). Later it 
was shown that the observed upregulation of MUC5AC and several other genes is not 
related to mucus formation in RAO affected horses (Ryhner et al. 2008). The complex 
genetic nature of RAO is further illustrated by a microsatellite analysis in two Swiss 
Warmblood horse families, where association between interleukin 4 alpha receptor 
(IL4RA) gene in ECA13 was found in one family but not in the other (Jost et al. 2007). 
Additional studies of the genetic mode of RAO inheritance in the two Swiss Warmblood 
families confirmed that in one family the condition is associated with a 20 kb 
quantitative trait locus (QTL) in ECA13 and inherited in an autosomal recessive mode 
(Swinburne et al. 2009), whereas in the other family, RAO is associated with ECA15 
and inherited in an autosomal dominant mode (Gerber et al. 2009; Swinburne et al. 
2009). At the same time, RAO phenotypes in the two families in the HOARSI scale 
(Laumen et al. 2010) were very similar, indicating genetic heterogeneity of the 
phenotype. Several follow-up studies confirm that the IL4R gene which regulates IgE 
production and stimulates Th2-cells (Lebman and Coffman 1988) is associated with 
RAO in some horse families (Klukowska-Rotzler et al. 2012b). However, no genetic 
variation has been found in the coding region of the gene and it is althought that 
probably the association is due to a variant in the non-coding regulatory region of IL4R 
(Shakhsi-Niaei et al. 2012). The QTL in ECA13 has also been analyzed for other 
candidate genes among which ITGAX caught attention because of its role in immune-
complex mediated hypersensitivity. However, no association between RAO and ITGAX 
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was found (Shakhsi-Niaei et al. 2010). Overall, while these studies have identified some 
genes and genomic regions associated with RAO, the complex genetics of predisposition 
and pathogenesis of RAO remain elusive.  
 
RAO and human asthma  
Many of the clinical symptoms observed in RAO are strikingly similar with those 
of human asthma (Zhang et al. 2008; Swinburne et al. 2009). Similarities are also in the 
genetics of the two conditions: both conditions show variable expression and genetic 
heterogeneity across populations, and the genetic factors underlying RAO and asthma 
remain elusive. However, while just a few candidate genes have been proposed for RAO 
(Jost et al. 2007; Shakhsi-Niaei et al. 2012), there are hundreds of candidate genes for 
asthma (Rogers et al. 2013). Both disorders involve immune system genes, such as 
interleukins IL-4 and IL-5, and interferon-gamma (IFN-γ) elevated levels of which have 
been observed in RAO and asthma (Lavoie et al. 2001; Lavoie-Lamoureux et al. 2010). 
However, compared to humans, the population structure of many horse breeds is better 
suited for identifying genotypes associated with RAO. Therefore, equine RAO may 
prove to be a good animal model for human asthma. Furthermore, RAO represents the 
only natural model of asthma (Swinburne et al. 2009; Scharrenberg et al. 2010) besides 
feline asthma, and has been investigated much more intensively than the latter (Snapper 
1986; Anton et al. 2005). 
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RAO and CNVs  
In humans, a large proportion of the established disease-related CNVs are 
associated with immune system disorders including asthma (Walsh et al. 2010; Lee et al. 
2011; Rogers et al. 2013). Among these associations, one of the best characterized is an 
association of a common deletion in GSTM1 gene with asthma and airflow obstruction 
(Rogers et al. 2009; Rogers et al. 2013). Likely involvement of CNVs in asthma is 
further supported by a recent study where 58 genes (21%) out of 270 candidate genes for 
asthma were located within or near a CNV (Rogers et al. 2013). The similarity of equine 
RAO with human asthma (Swinburne et al. 2009) and evidence of the association of 
human asthma with CNVs, strongly justifies the initiation of research aimed at 
identifying CNVs potentially associated with RAO. 
 
Disorders of Sexual Development (DSDs) and reproduction 
 
Disorders of sexual development and reproduction include a broad variety of 
complex conditions that affect sex determination, sexual differentiation, the development 
and function of gonads, and fertility (Wilhelm et al. 2007). The latter has a direct bearing 
on reproduction and production and is therefore an economically important trait. In 
contrast to the importance of the problem, very little is known about the genetic 
component of DSDs in horses or other species. This is largely because sexual 
development and reproduction are regulated by almost 20% of the genes (~5000) in the 
mammalian genome (Hargreave 2000; Matzuk and Lamb 2002; Carrell 2007; Krausz 
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and Giachini 2007) which function in complex spatio-temporally regulated gene 
networks. Difficulties are also encountered in precise clinical characterization of DSDs 
phenotypes and the collection of research samples (Blanchard et al. 2000; Turner and 
Casas-Dolz 2002).  
 
Mammalian sex determination and disorders of sexual development  
In the 1950s, human studies in females with Turner syndrome (45,XO) and males 
with Klinefelter’s syndrome (47,XXY) established that the Y chromosome determined 
maleness (Jacobs and Strong 1959). The search for the testis-determining factor (TDF) 
on the Y chromosome lasted for several decades with numerous candidate genes being 
studied and discounted (Silvers and Wachtel 1975; Page et al. 1987) until the early 
1990s when the sex determining region on the Y chromosome (SRY) was identified as 
the necessary and sufficient locus for male sex determination (Gubbay et al. 1990; 
Sinclair et al. 1990; Koopman et al. 1991). Subsequent research on the SRY identified 
several other genes involved in mammalian sex determination, including SRY-box 9 
protein (SOX9) (Morais da Silva et al. 1996), steroidogenic factor (SF1) (Parker et al. 
2002), fibroblast growth factor (FGF9) (Schmahl et al. 2004), and many others 
(Marshall Graves 2008; Sekido and Lovell-Badge 2008).  
Furthermore, recent studies have identified genes (RSPO1, WNT4, β-catenin) 
(Figure 2) necessary for the molecular pathways in female sex determination and ovarian 
differentiation (Chassot et al. 2008; Sekido and Lovell-Badge 2009) . Until then it was 
thought that while SRY initiates the male differentiation pathway, female development 
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happens as a default in the absence of the Y chromosome and SRY, and does not require 
specific genetic triggers. Despite these achievements, the overall knowledge about the 
complex genetic mechanisms underlying sex determination and sexual differentiation 
beyond the role of SRY in mammals is limited due to many contributing genes and 
pathways.  
Disruption of the many genes and genetic pathways that regulate sexual 
development can cause DSDs at many different levels. For example, disruption of the 
very early steps of sex determination at the stage of a bi-potential gonad can result in 
abnormal gonadal development in both sexes (Marshall Graves 2008; Sekido and 
Lovell-Badge 2009) (Figure 2). 
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Figure 2: The molecular and genetic events in mammalian sex determination.  
The bipotential genital ridge is established by genes including Sf1 and Wt1, the early 
expression of which might also initiate that of Sox9 in both sexes. β-catenin can begin to 
accumulate as a response to Rspo1–Wnt4 signaling at this stage. In XX supporting cell 
precursors, β-catenin levels could accumulate sufficiently to repress SOX9 activity, 
either through direct protein interactions leading to mutual destruction, as seen during 
cartilage development (Akiyama et al. 2004), or by a direct effect on Sox9 transcription. 
However, in XY supporting cell precursors, increasing levels of SF1 activate Sry 
expression and then SRY, together with SF1, boosts Sox9 expression. Once SOX9 levels 
reach a critical threshold, several positive regulatory loops are initiated, including 
autoregulation of its own expression and formation of feed-forward loops via FGF9 or 
PGD2 signaling. If SRY activity is weak, low or late, it fails to boost Sox9 expression 
before β-catenin levels accumulate sufficiently to shut it down. At later stages, FOXL2 
increases, which might help, perhaps in concert with ERs, to maintain granulosa 
(follicle) cell differentiation by repressing Sox9 expression. In the testis, SOX9 promotes 
the testis pathway, including Amh activation, and it also probably represses ovarian 
genes, including Wnt4 and Foxl2. However, any mechanism that increases Sox9 
expression sufficiently will trigger Sertoli cell development, even in the absence of SRY 
(Sekido and Lovell-Badge 2009). 
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Later on, disruption of genes involved in steroid hormone metabolism by the 
developing gonads, can affect sexual differentiation, gonadal maturation and the 
development of secondary sexual characteristics, such as sex specific behavior and 
external sexual phenotypes - the presence of penis and descended testes in males, and 
vulva and vagina in females (Auchus 2004; Hughes 2008; Fluck et al. 2011; Biason-
Lauber et al. 2013) (Figure 3). Many forms of DSDs manifest as discrepancies between 
the genetic sex (sex chromosomes), gonadal sex (testes or ovaries), and phenotypic sex. 
In literature, the resulting phenotypes appear under terms like intersexuality, gonadal 
dysgenesis, pseudohermaphroditism, testicular feminization, true hermaphroditism, and 
sex reversal syndromes (Howden 2004; Villagomez et al. 2011; Lear and McGee 2012), 
depending on at which levels (genetic, gonadal, phenotypic) sexual characteristics are 
altered or observed. 
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Figure 3: Synthesis of dihydrotestosterone via the classic and alternative pathways. 
The classic pathway of steroidogenesis leading to dihydrotestosterone is shown on the 
left, and the alternative pathway is shown on the right. The factors in the classic pathway 
are CYP11A1 (cholesterol side-chain cleavage enzyme, P450scc), StAR (steroidogenic 
acute regulatory protein), CYP17A1 (17α-hydroxylase/17,20-lyase, P450c17), HSD3B2 
(3β-hydroxysteroid dehydrogenase, type 2), HSD17B3 (17β-HSD3 [17β-hydroxysteroid 
dehydrogenase, type 3] and 5α-reductase, type 2 [5a-reductase 2, encoded by SRD5A2]). 
The alternative pathway is characterized by the presence of additional enzymes: 5α-
reductase, type 1 (5a-reductase 1, encoded by SRD5A1), AKR1C2 3 (3α-reductase, type 
3) and possibly AKR1C4 (3α-reductase, type 1) and RoDH (3-hydroxyepimerase, 
encoded by HSD17B6). Most steroids are identified by their trivial names; 17-hydroxy-
dihydroprogesterone (17OH-DHP) is 5α-pregnane-17α-ol-3,20-dione; 17-hydroxy-
allopregnanolone (17OH-allo) is 5α-pregnan-3α,17α-diol-20-one; 5α-
dihydroprogesterone (5α-DHP) is 5α-pregnane-3,20-dione, and allopregnanolone is 3α-
hydroxy-dihydroprogesterone (3α-OH-DHP) or 5α-pregnane-3α-ol-20-one (Fluck et al. 
2011). 
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Sex reversal syndromes  
Sex reversal is a situation where the genetic sex (the karyotype, sex 
chromosomes) disagrees with the gonadal and/or the phenotypic sex. The affected 
individuals are sterile with various degrees of abnormalities in sexual development. 
Cases of both male-to-female and female-to-male sex reversal have been reported and 
studied in mice, human and most of the domestic species (Vaiman and Pailhoux 2000; 
Villagomez et al. 2009; Jimenez et al. 2013) including the horse (Kent et al. 1986; 
Raudsepp et al. 2010; Pujar and Meyers-Wallen 2012; Jimenez et al. 2013). In horses, 
sex reversal syndrome is of particular concern because it not only negatively affects 
fertility but might raise issues regarding high-performance horses. For example, recently 
two elite Standardbred trotters with questionable sexual identity were disqualified from 
races in the female category and made headlines in New York Times (Finely 2009) and 
Horse.com (Lear and McGee 2012).  
In horses, the male-to-female sex reversal where phenotypic mares or mare-like 
individuals have 64,XY karyotype is probably the only true sex reversal condition 
(Raudsepp et al. 2010). A reversed situation where phenotypic males have normal 
female karyotype, as it has been described in humans (Zenteno-Ruiz et al. 2001), is 
probably not existing in horses. So far, all cases reported as equine 64,XX sex reversal, 
actually categorize as cases of intersex, hermaphroditism or male 
pseudohermaphroditism (Milliken et al. 1995; Meyers-Wallen et al. 1997; Buoen et al. 
2000; Chowdhary and Raudsepp 2000; Vaughan et al. 2001; Bannasch et al. 2007; 
Villagomez et al. 2009; Raudsepp et al. 2013). Chromosomes of these animals are 
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normal, and very little is known regarding molecular causes of 64,XX conditions in 
horses (Pujar and Meyers-Wallen 2012). Although, mutations in several genes, such as 
SOX3, SOX9, RSPO1, PISRT1, FOXL2, WNT4 have been reported for XX female-to-
male sex reversal syndromes in other species (Pujar and Meyers-Wallen 2012). 
Slightly more is known about the equine 64,XY sex reversal syndrome. This is 
probably because it is the second most frequent sex chromosome abnormality after X 
chromosome monosomy (Das et al. 2012) and accounts for approximately 12-30% of all 
cytogenetic abnormalities in horses (Power 1986; Bowling et al. 1987; Lear and Bailey 
2008; Raudsepp et al. 2010). The affected individuals are described as mares with the 
karyotype of a stallion (64,XY). Phenotypes of such animals range from feminine to 
highly-masculinized mares. The “feminine”-type animals have normal female external 
genitalia and no somatic or behavioral abnormalities (Kent et al. 1986; Power 1986; 
Bowling et al. 1987). The “masculine”-type animals are often categorized as male 
pseudohermaphrodites, showing stallion behavior and having abnormal genital tracts and 
gonads (Kent et al. 1986; Bowling et al. 1987; Kent et al. 1988; Howden 2004; 
Raudsepp et al. 2010; Villagomez et al. 2011). All described cases have been infertile 
except one that produced a normal 64,XX filly (Sharp et al. 1980). With regards the Y 
chromosome, the equine 64,XY sex reversal has two forms: the SRY-negative and the 
SRY-positive forms. Recent studies showed that the SRY-negative form is typically 
caused by various deletions on the Y chromosome, all of which include the SRY gene 
(Raudsepp et al. 2010). In contrast, the SRY-positive condition is likely genetically 
heterogeneous and involves multiple genes (Switonski et al. 2005; Raudsepp et al. 2010; 
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Lear and McGee 2012; Pujar and Meyers-Wallen 2012). In one Friesian 64,XY SRY-
positive horse with hypospadias a missense mutation was found in MAMLD1 gene, 
although without clear causative relationship to the sex reversal condition (De Lorenzi et 
al. 2010); in one Quarter Horse family, a c.1A>G mutation was found in the start codon 
of the AR gene (Revay et al. 2012). The latter is to date the only known causative 
mutation for SRY-positive sex reversal in horses, whereas the genetic causes of the 
majority of similar conditions remain, as yet, undefined. 
 
Cryptorchidism  
Cryptorchidism (CO) is the most common non-lethal developmental defect in 
mammals with prevalence varying in a wide range between species, breeds, and 
populations (Amann and Veeramachaneni 2006; Amann and Veeramachaneni 2007). A 
generally accepted frequency of CO in full term male birth is 2-8% for humans 
(Agoulnik et al. 2012) and horses (Hayes 1986; Amann and Veeramachaneni 2006; 
Amann and Veeramachaneni 2007; Foster and Ladds 2007; Arighi 2011; Russell and 
Pollock 2011), while a broader range of variation has been reported for CO in dogs and 
pigs (Dolf et al. 2008). The condition manifests in the failure of one (unilateral) or both 
(bilateral) testes to descend into the scrotum at the time typical for a species (Amann and 
Veeramachaneni 2006; Amann and Veeramachaneni 2007). Undescended testis can be 
retained at different locations along the path of testis descent from the abdomen through 
inguinal canal to a proper position in the scrotum. In most mammals, a retained testis 
most commonly is located in an abdominal position. In horses, retention of testes within 
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the inguinal canal is equally common (Amann and Veeramachaneni 2006; Amann and 
Veeramachaneni 2007). Overall, CO usually is unilateral and retention of the testes 
occurs with similar frequency on the left and right sides. In stallions, however, left-sided 
CO testes are more frequently located in the abdomen (75.2%), and right-sided CO testes 
in the inguinal canal (58.2%) (Stickle and Fessler 1978). Cryptorchidism might occur as 
an isolated condition or as a part of other developmental disorders, known as syndromic 
CO (Amann and Veeramachaneni 2006; Amann and Veeramachaneni 2007). 
The retained testis undergoes dysgenesis, rendering bilateral CO sterile (Amann 
and Veeramachaneni 2006; Agoulnik and Feng 2007; Amann and Veeramachaneni 
2007; Massart and Saggese 2010; Arighi 2011), while unilateral CO are generally fertile. 
In stallions, where unilateral CO accounts for 81-93% of diagnosed cases (Hayes 1986; 
Amann and Veeramachaneni 2007; Arighi 2011), the undescended testis is of reduced 
testicular mass with no exocrine capability, resulting in reduced numbers of ejaculated 
sperm (Foster and Ladds 2007; Russell and Pollock 2011). However, the affected 
stallions generally produce sufficient normal sperm to yield acceptable pregnancy rates 
in commercial breeding programs. Surgical removal of a retained testis might be 
indicated because studies in humans (Wood and Elder 2009), dogs (Liao et al. 2009) and 
to a lesser extent in horses (Pratt et al. 2003; Foster and Ladds 2007; Arighi 2011) reveal 
that a maldescended testis poses an increased risk for the development of primary 
testicular neoplasms, such as seminomas, Leydig cell tumors and Sertoli cell tumors. 
Surgical removal of an undescended testis, depending on the position of the testis, might 
be challenging and further increase the health risk (Russell and Pollock 2011). Also, the 
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undescended testes continue testosterone production, due to which males with bilateral 
cryptorchidism show the same behavioral characteristics as males with two scrotal 
testes. Therefore, castration of CO stallions is necessary to eliminate associated 
behavioral characteristics (Russell and Pollock 2011). However, the surgical procedures 
required for castratration of a uni-or bilateral cryptorchid stallion are more complicated 
and expensive, as compared to routine castration (Arighi 2011; Russell and Pollock 
2011).  
Because of possible infertility, increased risk for gonadal tumors, clinical 
complications, vertical transmissibility, and increased medical/veterinary costs, CO has 
been a focus of clinical and genetic research for a long time. The majority of studies 
involve humans (Agoulnik and Feng 2007; Harris et al. 2010; Agoulnik et al. 2012; 
Cannistraci et al. 2013) and model species, such as mice and rats (Barthold 2008; 
Agoulnik et al. 2012; Barthold et al. 2013). Among domestic species, CO has been 
studied mainly in horses (Hayes 1986; Arighi 2011; Russell and Pollock 2011), followed 
by pigs (Rothschild et al. 1988; Dolf et al. 2008) and dogs (Amann and Veeramachaneni 
2007; Dolf et al. 2008), and to a lesser extent in cattle, sheep and goats (Amann and 
Veeramachaneni 2007). Despite this, the etiology of cryptorchidism remains, for the 
most part, unknown. It is generally accepted that the causes of cryptorchidism are 
complex and multifactorial. These include environmental factors, such as endocrine-
disrupting chemicals with anti-androgenic and/or estrogenic effects, but also epigenetic 
and genetic factors (Barthold 2008).  
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Abundant evidence supports the presence of a genetic component in CO. For 
example, about 25% of CO cases in humans are inherited (Barthold 2008); there are 
multiple reports about familial CO in humans (Agoulnik and Feng 2007; Massart and 
Saggese 2010) and animals (Diribarne et al. 2009; Zhao et al. 2010); reports about 
pedigrees where multiple generations have been affected (Perrett and O'Rourke 1969), 
and case reports of unilateral CO where the contralateral, normally descended testis may 
also be altered (Foresta et al. 1996). Some breeds of horses, like Percherons, American 
Saddlebreds, American Quarter Horses, and ponies, are more prone to have CO than, for 
example Thoroughbreds (Hayes 1986), thereby pointing to a likely genetic 
predisposition. Furthermore, it is well known that syndromic CO is frequently a part of 
complex congenital disorders that are caused by chromosomal aneuploidies and 
aberrations (Massart and Saggese 2010), although no chromosomal abnormalities have 
been consistently associated with isolated cryptorchidism.  
Despite these observations, the mechanisms of genetic contributions to 
cryptorchidism are not well understood. There is no consensus about the mode of CO 
inheritance – an indication that the genetic component of CO is heterogeneous and 
involves multiple genes. Indeed, the majority of studies in humans (Klonisch et al. 2004; 
Massart and Saggese 2010), pigs (Rothschild et al. 1988) and dogs (Nielen et al. 2001) 
propose a polygenic recessive model involving abnormalities in over 20 genes, while a 
small number of studies support autosomal dominant or Y-linked inheritance for some 
forms of CO in humans (Pardo-Mindan et al. 1975; Barthold 2008).  
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Difficulties to identify the genetic component of CO are largely due to the 
complexity of the gene network regulating sexual differentiation and testes development 
(Sekido and Lovell-Badge 2009). Testes descent requires an interaction of multiple 
genes with testicular hormones testosterone, and its more potent derivative 
dihydrotestosterone (DHT) (Fluck et al. 2011). Testosterone, DHT and their receptor AR 
(Androgen receptor) are critically involved in multiple stages of testes development, 
including the transinguinal phase (Agoulnik and Feng 2007; Barthold 2008; Hughes and 
Acerini 2008). The classic biosynthetic pathway from cholesterol to testosterone and the 
subsequent conversion of testosterone to DHT is well established (Fluck et al. 2011). 
However more recently, an alternative pathway for DHT synthesis that does not involve 
testosterone was discovered in marsupials (Wilson et al. 2003), and thereafter shown to 
be present in humans and other eutherian mammals (Auchus 2004; Fluck et al. 2011; 
Biason-Lauber et al. 2013; Fukami et al. 2013). The pathway is called ‘the backdoor 
pathway’ (Auchus 2004) and involves genes and enzymes, such as 3α-reductases 
(AKR1C gene family) that are not present in the ‘classic’ DHT synthesis pathway. The 
importance of the ‘backdoor pathway’ and AKR1C genes in male sexual development 
was recently demonstrated by a study in humans showing that mutations in AKR1C2 and 
AKR1C4 genes are associated with various disorders of sexual development (DSDs) 
including CO (Figure 3) (Fluck et al. 2011; Biason-Lauber et al. 2013).  
Another important hormone/receptor system in testes development involves the 
insulin-like factor 3 (INSL3) and its G-protein-coupled receptor RXFP2 which control 
gubernaculum differentiation, and are essentially involved in trans-abdominal phase of 
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testis descent. Testes migration depends also on calcitonin-related polypeptide alpha 
(CALCA) which is a chemoattractant and induces the growth of the developing tip of the 
gubernaculum (Ng et al. 2005). The latter enlarges under stimulation of INSL3 to anchor 
the testes in place during gradual abdominal translocation. Further, the production of 
testosterone during testicular descent is regulated by genes involved in the steroidogenic 
pathway such as luteinizing hormone (LH) and its receptor (LHCGR) that stimulate 
Leydig cells to produce testosterone. Testosterone synthesis, in turn, depends on 3β- 
steroid delta-isomerase 1 (HSD3B1) and aromatase (CYP19A1) – the key enzymes which 
convert testosterone to estradiol and control its availability (Agoulnik and Feng 2007). 
Additionally, several other loci, such as homeobox A10 (HOXA10) and A11 (HOXA11), 
zinc finger proteins ZNF214 and ZNF215 implicate testicular descent (Massart and 
Saggese 2009; Massart and Saggese 2010).  
The complex genetic regulation of sexual differentiation and testes development 
is probably the reason why only limited success has accompanied studies using 
candidate gene approach. Sequencing and mutation analysis of over 20 candidate genes 
in humans (Massart and Saggese 2009; Massart and Saggese 2010), mice (Agoulnik and 
Feng 2007; Agoulnik et al. 2012) and dogs (Pathirana et al. 2010; Zhao et al. 2010) have 
not revealed any mutations or single nucleotide polymorphisms (SNPs) that are 
consistently and significantly associated with CO. Likewise, no significant associations 
were detected by microsatellite genotyping in seven CO candidate genes (AR, CALCA, 
ESR1, HOXA10, INSL3, NR5A1, RXFP2) in a Thoroughbred pedigree composed of 23 
CO and 24 unaffected horses (Diribarne et al. 2009).  
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Some progress, although no true breakthrough, has accompanied genome-wide 
association studies (GWAS) by genotyping case-control cohorts on SNP beadchips. An 
association to TGFBR3 and BMP7 genes was shown by GWAS in men with testicular 
dysgenesis syndrome (TDS) – a condition which links testicular germ cell cancer, 
cryptorchidism and some cases of hypospadias (Dalgaard et al. 2012). GWAS in 
Siberian Huskies associated CO with chromosomes 6, 9, 24, 27 and X (Zhao et al. 
2013). However, as these studies have not been followed up by in depth analysis of 
positional candidate genes, no causative mutations or risk genotypes for CO have been 
as yet determined. Nevertheless, identification of multiple associated genes and genomic 
regions is in agreement with the proposed polygenic nature of CO.  
 
Disorders of sexual development and CNVs 
Recently, another form of genome variation – copy number variation - has come 
to the spotlight in the genomics of DSDs and CO. Indeed, studies in humans associate 
CNVs with disorders of sexual development and reproduction, including urogenital 
abnormalities, sex reversal, hypospadias and CO (Smyk et al. 2007; Tannour-Louet et al. 
2010; Li et al. 2011). For example, in CO individuals, imbalances have been found in 9 
genomic regions of which 5, viz., 5p12, 10p14, 12q24, 15q11, and Xq28, were clinically 
significant (Tannour-Louet et al. 2010). The findings encourage continuing in depth 
studies of the candidate regions in humans and the initiation of similar research in other 
species, including the horse. 
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Goals of this study 
 
The focus of this dissertation is the study of copy number variation in the horse 
genome. The overall goal is to improve the knowledge of CNVs in equine health and 
disease by characterizing CNVs in normal horse breeds and populations, and in equine 
congenital disorders and diseases. The findings are expected to facilitate the 
development or improvement of molecular diagnostic tools for horses, and might also 
serve as useful models for related biomedical conditions in other domestic species and 
humans.  
We hypothesize that CNVs are associated with normal phenotypic variation, as 
well as with complex diseases and genetic disorders in the horse. The immediate goals of 
this dissertation research are:  
 
Objective #1: Investigate naturally occurring CNVs in diverse horse breeds and generate 
a baseline for future studies. 
 
We argue that in order to find CNVs that that are associated with genetic 
abnormalities, the first step is to obtain an in depth knowledge about the CNVs in the 
genomes of normal horses of diverse horse breeds and populations. We will carry out 
genome-wide CNV analysis using array CGH in diverse horse breeds, each represented 
by at least 2 individuals. The findings will be compared and merged with the currently 
available CNV data for the horse. We intend to generate a composite CNV database and, 
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thus, lay a critical foundation for the discovery of CNVs that are associated with equine 
diseases, disorders, and traits of importance. 
 
Objective #2: Comparative analysis of genomic copy number variation among horses 
susceptible and resistant to Recurrent Airway Obstruction (RAO).  
 
Array CGH will be conducted in severely RAO affected (HOARSI 4) and 
healthy control (HOARSI 1). The goal is to determine the role of CNVs in the genetics 
of complex equine diseases, such as RAO.  
 
Objective #3: CNV research in equine disorders of sexual development (DSDs) – XY 
SRY-positive sex reversal and cryptorchidism.  
 
Array CGH will be used to study CNVs in two disorders SRY-positive sex 
reversal 64XY females and in equine bilateral abdominal isolated cryptorchidism. The 
findings will contribute to expand the currently limited knowledge about the genetic 
regulation of sexual development in horses and other mammals. 
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CHAPTER II 
GENOMIC COPY NUMBER VARIATION IN EQUINE POPULATIONS 
 
Introduction 
 
The outstanding role of DNA copy number variants (CNVs) in phenotypic 
diversity, adaptations, and evolution was first recognized over 40 years ago by Susumu 
Ohno (Ohno 1970). Yet, systematic genome-wide discovery and functional 
interpretation of CNVs started in the past decade with foundational studies in humans 
(Iafrate et al. 2004; Redon et al. 2006) and mice (Li et al. 2004), followed by genome-
wide (GW) CNV discovery in chicken (Griffin et al. 2008), cattle (Liu et al. 2010) and 
other domestic species (Clop et al. 2012). It is now well established that CNVs are a 
common feature of vertebrate genomes. They provide a genetic basis for normal 
phenotypic variations and adaptations, but can also be molecular signatures for 
congenital disorders and diseases (Girirajan and Eichler 2010; Hall and Quinlan 2012).  
According to the current definition, CNVs are DNA sequence variants from at 
least 50 base-pairs (bp) to over several megabase-pairs (Mb) in size that are involved in 
deletions, insertions, duplications and translocations, causing structural differences 
between genomes (Conrad et al. 2010b; Weischenfeldt et al. 2013). Because CNVs are 
larger than single nucleotide polymorphisms (SNPs), they are responsible for more 
heritable sequence differences (0.5-1%) between individuals than SNPs (0.1%) (Conrad 
et al. 2010b; Pang et al. 2010; Weischenfeldt et al. 2013).  
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One of the central goals of CNV research has been to determine their association 
with genome instability, genetic diseases, and congenital disorders. It is assumed that 
CNVs, as a major source of inter-individual genetic variation, could explain variable 
penetrance of Mendelian and polygenic diseases, and variation in the phenotypic 
expression of complex traits (Beckmann et al. 2007; Beckmann et al. 2008). Indeed, 
CNVs have been associated with common complex and polygenic disorders in humans 
affecting a broad range of biological processes, such as immune response, autoimmunity 
and inflammation (Redon et al. 2006; Cooper et al. 2007; Rogers et al. 2013); 
musculoskeletal (Robinson et al. 2012; Alvarado et al. 2013) and cardiovascular systems 
(Hitz et al. 2012; Peng et al. 2013); neurodevelopment, cognition and behavior (Lupski 
2007b; Grayton et al. 2012), and sexual development and reproduction (Ledig et al. 
2010a; Tannour-Louet et al. 2010; Carrell and Aston 2011; Tuttelmann et al. 2011; 
White et al. 2011). 
The availability of whole genome (WG) sequence draft assemblies, combined 
with the advances in array-based technologies and next generation sequencing (NGS), 
has prompted CNV research in all main domestic species with the most advanced 
information currently available for the cattle (Matukumalli et al. 2009; Fadista et al. 
2010; Liu et al. 2010; Bickhart et al. 2012; Hou et al. 2012a; Hou et al. 2012b; Hou et al. 
2012c; Liu and Bickhart 2012), followed by pigs (Chen et al. 2012; Li et al. 2012; Wang 
et al. 2012; Wang et al. 2013a; Wang et al. 2013b; Wang et al. 2014a), dogs (Chen et al. 
2009; Nicholas et al. 2009; Alvarez and Akey 2012; Berglund et al. 2012; Gurgul et al. 
2014; Molin et al. 2014), sheep (Fontanesi et al. 2010a; Liu et al. 2013) and goats 
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(Fontanesi et al. 2010b). Five CNV studies have been conducted in horses reporting the 
discovery of copy number variants in the whole genome (Doan et al. 2012b; Dupuis et 
al. 2013; Metzger et al. 2013a; Wang et al. 2014b) or in gene exons (Doan et al. 2012a), 
and attempting to associate CNVs with diseases (Dupuis et al. 2013), adaptations (Wang 
et al. 2014b) or phenotypic traits (Doan et al. 2012a; Metzger et al. 2013a). While these 
studies set a foundation for understanding the role of CNVs in horse biology, the current 
information is inadequate for efficient discovery of variants affecting equine health and 
disorders. This is because the studies have used different CNV discovery platforms, the 
number of breeds and individuals in some studies is very limited, and the majority of 
reported CNVs are unique and not validated by two or more independent studies. Also, 
the available information has not been integrated into a composite dataset to facilitate the 
analysis of known, and the discovery of new CNVs. 
The aim of this study is to improve the current rather limited knowledge of 
CNVs in horses by their genome-wide discovery in multiple individuals of additional 
diverse horse breeds. Using a custom-made WG tiling array, we generate a CNV map 
for the horse genome and integrate this with the previous CNV studies into a composite 
dataset.  
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Material and methods 
 
Array design  
 
Recently, as collaboration between Texas A&M University (Drs. Raudsepp and 
Chowdhary) and the University of Adelaide (Dr. Adelson), a whole-genome tiling array 
for the horse was constructed (Qu et al. 2011 PAG abstract). The array comprises 
417,377 60-mer oligonucleotides distributed in gene containing and intergenic sequences 
of the horse genome. Median distance between the tiles on the array is 7.5 kb, reducing 
to 4 kb in subtelomeric regions, and increasing to ~ 20 kb in the Y chromosome. The 
array was designed using horse genome draft sequence (EcuCab2); (Wade et al. 2009), 
Oligowiz2.0, ArrayOligoSelector, and ArrayDesign (Rouillard et al. 2002) software 
packages. Array sequences for the autosomes and the X chromosome originated from the 
horse reference genome (Thoroughbred mare Twilight; Wade et al. 2009). Sequences for 
the Y chromosome originated from the genome of the DNA donor of the CHORI-241 
horse genomic BAC library (Thoroughbred male, Bravo) (Paria et al. 2011; our 
unpublished data). Before inclusion to the array, the specificity of all sequences were 
analysed with BLAT and BLAST against EcuCab2 reference genome sequence. Probes 
with more than one hit in the genome were discarded. Possible cross-hybridization of the 
probes was further evaluated using Kane’s parameters (Kane et al. 2000) and all probes 
that had a total percent identity >75-80% with a non-target sequence, or probes with 
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contiguous stretches of identity >15 nucleotides with a non-target sequence were 
discarded.The array was designed to target the following regions of interest: 
 
Genes  
The array consists of 85,852 probes corresponding to one or more exons of 
18,763 annotated equine genes. Genes with one to four exons have a probe 
corresponding to each exon. The number of probes (N) for genes with more than four 
exons was determined by the formula N = [(M-4)/5-4}] (where M is the number of 
exons). Probes could not be designed for the exons of 967 genes. Instead, introns and 
300 bp upstream or downstream sequences were used to select suitable oligonucleotides. 
Despite these efforts, no probes could be designed for 336 equine genes. The majority of 
these are members of large gene families, such as olfactory receptors, keratins and 
ribosomal proteins. 
 
Intergenic chromosomal regions (excluding subtelomeres) 
These regions are represented by 305,416 probes and correspond to all horse 
autosomes, the X chromosome and chromosome Un. The latter represents sequence 
scaffolds that have not yet been assigned to chromosomes.  
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Subtelomeric regions 
A total of 5,716 probes were designed from subtelomeric sequences defined as 
the terminal 1 Mb of each chromosome arm. These regions were specifically targeted 
because subtelomeres contain transcribed gene families and are hotspots of DNA 
breakage and repair, and undergo structural rearrangements more frequently than the rest 
of the genome (DeScipio et al. 2008; Riethman 2008). Enrichment of the array with 
subtelomeric sequences is an important and unique feature because one of the pitfalls of 
most animal and many human arrays is the under-representation of probes in the 
subtelomeric regions (Stankiewicz and Beaudet 2007). At the same time, subtelomeric 
regions which are extremely difficult to study by cytogenetic methods, are frequently 
involved in structural imbalances associated with congenital disorders and diseases both 
in humans (Tannour-Louet et al. 2010) and animals (Thomas et al. 2009). 
 
The Y chromosome 
Another unique feature of the array is the incorporation of 519 sequences from 
horse Y chromosome (unpublished data). Typically, the Y chromosome is missing from 
tiling arrays because Y sequences are not available for most species.  
A Cytoband file was generated to align the horse draft sequence assembly with 
the cytogenetic map (ISCNH 1997). This allows the generation of files showing the 
distribution of SVs along individual chromosomes. For bioinformatics purposes, 
fictional cytoband files were generated also for chromosome Un (probes with sequence 
information but no chromosomal assignment) and for the Y chromosome (probes with 
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chromosomal location but not included in WG sequence assembly). Thus, the CNV 
analysis will encompass the entire horse genome including the Un and the Y 
chromosomes. 
 
Array production  
 
The array, designated as Texas-Adelaide horse WG tiling array, was fabricated 
by Agilent Technologies using Agilent SurePrint G3 technology and 2 x 400K chip 
format (two arrays on a single slide). The array is available at Agilent Technologies; 
Design ID #030025, Cat. No G4124A. 
 
Selection of breeds and animals  
 
The CNV discovery cohort comprised 38 horses representing 16 diverse breeds 
and the Przewalski’s horse (Table 6). An additional cohort of 52 horses representing the 
same 16 breeds was used for quantitative PCR validation of CNVs.  
Horse breeds were selected according to the recent population studies (Wade et 
al. 2009; McCue et al. 2012; Petersen et al. 2013a; Petersen et al. 2013b) with an aim to 
maximize the genetic diversity among samples and to encompass the common warm 
blood, cold blood (draft) and native pony breeds (Gorrie et al. 2008). The warm blood 
horses were represented by Akhal-Teke, American Quarter Horse, Arabian, 
Standardbred, Swiss Warmblood, and the Thoroughbred – well-known breeds used for 
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racing, riding, show jumping, dressage, and other show competitions. The draft horses 
were represented by Belgian, Clydesdale, Friesian, and Percheron breeds. Among the 
indigenous ponies, the Mongolian native horse is used for riding/racing, but also for 
meat and milk. Caspian, Fell and Exmoor ponies are distinguished by small size and 
hardiness, and used for agriculture, dressage, and as pets. The American Miniature 
Horse is characterized by extremely small body size (Petersen et al. 2013b), and the 
Sorraia horse represents Iberian horse breeds and is used for riding and as a pet (Gorrie 
et al. 2008). 
Geographically, the selection included breeds from Asia/Orient, such as Akhal-
Teke, Arabian, Caspian, and Mongolian; from Europe, such as Belgian, Clydesdale, 
Exmoor Pony, Fell Pony, Friesian, Percheron, Sorraia, Swiss Warmblood, and 
Thoroughbred, and breeds of American origin, such as the American Miniature Horse, 
American Standardbred, and American Quarter Horse (Gorrie et al. 2008).  
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Table 6: Horse breeds (n=16) and individuals (n=38) used in this study. 
 
Domestic horse, Equus caballus 
Breed ID Sex Source of DNA 
Akhal-Teke1 BP131 M Blood 
Akhal-Teke2 BP132 M Blood 
American Miniature Horse1 BP7 M Blood 
American Miniature Horse2 BP353 F Hair 
American Quarter Horse1 BP3 M Blood 
American Quarter Horse2 H261 F Blood 
American Quarter Horse3 H528 M Blood/hair 
Arabian1 BP35 M Blood 
Arabian2 BP290 F Hair 
Belgian Draft1 BP117 M Blood 
Belgian Draft2 BP291 F Hair 
Caspian Pony1 BP60 M Blood 
Caspian Pony2 BP288 F Hair 
Clydesdale1 BP65 M Blood 
Clydesdale2 BP322 F Hair 
Exmoor Pony1 BP197 M Blood 
Exmoor Pony2 BP297 F Hair 
Fell Pony1 BP85 M Blood 
Fell Pony2 BP285 F Hair 
Friesian1 H519 M Blood 
Friesian2 H481 F Blood 
Friesian3 H525 M Blood 
Friesian4 H526 M Blood 
Mongolian Native Horse1 BP304/GC52020 M Hair 
Mongolian Native Horse2 BP287/GC52022 F Hair 
Percheron1 H520 M Blood 
Percheron2 BP351 F Hair 
Sorraia1 BP303/ECAS32 M Blood/hair 
Sorraia2 BP295 F Hair 
Standardbred1 BP356/M1054 M Blood 
Standardbred2 BP357/M1039 F Blood 
Swiss Warmblood1 HOARSI1-154 M Blood 
Swiss Warmblood2 HOARSI1-146 F Blood 
Swiss Warmblood3 HOARSI1-140 F Blood 
Thoroughbred1 Bravo* M Blood 
Thoroughbred2 Twilight** F Blood 
Przewalski horse, Equus przewalskii 
Przewalski’s Horse1 KB4064 M Fibroblasts 
Przewalski’s Horse2 KB4070 F Fibroblasts 
* Male Thoroughbred Bravo was the DNA donor for the CHORI-241 horse whole genome BAC library 
(http://bacpac.chori.org/equine241.htm);   
** Female Thoroughbred Twilight was the DNA donor for the horse genome sequence draft assembly EcuCab2 (Wade et al. 2009). 
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DNA isolation & quality control 
 
DNA was isolated from peripheral blood and/or hair using standard PCI (Phenol/ 
Chloroform/ Isoamyl alcohol) method (Sambrook et al. 1989) or Gentra Puregene Blood 
Kit (QIAGEN, USA) according to manufacturer’s protocol. The latter was modified to 
adjust it for DNA isolation from hair follicles. Briefly, hair follicles were incubated in 
cell lysis solution for at least 72 hrs. After isopropanol treatment to precipitate DNA 
pellet, the sample was centrifuged at 16,000 x g for 20-30 minutes, instead of 3 minutes 
at 2000 x g, according to the original protocol. The same applied after treatment with 
70% ethanol. The DNA was cleaned with DNeasy Blood and Tissue kit (Qiagen) with 
the following modifications to the manufacturer’s protocol: during DNA purification, 
80% ethanol was used instead of solution AW2, and the final DNA pellet was eluted in 
water instead of solution AE. The final quality and quantity of the DNA samples were 
checked by gel electrophoresis on a 1% agarose gel and by Nanodrop spectrophotometry 
(Thermo Scientific).  
 
Array Comparative Genomic Hybridization  
 
Probe labeling and array CGH experiments were performed according to Agilent 
Technologies Protocol Version 6.2.1. All hybridizations comprised of a pair of 
differently labeled probes, one of which was always the reference DNA – a 
Thoroughbred mare Twilight for females and a Thoroughbred stallion Bravo for males. 
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Briefly, 1µg of purified genomic DNA was digested with restriction enzymes RsaI and 
AluI for 2 hours at 37C and 20 minutes at 65C to produce 200-500 bp fragments. 
Cleaved samples were labeled with fluorescence dyes Cy3 (for the reference DNA) or 
Cy5 (for sample DNA) by random priming using Genomic DNA Enzymatic Labeling 
Kit (Agilent Technologies). The final labeling reaction contained random primer (5 µl), 
1X dNTP mix (5µl), 1X reaction buffer (10 µl), Exo-Klenow enzyme (1 µl), and Cy3- or 
Cy5-dUTP (3 µl) and was conducted for 2 hours at 37C, 10 minutes at 65C. The 
products were cleaned with 30 kDa filters (Amicon) and the yield and specific activity of 
labeled DNA was determined with a Nanodrop spectrophotometer. Typical yield for 1 
µg of starting DNA was 6-8 µg; specific activity for Cy3 was 25-40 pmol/µg and for 
Cy5 20-35 pmol/µg. The hybridization mixture was prepared using Agilent Oligo aCGH 
Hybridization Kit and contained equal quantity of Cy3 and Cy5 labeled probes, 1 µg/µL 
horse Cot1 DNA, 10X blocking agent, and 2X Hi-RPM buffer. Denatured and pre-
annealed probe mixture was applied onto gasket slide, placed in Agilent SureHyb 
hybridization chamber, ‘sandwiched’ with an array slide and incubated in Agilent 
hybridization oven at 65C for 40 hours. The array slides were washed with Agilent 
aCGH Wash Buffers 1 and 2, and dried with Acetonitrile and Stabilization and Drying 
Solutions. Washing in Wash Buffer 1 was done for 10 minutes instead of the 5 minutes 
recommended by the Agilent protocol. 
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Array CGH data analysis 
 
The array slides were scanned with Agilent SureScan DNA Microarray Scanner 
and Agilent Scanner Control software v8.3 with the following settings: slide id - auto 
detect; channels - R+G; resolution – 2 µm; tiff – 16bit; R PMT and G PMT are 100%, 
and XDR set to “0.05”. The settings can be changed according to labeling and 
hybridization performance.  
The data were extracted and normalized with Agilent Feature Extraction software 
v10.10.1.1 and saved in .fep format. The Feature Extraction software also checks the 
quality of aCGH by measuring Derivative Log2 Ratio Standard Deviation (DLRSD), 
Signal-To-Noise Ratio (SNR) and Background Noise (BGNoise).  
The data were further analyzed with Agilent Genomic Workbench 5.0 software. 
In each array spot log2 ratios of Cy3 versus Cy5 were computed with the default P-value 
threshold 0.05 and overlap threshold value 0.9. The CNVs were represented by gains 
and losses of normalized fluorescence intensities relative to the reference and called by 
conservative criteria which required alternations of >0.5 log2 ratios over 5 neighboring 
probes. Homozygous losses were called when signal log2 ratio was <-2.0. Copy number 
variable regions (CNVRs) were determined by ADM-2 algorithm (Lipson et al. 2006) by 
combining overlapping CNVs in all samples across the CGH experiments.  
Parameters used in this analysis were as follows: Threshold of ADM-2: 6.0; 
Centralization: ON (Threshold: 6.0, Bin Size: 10); Fuzzy Zero: ON; Aberration Filters: 
ON (minProbes = 5 & minAvgAbsLogRatio = 0.5 & maxAberrations = 10000 AND 
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percentPenetrance = 0); Feature Level Filters: ON, IntraArray: ON). Output files were 
generated with genomic coordinates and cytoband locations for all CNVs. The raw data 
were submitted to NCBI Gene Expression Omnibus (GEO) accession GSE55266. 
 
Array performance evaluation  
 
To evaluate baseline variations and determine false discovery rate (FDR) 
(Benjamini and Hochberg 1995; Wang et al. 2005) female and male self-to-self, and 
female-to-male control hybridizations were conducted using blood DNA from one 
female and one male Thoroughbred horses. The female Thoroughbred, Twilight, was the 
DNA donor for the horse reference sequence EcuCab2 (Wade et al. 2009) and the origin 
of the probes on the tiling array. The male Thoroughbred, Bravo, a half-sibling to 
Twilight, was the DNA donor for the CHORI-241 BAC library and the origin of all Y 
chromosome probes on the array. The FDR was calculated as a percentage of the ratio of 
CNVs in self-to-self hybridization to the total number of CNVs in all experiments. 
Additionally, array performance was evaluated by self-to-self hybridizations with blood 
and hair DNA from one Quarter Horse (H528, Table S1). Hybridization quality was 
assessed by DLRSD which calculates probe-to probe log ratio noise of an array: DLRSD 
< 0.2 was considered excellent; 0.2 ≥ DLRSD ≤ 0.3 was good, and values > 0.3 
indicated poor quality hybridization. 
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Array CGH data validation by qualitative and quantitative PCR (qPCR) 
 
Genomic copy number changes as detected by aCGH were validated by 
quantitative PCR (qPCR) for 18 selected CNVRs using 22 probe-specific primers. 
Additionally, 8 putative homozygous deletions were validated by regular (qualitative) 
PCR. Primers (Table S2) were designed inside CNVRs using array probe sequences and 
the horse whole genome sequence information (EquCab2 at UCSC and Ensembl) 
(Karolchik et al. 2003; Stalker et al. 2004) and Primer3 software (Koressaar and Remm 
2007; Untergasser et al. 2012). Specific criteria for the design of primers for qPCR were: 
a) GC content over 50%, b) complementarity = 4, c) qPCR product size 100-200 bp, and 
d) annealing temperature between 55°C and 60°C.  
The best DNA concentration for qPCR was 25 ng/µL which was determined by 
serial dilutions of 200ng/µL, 100 ng/µL, 50 ng/µL, 25 ng/µL, 12.5 ng/µL and 6.25 
ng/µL. The qPCR experiments were performed with LightCycler® 480 (Roche 
Diagnostics) in triplicate assays. Each assay was done in triplicate 20 µL reactions 
containing 50 ng of template DNA, 10 μM primers, and the SYBR Green PCR kit 
(Roche).  
Relative copy numbers of the selected regions were determined in comparison to 
the reference sample (Thoroughbred and Quarter Horse) and normalized to an autosomal 
reference gene GAPDH. The cycling conditions were 1 cycle 5 min at 95°C; 45 cycles 
10 sec at 95°C, 5 sec at 58°C, and 10 sec at 72°C; 1 cycle for melting curve 30 sec 95°C, 
30 sec 65°C and final cooling 20 sec at 50°C.  
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Quantification of the copy number was carried out using the comparative CT 
method (2
ΔΔ
Ct) (Livak and Schmittgen 2001; Bodin et al. 2005) with p<0.05 as a cut-off 
threshold for statistical significance. Qualitative PCR results were analyzed by agarose 
gel electrophoresis. 
 
Array CGH data validation by fluorescence in situ hybridization (FISH) 
 
CNV specific primers were used to screen CHORI-241 BAC library (CHORI-
241) by PCR (Table S2). The BAC DNA was isolated by Plasmid Midiprep kit 
(Qiagen), labeled with biotin-16-dUTP or digoxigenin-11-dUTP using Biotin- or DIG-
Nick Translation Mix (Roche), and hybridized to metaphase chromosomes of CNV 
carriers and control horses following standard protocols (Raudsepp and Chowdhary 
2008a). A BAC clone representing a non-CNV region was used as a control in each 
FISH experiment. Images for a minimum of 20 metaphase and/or interphase cells were 
captured for each experiment and analyzed with a Zeiss Axioplan2 fluorescent 
microscope equipped with Isis v5.2 (MetaSystems GmbH) software. 
 
Gene ontology enrichment analysis  
 
Ensembl gene list (Ensembl Genebuild 73.2) along with their position in the 
horse genome was added to Agilent Genomic Workbench as a custom track to determine 
the genic and intergenic CNVs. Gene Ontology analysis (GO) and Kyoto Encyclopedia 
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of Genes and Genomes (KEGG) pathway analysis of the genes present in CNVs were 
performed using DAVID (The Database for Annotation, Visualization and Integrated 
Discovery) bioinformatics tool with default settings (Huang da et al. 2009b; Huang da et 
al. 2009a). TheGO annotations used were: BP (Biological Process), MF (Molecular 
Function) and CC (Cellular Component).  
Because only a limited number of genes in the horse genome have been 
annotated, horse gene IDs were converted to orthologous human Ensembl gene IDs by 
BioMart, followed by GO and pathway analyses, as described above. Biological 
functions of the genes in CNVRs were further analyzed manually by data mining in 
Ensembl (Stalker et al. 2004), UCSC (Karolchik et al. 2003) and NCBI (Sayers et al. 
2010) Genome Browsers searching for data for equine orthologs in other mammalian 
species. CNVs present in intergenic regions were analyzed in UCSC genome browser 
and NCBI and GeneCards (MacDonald et al. 2014) for similarities to known mammalian 
genes.  
 
Chromosome CNVR enrichment 
 
Horse chromosome enrichment percentage was determined by the total length of 
CNVRs present each chromosome, divided by length of the chromosome. The genome 
Enrichment was calculated by the division of the total length of all CNVRs with the 
length of the assembled horse genome. Enriched chromosomes were acknowledged if 
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their enrichment percentage was more than the enrichment percentages of the whole 
horse genome. 
 
Generation of a composite CNV dataset for the horse 
 
Genomic positions of CNVs/CNVRs from this and all previously published 
studies (Doan et al. 2012a; Doan et al. 2012b; Dupuis et al. 2013; Metzger et al. 2013a; 
Wang et al. 2014b) were aligned, and partially or completely overlapping and adjacent 
CNVs (the end position of a previous CNV and the start position of the next CNV are 
the same) were consolidated into one CNVR. 
 
Phylogenetic analysis 
 
Genotypes for 15 microsatellite loci (Khanshour et al. 2013); E.G. Cothran, 
unpublished) were available for 32 out of 41 horse breeds involved in CNV studies. 
Majority-rule consensus of Restricted Maximum Likelihood (RML) trees were 
constructed and visualized as described elsewhere (Khanshour et al. 2013). The 
Przewalski horse population was used as an out-group. 
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Results 
 
Performance of the Texas-Adelaide horse WG tiling array  
 
Self-to-self control hybridizations (Figure 4) showed 1.55% of FDR (4/258*100) 
- an indication that array design, fabrication, and aCGH procedures were optimal. As a 
proof-of principle, female-to-male hybridizations between two half-sib Thoroughbreds, 
Twilight (female) and Bravo (male), showed massive loss in the X chromosome and a 
gain in the Y chromosome in the male (Figure 5), whereas only one CNV was detected 
in an autosome, chr3. The DLRSD values for all hybridizations with blood DNA from 
Twilight and Bravo were < 0.2. Therefore, and because the oligonucleotides on the array 
were derived from the sequences of these two horses, DNA of Twilight and Bravo was 
used as a reference for all aCGH experiments: Twilight for females and Bravo for males.  
Further, because the DNA collection from horse breeds contained samples 
isolated from blood and hair, an additional self-to-self hybridization was conducted 
using DNA from blood and hair of one male American Quarter Horse QH3-H528 (Table 
6). Hybridization quality was evaluated by measuring Derivative LogRatio Standard 
Deviation (DLRSD) that assesses the log ratio variances between successive probes 
divided by the square of 2, and calculates probe to probe noise across the array. Blood 
DNA gave good quality results with DLRSD = 0.14, whereas consistent and high level 
hybridization noise was observed for hair DNA (DLRSD = 0.41) (Figure 6). Due to this, 
CNVs in all experiments were called with stringent criteria: log2 ratio alternations higher 
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than 0.5 over 5 neighboring probes. With median probe spacing of 7.5 kb on the array, 
this allowed detection CNVs of about 30 kb, and in probe-dense regions even smaller. 
We concluded that the performance of the equine 400K Texas-Adelaide whole-genome 
CGH array was optimal for the discovery of CNVs in the horse genome. 
 
 
 
 
 
 
 
 
Figure 4: Genome-wide distribution of CNVs in self-to-self hybridization.  
(upper) compared to cumulative hybridizations with all animals (lower) to determine 
FDR; green vertical lines denote CNVs 
 
 
CNV discovery and construction of a whole-genome CNV map for the horse 
 
Altogether, 950 CNV calls were made across 36 animals (Appendix 2.1) with an 
average of 26.4 calls (19.1 losses and 7.3 gains) per individual (Table 2.2). The number 
of CNV calls was the highest in the two American Miniature Horses (59 and 46) and the 
lowest in American Quarter Horses (12 and 14) and a Caspian Pony (12) (Table 7; 
Appendix 2.1). Because the Thoroughbred served as a reference, no calls were made in 
Thoroughbred2 (Twilight) self-self 
hybridization 
Cumulative hybridizations with all 36 
animals 
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Thoroughbreds. The number and distribution of CNVRs in the two Przewalski horses 
were similar to those in domestic horses (Table 7; Appendix 2.1).  
 
 
 
 
 
 
 
 
Figure 5: Male-to-female aCGH for the X chromosome.  
Massive loss (red dots) was seen in the X chromosome of the male (upper), whereas no 
gains and losses were detected in the pseudoautosomal region (PAR) between the male 
and female genomes. 
 
 
 
 
 
 
 
 
Figure 6: Comparative DLRSD values.  
aCGH using DNA from blood (left) and from hair (right) of the same individual. 
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Table 7: Breed- and individual-wise summary of CNVRs in horses. 
 
Horse breed CNVRs per 
individual 
Gains Losses 
Akhal-teke 1 37 12 25 
Akhal-teke 2 26 13 13 
American Miniature Horse 1 59 16 43 
American Miniature Horse 2 46 4 42 
American Quarter Horse 1 12 0 12 
American Quarter Horse 2 21 2 19 
American Quarter Horse 3 14 10 4 
Arabian 1 21 17 4 
Arabian 2 17 0 17 
Belgian 1 31 14 17 
Belgian 2 14 1 13 
Caspian Pony 1 40 16 24 
Caspian Pony 2 12 1 11 
Clydesdale 1 25 6 19 
Clydesdale 2 16 1 15 
Exmoor Pony 1 29 15 14 
Exmoor Pony 2 18 8 10 
Fell Pony 1 25 11 14 
Fell Pony 2 47 11 36 
Friesian 1 29 6 23 
Friesian 2 39 10 29 
Friesian 3 41 9 32 
Friesian 4 22 12 10 
Mongolian Native Horse1 22 1 21 
Mongolian Native Horse2 18 2 16 
Percheron 1 17 11 6 
Percheron 2 12 1 11 
Przewalski's Horse 1 21 5 16 
Przewalski's Horse 2 21 3 18 
Sorraia 1 36 8 28 
Sorraia 2 18 1 17 
Standardbred 1 17 7 10 
Standardbred 2 44 13 31 
Swiss Warmblood 1 23 1 22 
Swiss Warmblood 2 30 6 24 
Swiss Warmblood 3 29 9 20 
Average 26.4 7.3 19.1 
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Figure 7: A CNVR map of the horse genome. 
Green line – loss; red line – gain; yellow line – complex; black dots – genes involved. 
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Table 8: Chromosome-wise CNVR statistics for the horse genome. 
Shared – found in 2 or more individuals; private – in one horse only; novel – not reported before; horse genome statistics 
retrieved from Ensembl. 
 
Ch
r 
#CN
VR 
Sh
are
d 
Priva
te 
Novel Gai
ns 
Loss
es 
Comple
x 
Genic Intergeni
c 
Sub-
telo 
meric 
Mean CNVR 
size (bp) 
CNVR 
length (bp) 
Chr. size (bp) Enric
h-
ment, 
% 
Gene/ 
Mb 
1 21 8 13 9 2 17 2 14 7 0 241,828 5,078,379 185,838,109 2.73 6.63 
2 13 3 10 5 5 7 1 9 4 1 69,711 906,246 120,857,687 0.75 6.64 
3 14 3 11 3 3 11 0 11 3 0 80,328 1,124,591 119,479,920 0.94 5.19 
4 9 4 5 3 1 8 0 7 2 0 119,780 1,078,019 108,569,075 0.99 4.94 
5 7 5 2 2 3 3 1 4 3 2 60,379 422,653 99,680,356 0.42 8.14 
6 11 5 6 3 1 9 1 9 2 0 206,650 2,273,151 84,719,076 2.68 9.08 
7 12 4 8 3 2 8 2 8 4 0 119,155 1,429,861 98,542,428 1.45 9.36 
8 9 5 4 1 4 5 0 8 1 1 170,025 1,530,227 94,057,673 1.63 5.66 
9 14 6 8 11 5 8 1 4 10 1 45,785 640,986 83,561,422 0.77 5.66 
10 16 7 9 7 4 12 0 13 3 1 72,954 1,167,268 83,980,604 1.39 8.16 
11 2 0 2 1 0 2 0 2 0 0 5,235 10,470 61,308,211 0.02 14.71 
12 6 5 1 1 0 3 3 5 1 0 538,645 3,231,871 33,091,231 9.77 14.97 
13 5 2 3 1 1 3 1 5 0 0 23,837 119,184 42,578,167 0.28 11.69 
14 8 3 5 3 5 3 0 5 3 1 55,523 444,184 93,904,894 0.47 5.41 
15 2 0 2 2 0 2 0 2 0 0 80,429 160,857 91,571,448 0.18 5.32 
16 5 3 2 4 0 5 0 4 1 0 46,120 230,599 87,365,405 0.26 5.95 
17 6 2 4 3 1 5 0 3 3 0 100,527 603,159 80,757,907 0.75 3.1 
18 8 4 4 4 2 6 0 5 3 0 59,831 478,649 82,527,541 0.58 3.66 
19 6 1 5 5 1 5 0 2 4 0 69,818 418,908 59,975,221 0.70 5.23 
20 19 11 8 4 5 14 0 13 6 0 102,575 1,948,920 64,166,202 3.04 8.85 
21 2 1 1 1 0 1 1 2 0 1 230,842 461,684 57,723,302 0.80 4.87 
22 4 2 2 1 1 3 0 2 2 0 48,296 193,182 49,946,797 0.39 8.08 
23 8 2 6 4 1 6 1 5 3 0 122,812 982,492 55,726,280 1.76 3.91 
24 4 1 3 2 1 3 0 3 1 0 104,966 419,862 46,749,900 0.90 6.19 
25 3 2 1 1 0 2 1 2 1 0 46,573 139,720 39,536,964 0.35 10.56 
26 6 4 2 3 1 5 0 2 4 0 105,913 635,479 41,866,177 1.52 3.68 
27 2 1 1 0 0 1 1 2 0 0 15,084 30,168 39,960,074 0.08 3.91 
28 4 2 2 2 1 3 0 2 2 0 37,557 150,227 46,177,339 0.33 6.42 
29 3 2 1 2 1 2 0 3 0 0 250,105 750,316 33,672,925 2.23 4.17 
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Table 8 continued. 
Ch
r 
#CN
VR 
Sh
are
d 
Priva
te 
Novel Gai
ns 
Loss
es 
Comple
x 
Genic Intergeni
c 
Sub-
telo 
meric 
Mean CNVR 
size (bp) 
CNVR 
length (bp) 
Chr. size (bp) Enric
h-
ment, 
% 
Gene/ 
Mb 
30 4 1 3 2 2 2 0 2 2 0 67,956 271,825 30,062,385 0.90 4.23 
31 2 1 1 2 0 2 0 0 2 1 34,286 68,572 24,984,650 0.27 4.58 
X 12 5 7 10 4 7 1 0 12 1 87,146 1,045,753 124,114,077 0.84 4.46 
Un 11 9 2 11 6 0 5 0 11 0 4,118 45,298  117,461,955 0.04 - 
Y 0 0 0 0 0 0 0 0 0 0 0 0 0 0.00 0.57 
To
tal 
258 
11
4 
144 116 63 173 22 158 100 10 110,437 28,492,760 2,484,515,402 1.15 
- 
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The ADAM-2 algorithm arranged individual CNV calls into 258 CNV regions 
(CNVRs; Appendix 2.2) of which 114 were shared between at least 2 individuals of the 
same or different breeds, while 144 were private and found only in one individual Table 
8). Two CNVRs were found in two or more individuals of the same breed but not in 
other breeds and were tentatively considered as breed-specific: a 14 kb loss in chr9 in 
Exmoor ponies and a 39 kb loss in chr20 in Swiss Warmblood horses (Table 9). 
Based on the 258 CNVRs, a whole genome CNV map for the horse was 
constructed (Figure 7) details of which are summarized in Table 8. The mean size of 
CNVRs was 110 kb ranging from 1 kb to 2.5 Mb. The CNVRs occupied 1.15 % of 
equine genome and were distributed over all horse chromosomes, except the Y, with the 
highest enrichment in chromosomes 12 (9.7%) and 20 (3.0 %). Even although chr12 is 
the gene richest chromosome in the horse genome (15 genes/ Mb), there was no overall 
correlation between CNV enrichment and gene density. For example, the enrichment 
values for the second and third gene densest chromosomes, chr11 and chr13, were 
0.02% and 0.28%, respectively (Table 8). Likewise, we did not observe CNV 
enrichment in sub-telomeres, as previously reported for humans (Riethman 2008): the 
array contained 5,716 sub-telomeric probes, although only 10 CNVRs were detected in 
these regions in horses. 
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Table 9: Tentative breed-specific CNVRs 
 
Breed and 
individual 
Chr Start Stop Size Gain  
log2  
Loss    
log2  
Previo
us 
report 
Br
ee
d 
Genes 
Exmoor 
Pony 1 
9 833,013 847,731 14,71
8 
0 -
2.34632
1 
none  
n/a  
intergen
ic 
Exmoor 
Pony 2 
9 833,013 847,731 14,71
8 
0 -
0.73266
6 
none  
n/a  
intergen
ic 
Swiss 
Warmbloo
d 2 
20 47,378,05
5 
47,417,70
0 
39,64
5 
0 -
0.60972
6 
none  
n/a  
mRNA  
JL6268
84  
Swiss 
Warmbloo
d 3 
20 47,378,05
5 
47,417,70
0 
39,64
5 
0 -0.64524 none  
n/a  
mRNA  
JL6268
84  
 
 
In general, losses (173; 67%) prevailed over gains (63; 24%), although 6 horses 
had more gains than losses (Table 7). Twenty-two CNVRs (8.5%) were complex 
involving both losses and gains in different individuals (Table 8). Even although aCGH 
on diploid samples cannot discriminate between copies of alleles and thus, distinguish 
between heterozygous and homozygous CNVs, two gains and 14 losses were tentatively 
considered homozygous because of log2 alterations over 2.0 (Appendix 2.3). 
Homozygosity of 8 losses was confirmed by qualitative PCR (Figure 8). 
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Figure 8: Confirmation of homozygous deletion CNVs by qualitative PCR. 
Red arrows indicates deleted CNVs. 
 
 
Gene content of CNVRs and functional categories of copy number variable genes 
The majority (82%) of horse CNVRs contained one or more known Ensembl 
horse genes (158 CNVRs) or non-horse mammalian reference genes (54 CNVRs) 
(Appendix 2.4), while 46 CNVRs (18%) were located in intergenic regions (Appendix 
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2.5). Gene containing CNVRs were also predominant in individual chromosomes with 
the exception of chr31 which was enriched with intergenic variants (Figure 9). However, 
the calls for intergenic CNVRs are tentative and subject to change as the annotation of 
the horse genome is still in progress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Altogether, the CNVRs involved 805 protein-coding genes (750 Ensembl genes, 
33 non-Ensembl genes and 22 horse mRNAs; (Appendix 2.4) but also non-coding small 
and long RNA genes, and pseudogenes. The largest CNVRs with the highest number of 
genes corresponded to clusters of olfactory and non-olfactory G-protein coupled 
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Figure 9: Chromosome-wise distribution of CNVRs in the horse genome. 
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receptors (GPCRs) or to immunity related genes, such as immunoglobulins, T-cell 
receptors, and MHC protein complex genes - a typical feature of CNVRs in all 
mammalian genomes studied so far (Redon et al. 2006; Berglund et al. 2012; Bickhart et 
al. 2012; Doan et al. 2012a; Hou et al. 2012a; Li et al. 2012). Likewise, Gene Ontology 
(GO) analysis indicated that equine copy number variable genes are predominantly 
involved in biological processes and molecular functions related to transmembrane 
signal transduction, chemo-attractant sensory perception, immune response and steroid 
metabolism (Figure 10; Appendix 2.6). In addition, only one CNVR was involved in the 
following cellular components and molecular processes: the structural constituent of 
cytoskeleton; keratin filament; testosterone 17-beta-dehydrogenase activity, and aldo-
keto reductase activity of secondary sexual development (Appendix 2.6).  
 
 
 
Figure10: GO classifications of copy number variable genes in horses. 
GO= Gene Ontology 
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A composite CNV dataset for the horse genome 
 
Comprehensive knowledge of CNVs in normal horse populations, within and 
across breeds, is a prerequisite for the discovery of variants that contribute to equine 
genetic diseases and disorders. Therefore, we aligned the 258 CNVRs identified in this 
study with previously published CNV data for the horse, viz., (Doan et al. 2012a; Doan 
et al. 2012b; Dupuis et al. 2013; Metzger et al. 2013a; Wang et al. 2014b). Altogether, 
we found records of about 2041 CNVs and CNVRs (calling criteria vary between 
studies). These were further consolidated, based on adjacent locations or partial 
overlaps, into 1476 CNVRs of which 301 CNVRs (20%) were shared between two or 
more studies (Appendix 2.7, Figure 11). The majority of common CNVRs involved 
genes associated with olfactory reception (50 CNVRs) and membrane transport (49 
CNVRs) but also genes involved in transcription (30 CNVRs), cell cycle regulation (12 
CNVRs) and RNA genes (34 CNVRs). Expectedly, CNVRs that were found in more 
than 100 horses and reported by all 6 studies exclusively involved olfactory receptors. 
Most of the shared CNVs between studies are autosomal. In contrast, X chromosome 
CNVs have been reported just in two studies: 21 CNVs by Doan et al. 2012a and 12 in 
this study. Of these, 2 are shared – one involving a long non-coding RNA gene and 
another, an ATPase gene (Appendix 2.4 and 2.7).  
Comparative analysis also revealed that novel CNVRs predominated over shared 
ones in all 6 studies (Figure 11). Novel CNVRs of functional interest from this study 
involved genes related to sperm-egg interaction and fertilization in chr4:19.8-19.9 Mb; a 
 102 
 
long non-coding RNA SOX2-OT in chr19:20.1 Mb which might regulate the SOX2 gene 
and is possibly involved in developmental processes (Amaral et al. 2009); an X-linked 
region harboring genes of circadian pacemaker function in chrX:83.8-84.0 Mb, and a 
complex CNVR in chrUn:225-226 kb with cancer related genes. Notably, the latter two 
CNVRs were found in more than 10 horses each. Details of all novel and shared CNVRs 
are presented in Appendix 2.7. 
 
 
 
 
Figure 11: A summary diagram for the CNVs identified in the horse genome.  
Total CNVs=1476. Numbers in arrow-heads denote the contribution of each study to the 
common pool of 301 shared CNVs/CNVRs; numbers in arrow-tails denote the total and 
novel (in parentheses) CNVs/CNVRs per study. 
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Comparative analysis of horse CNVRs 
 
Attempts were made to align horse CNVR sequences with the human genome in 
UCSC table browser to identify evolutionarily conserved CNVRs shared by the two 
species. In many cases a CNVR in the horse retrieved multiple sequence coordinates in 
the human genome and confounded the analysis. However, some success accompanied 
the alignment of horse gene-containing CNVRs. The corresponding human sequences 
were further analyzed for CNVs in the human Database of Genomic Variants 
(MacDonald et al. 2014). Altogether, after excluding CNVRs containing clusters of 
olfactory receptor and immunity related genes, we identified 80 horse genic CNVRs 
with a homeologous CNVR in the human genome (Appendix 2.8).  
Further, genes involved in CNVRs were compared with Online Mendelian 
Inheritance in Man (OMIM) and Online Mendelian Inheritance in Animals (OMIA) 
databases to see whether any of the equine copy number variable genes are involved in 
known human or animal phenotypes. Notably, 108 CNV-genes from this study were 
present in OMIM database, and 5 genes in OMIA database. The latter were associated 
with known OMIA phenotypes for immune, reproductive, or neuromuscular diseases 
(Table 10). 
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Table 10: Equine copy number variable genes with known mammalian phenotypes. 
 
Gene 
symbol 
Biological system and 
phenotype 
OMIA ID Ensembl ID Location 
Chr:Mb 
CNVR 
size, kb 
CNVR 
Type 
Discovery breeds Reference 
BMPR1B REPRODUCTIVE: Fecundity 
in Booroola and Bonpala 
sheep 
676; 3210 ENSECAG 
00000012140 
3:43.57-43.60 28 Loss Friesian, Quarter 
Horse, 
Standardbred, 
Swiss Warmblood 
This study, 
(Doan et al. 
2012a) 
BTN1A1 IMMUNE: Resistance to 
avian sarcoma and leucosis 
viruses in chicken 
3167 ENSECAG 
00000017948 
20:24.22-24.62 405 Gain American 
Miniature, 
Arabian, Belgian, 
Caspian, 
Clydesdale, Fell 
Pony, Friesian, 
Standardbred, 
Sorraia, Swiss 
Warmblood 
This study, 
(Doan et al. 
2012a; Dupuis 
et al. 2013; 
Wang et al. 
2014b) 
CFH IMMUNE: Thrombocytopenia 
in cattle and dogs 
2691; 1729 ENSECAG 
00000011534 
30:24.74-24.87 132 Loss Sorraia, 
Clydesdale, Fell 
Pony, Friesian, 
Standardbred, 
Swiss Warmblood 
Novel 
GLB1 NEUROMUSCULAR: 
Gangliosidosis in sheep, 
cattle, dogs and cats with 
progressive neuromuscular 
dysfunctions 
700-703 ENSECAG 
00000011942 
16:51.36-51.37 12 Loss Fell Pony  Novel 
KRT1 IMMUNE: Epidermolytic 
hyperkeratosis in dogs 
2618; 2787 ENSECAG 
00000022233 
6:69.75-69.77 21 Loss Akhal-Teke, 
Belgian, Fell 
Pony, Friesian, 
Mongolian, 
Standardbred, 
Swiss Warmblood 
This study, 
(Doan et al. 
2012a; 
Metzger et al. 
2013a) 
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Validation of CNVRs by qPCR 
 
Nineteen CNVRs were validated by quantitative PCR (qPCR) using array probe-
specific primers (Appendix 2.9). The regions were selected upon three criteria – size, 
gene content, and novelty. The tested CNVRs covered a size range from 4 kb to 2 Mb; 
13 involved clusters of horse genes, and 6 were novel. Summary of qPCR results are 
presented in Figures 12 and Appendix 2.10. Overall, qPCR agreed well (P-value < 0.05) 
with the array CGH data. For example, it confirmed a complex CNVR in chr27 
involving CSMD1 gene (CUB and Sushi multiple domains 1) which encodes a 
transmembrane and a candidate tumor suppressor protein (Shull et al. 2013). Copy 
numbers in this region were tested on 11 breeds with at least 2 individuals each and 
showed a gain in native ponies, draft breeds, and the Przewalski horse, and a loss in 
American Miniature horses in relation to the Thoroughbred (Figure 12 F). Likewise, 
qPCR confirmed a CNVR in chr20 (Figure 12 C) which has been found only in this 
study and in indigenous plateau horses (Wang et al. 2014b).  
We also found some differences: instead of a loss, qPCR showed a significant 
gain in chr20:32.0-32.4 Mb and chr17:18.8-19.0 Mb in Swiss Warmblood and 
Mongolian horses, respectively. Also, a loss in chr7:74.8-74.9 Mb in Swiss Warmblood 
horses was not significant by qPCR. These minor discrepancies can be attributed to 
intra-breed variation: array CGH was based on 2 to 4 individuals, while qPCR involved 
4 or more horses per breed (Figure 12; Appendix 2.10). 
  
 106 
 
 
 
Figure 12: Validation of CNVRs by qPCR.  
A. gains and B. losses in Chr27 (37.3 Mb; probe Gs_27_37371896) involving CUB and 
Sushi multiple domains 1 (CSMD1) gene; C. Loss in Chr20 (24.8 Mb; probe 
Eic_20_24841849) involving olfactory receptors; n – number of individuals analyzed. 
D-T. Validation of other selected CNVRs. 
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Validation of CNVRs by FISH 
 
As cell suspensions were not available for most of the horses studied by array 
CGH, FISH validation was carried out for just a few CNVRs using CNV-containing 
CHORI-241 BAC clones. These included BAC 132B13 for a complex 200 kb gain-loss 
region in chr1:114.0-114.2 Mb (Figure 13), and BAC 91B23 for a 2.2 kb gain in chrUn: 
529-531 kb (Figure 14). Clear differences in copy numbers between individual horses, as 
well as between homologous chromosomes of the same horse were observed. 
Additionally, the CNVR in chrUn was mapped to horse chr19q12-q13 (Figure 14).  
 
 
 
 
Figure 13: Validation of a copy number gain in chr1 (114.0 Mb) by FISH. 
A. and B. – metaphase and interphase of the Thoroughbred control; C. and D. metaphase 
and interphase of a Quarter Horse; red signals - BAC 132B13; green signals in D. – a 
single-copy control BAC. Note the difference in copy numbers between homologous 
chromosomes in both horses. 
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Figure 14: Chromosomal assignment and validation of a CNVR. 
CNV present in ChrUn(529-531 kb). A. Mapping the CNVR to chr19q12-q13 by FISH 
with BAC 132B13 (red); green - a control BAC with UMPS gene in chr19q21 
(Raudsepp and Chowdhary 2008a); B. The CNVR (red) in interphase chromosomes of a 
Percheron; green – a single-copy control probe; C. The CNVR (red) in interphase 
chromosomes of a Thoroughbred (Twilight). Note the difference in copy numbers 
between the Percheron and the Thoroughbred, as well as between homologous 
chromosomes. 
 
 
Discussion 
 
Copy number variation is an important and characteristic feature of mammalian 
genomes. It is part of normal genetic variation contributing to phenotypic diversity and 
adaptations (Redon et al. 2006; McCarroll et al. 2008b; Zhang et al. 2009), but can also 
be pathogenic and associated with diseases and disorders. For example in humans, 
CNVs have been associated with autoimmune disorders (Fanciulli et al. 2010; Olsson 
and Holmdahl 2012; Robinson et al. 2012), psychoneurological conditions such as 
schizophrenia (Vassos et al. 2010; Crespi and Crofts 2012; Kirov et al. 2014; Tansey et 
al. 2014) and autism (Krumm et al. 2013; Poultney et al. 2013; Rangasamy et al. 2013; 
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Walker and Scherer 2013), as well as infectious (Fanciulli et al. 2010) and 
cardiovascular diseases (Wineinger et al. 2011; Costelloe et al. 2012; Duschek et al. 
2013). In addition, CNVs pose interest for pharmacogenomics – a field of genomics 
studying the molecular differences in drug metabolism, drug sensitivity, toxicity and 
efficacy between individuals  (He et al. 2011). Furthermore, some CNVs can have both 
adaptive value and pathogenic effect, as recently shown for the CNV in the human 
salivary amylase gene (AMY1) which is associated with diet processing, as well as with 
obesity phenotypes (Falchi et al. 2014). In order to understand the functions of CNVs 
and distinguish between normal and pathogenic variants, detailed knowledge about 
CNVs in the species of interest is needed.  
Here we report about the construction of a 400K high-density WG tiling 
oligoarray for the horse and its application for the discovery of CNVs in 38 normal 
horses of 16 diverse breeds. Probes on the array were designed to detect CNVs in 18,763 
equine autosomal and X-linked genes but also in intergenic, sub-telomeric and Y 
chromosome sequences. Compared to previous CNV studies in the horse, our CNV 
discovery platform most closely resembled the WG 1.3 M NimbleGen CGH array by 
Wang and colleagues (Wang et al. 2014b), but essentially complemented the exon CGH 
array by Doan and colleagues (Doan et al. 2012a) and the studies based on WG SNP50 
BeadChip (McCue et al. 2012; Metzger et al. 2013a). The latter is of a magnitude lower 
density and not specifically designed for CNV capture.  
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Also, as shown in humans and cattle, the efficiency of CNV discovery is lower in 
SNP platforms compared to CNV-focused arrays (Haraksingh et al. 2011; Liu and 
Bickhart 2012). While the future direction for CNV research in any species is probably 
next generation sequencing (NGS), the approach has as yet found only limited 
application in horses: for the discovery of CNVs in the genome of a Quarter Horse mare 
(Doan et al. 2012b) and for the discovery of segmental duplications in 6 horse breeds 
and the donkey (Orlando et al. 2013).  
A unique feature of our CGH array was the inclusion of probes from the Y 
chromosome and sub-telomeric regions. This was because CNVs and segmental 
duplications are known to be an integral part of the architecture of the mammalian Y 
chromosome (Skaletsky et al. 2003; Li et al. 2013), while sub-telomeres are hotspots of 
DNA breakage and repair, and undergo structural rearrangements more frequently than 
the rest of the genome (DeScipio et al. 2008; Riethman 2008). Despite this, only 10 
CNVs were detected in sub-telomeres and none in the Y chromosome (Table 8). It is 
likely that the complex sub-telomeric sequences are missing or underrepresented in the 
current horse sequence draft assembly (Wade et al. 2009), so the designed probes did not 
originate from actual sub-telomeres. Also, because the Y chromosome contains 
ampliconic genes and has acquired sequences from other parts of the genome (Paria et 
al. 2011), many potential copy number variable Y probes did not pass the ‘uniqueness’ 
test by BLAST and were dropped during the array design.  
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Copy number variable genes and intergenic regions 
 
 Our study showed that CNVs tend to be located more frequently in genes than in 
intergenic regions. We also showed that among CNV genes predominately those 
involved in transmembrane signal transduction and chemo-attractant sensory perception 
(olfactory and non-olfactory G-protein coupled receptors, GPCRs), immune response 
(immunoglobulins, T-cell receptors, MHC protein complexes), and steroid metabolism 
(Appendix 2.4, 2.6). Notably, predominance of genic CNVs over intergenic variants, and 
the involvement of the same above mentioned functional gene categories are reported in 
all other CNV studies in horses (Doan et al. 2012a; Doan et al. 2012b; Dupuis et al. 
2013; Metzger et al. 2013a; Wang et al. 2014b), humans (Redon et al. 2006; Hasin et al. 
2008), cattle/ruminants (Fontanesi et al. 2010a; Fontanesi et al. 2010b; Bickhart et al. 
2012), pigs (Wang et al. 2014a), dogs (Berglund et al. 2012) and chickens (Wang et al. 
2010). It is likely that variation in these groups of genes is important for the adaptive 
plasticity of a species as already proposed by Susumu Ohno (Ohno 1970).  
Although the majority of CNVRs involved genes, it is noteworthy that 20% of 
the CNVRs detected in this study were located in intergenic regions. These CNVRs were 
relatively small (average 50 kb, median 35 kb) and represented predominantly losses 
(Appendix 2.5). Prevalence of losses among intergenic CNVRs has also been found in 
humans (Conrad et al. 2006; Freeman et al. 2006) and dogs (Berglund et al. 2012).  
Although there is no information about possible phenotypic effects of these 
regions in animal genomes, studies in humans show that intergenic deletions are 
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significantly enriched among so called regulatory CNVs (Schlattl et al. 2011) and 
probably modulate the expression of nearby genes (Kurth et al. 2009; Kantaputra et al. 
2010). This is in line with the outstanding findings of the ENCODE project (Dunham et 
al. 2012) showing that only 2-3% of the mammalian genome is protein coding. The 
remaining 97-98% of the genome, earlier although to be junk DNA, is actually 
transcriptionally active, contains over 400,000 enhancer like elements and over 70,000 
promoter-like sequences, and is probably involved in a variety of regulatory functions. It 
is therefore plausible that functions of some of these regulatory regions are further 
modulated by CNVs. Thus, with the improvement of genome sequence assembly and 
annotation in horses, intergenic CNVRs would be of interest for future studies.  
 
Copy number variants and segmental duplications  
 
Studies in human (Redon et al. 2006; Du et al. 2012) and cattle (Bickhart et al. 
2012) have noted strong correlation between CNVs and segmental duplications (SDs). 
This is because SDs share 90% sequence similarity with another genomic location and 
can promote CNV formation by non-allelic homologous recombination (Stankiewicz and 
Lupski 2010). 
 Similar tendency has been observed in horses (Doan et al. 2012a), although 
horse SDs are relatively small (largest ~ 60 kb) and involve only about 0.5 – 0.6 % of the 
genome (Wade et al. 2009), thus less than the portion involved in CNVs. An additional 
0.4% of the genome shows SDs in unplaced contigs (chrUn), although in this study only 
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0.04 % of chrUn sequences had CNVs (Table 8). Likewise, chr25 which is the most SD-
rich chromosome (1.7%) according to EcuCab2 genome assembly (Wade et al. 2009), 
was only moderately enriched with CNVs (0.35%) in this study. Yet, findings by us and 
others support the correlation between CNVs and SDs in other regions of the horse 
genome. For example, a known large (750 kb) segmental duplication at the boundary of 
ELA class I and class III (Brinkmeyer-Langford et al. 2010) falls into a large common 
CNVR in chr20:30,127,886-31,231,182 (Appendix 2.4). Interrelation between the two 
types of variation is also supported by GO analysis showing that functional categories, 
such as olfactory reception and immune response, prevail among the genes involved 
both in CNVs and SDs (Orlando et al. 2013).  
 
Integration and comparison of CNV data for the horse 
 
In order to obtain a comprehensive overview about the status of CNV discovery 
in horses, we integrated the CNVRs identified in this study with the CNVs/CNVRs from 
all previous horse studies (Doan et al. 2012a; Doan et al. 2012b; Dupuis et al. 2013; 
Metzger et al. 2013a; Wang et al. 2014b). A composite dataset of 1476 CNVRs was 
generated (Figure 11; Appendix 2.7).  
It is noteworthy that despite six CNV studies in the horse; only 301 CNVRs are 
shared between the studies and can be considered as validated. The remaining 1174 
CNVs/CNVRs are study-specific and just a few have been confirmed by qRT-PCR 
and/or FISH. A similar situation has been encountered in human and other mammalian 
 114 
 
CNV studies (Perry et al. 2006; Perry et al. 2008; Hou et al. 2011) indicating that 
methodological differences in CNV detection may essentially affect the results. With 
this regards, it is important to mention that over 32% (37 out of 116) of novel (study-
specific) CNVRs identified by us aligned with a known CNVRs in the human genome 
(Appendix 2.8), providing an indirect evidence of these being true variants. 
Nevertheless, further work is necessary to confirm that the 1174 regions in the horse 
genome are indeed CNVRs and not just a noise caused by methodology. This is of 
particular importance because the present and all previous CNV studies in horses (Doan 
et al. 2012a; Doan et al. 2012b; Dupuis et al. 2013; Metzger et al. 2013a; Wang et al. 
2014b) differ by discovery platforms, genome coverage, resolution, study cohorts, and 
methodological tools (Tables 11). Therefore, the overall numbers, size ranges, and 
chromosomal distribution of CNVs vary between the studies. For example, due to 
analytical reasons (Wang et al. 2012), all CGH-based studies ((Doan et al. 2012a; Wang 
et al. 2014b), this study) have detected more losses than gains. In contrast, gains 
predominate (97%) among the CNVs found by NGS in a Quarter Horse mare (Doan et 
al. 2012b). Regarding chromosomal representation, CNVs in the X chromosome have 
been found only in this study and by Doan & colleagues (Doan et al. 2012a), and CNVs 
in chrUn only in this study. Further, Wang & colleagues (Wang et al. 2014b) did not 
detect any CNVs in chrs30 and 31, while these two small autosomes show the highest 
number of CNVs in the Quarter Horse mare (Doan et al. 2012b). Major differences are 
also in the size, diversity and origin of study cohorts, ranging from just a few breeds and 
individuals (Doan et al. 2012b; Wang et al. 2014b) to over 15 breeds (this study and 
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(Metzger et al. 2013a)) and hundreds of individuals (Dupuis et al. 2013; Metzger et al. 
2013a) (Table 11).  
 
 
Table 11:  Summary statistics of all CNV studies in horses 
 
 This study Doan et al. 
2012a 
Doan et al. 
2012b 
Dupuis et 
al. 2012 
Metzger et al. 
2013 ** 
Wang et al. 
2014 
Platform Tiling array Tiling array - SNP 
Beadchip 
SNP Beadchip Tiling array 
Genome 
coverage 
WG Exons and UTRs WG WG WG WG 
No of probes 400K 400K - 50K 50K 1.3M 
Method CGH CGH NGS genotyping genotyping CGH 
Breeds 16 15 1 4 17 6 
Horses 38 16 1 477 717 6 
CNVs/CNVRs
* 
258 775  282 478 166-1090 353 
CNV size 
range 
1 kb - 2.5 Mb 197 bp - 3.5 Mb 3.7 kb - 4.8 
Mb 
97 bp - 2.7 
Mb 
516 bp – 0.9 
Mb 
6.1 kb -  
0.5 Mb 
CNVs 
discovered 
WG, X, Un WG, X Autosomes Autosomes Autosomes Autosomes, 
except chr 
30, 31 
Most enriched 
chr. 
12 12 12 12 12 12 
Chrs. with 
highest no. of 
CNVs 
1; 20 1; 7 30; 31 1 12 20 
Genome 
enrichment % 
1.15 3.65 3.53 2.32 1.7 - 22.0 0.61 
* As reported by original studies and before consolidating overlapping and tandemly 
located CNVRs into composite dataset  
** The data by Metzger and colleagues (2013) vary in a broad range because the authors 
carried out multiple analyses to test different software packages.  
 
 
Besides the differences, there are also outstanding similarities between horse 
CNV studies (Table 11): all agree that CNVs account for about 1 to 3 % of the horse 
genome; that there are more CNVs in genes than in intergenic regions, and all studies 
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unanimously find chr12 being the most CNV-enriched - not because of many CNVs, but 
because of a few very large clusters of olfactory receptors and immunity-related genes 
(Appendix 2.4, Appendix 2.6).  
 
Breed-specific CNVs 
 
One of the goals of CNV research in horses is to find breed specific variants that 
could be related to particular phenotypic traits or adaptations. To achieve this goal, CNV 
research in a large number of diverse horse breeds, each represented by multiple 
individuals, is needed. In order to evaluate the status of CNV research in horses from 
this viewpoint, we made a list of all horse breeds studied for CNVs and performed a 
phylogenetic analysis using population data of 15 microsatellite loci (Khanshour et al. 
2013). 
Currently, 41 horse breeds, thus less than 10% of the over 400 horse breeds 
known worldwide (Hendricks 1995), have been studied for CNVs (Table 12). 
Importantly, 25% (11/41) of the studied breeds were included in this study and 
represented mainly native ponies and draft horses. Genetic relationships of 32 breeds 
(the ones for which microsatellite genotyping data was available; E.G. Cothran, 
unpublished) are presented in Figure 15. The dendrogram shows that while the major 
clades of domestic horses are represented, there is a clear preponderance of the breeds 
with Thoroughbred ancestry.  
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Furthermore, only 7 breeds have been involved in 2 or more studies (Figure 15, 
Table 12) and several breeds are represented by just one individual (Doan et al. 2012a; 
Wang et al. 2014b). Therefore at this stage of research, any horse CNV reported to be 
breed-specific should be taken with caution. For example, our composite CNV dataset 
(Appendix 2.7) shows that the 18 CNVs reported to be specific for Hanoverians 
(Metzger et al. 2013a) are present in other breeds. Likewise, only one of the 7 CNVs 
considered to be specific to plateau breeds (Wang et al. 2014b), is not found in other 
breeds. The same happened with our data where initially we identified over 10 putative 
breed-specific CNVs which, after comparison, reduced to 2: one in Exmoor pony, 
another in Swiss Warmblood horse (Table 9). Interestingly, no specific CNVs were 
found in the Przewalski horse which shared similarity mainly with ponies and draft 
breeds (Appendix 2.1). Besides, only 9 of the 25 CNVs in Przewalski horses were shared 
between the two individuals studied. Similar tendency for intra-breed individual 
variation was observed for domestic horses where private CNVs predominated over the 
shared ones. Nevertheless, as suggested by other studies in horses (Doan et al. 2012a), 
cattle (Liu and Bickhart 2012), pigs (Wang et al. 2014a) and dogs (Molin et al. 2014),we 
anticipate that a small percentage of CNVs might remain unique to their respective 
breeds, although this requires analysis of much larger and more diverse equine 
populations. 
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Table 12: List of horse breeds studied for CNVs 
 
Breed Reference 
Abaga horse Wang et al. 2014 
Akhal-Teke This study 
American Miniature Horse Doan et al. 2012a, this study 
American Quarter Horse Doan et al. 2012a, Doan et al. 2012b, this study 
Andalusian Doan et al. 2012a 
Anglo-Arabian Metzger et al. 2013 
Arabian Doan et al. 2012a, Metzger et al. 2013, this study 
Arabian (Shagya) Doan et al. 2012a 
Belgian Draft This study 
Brandenburger Metzger et al. 2013 
Caspian Pony This study 
Clydesdale This study 
American Baskhir Curly Doan et al. 2012a 
Debao Wang et al. 2014 
Exmoor This study 
Fell Pony This study 
Friesian This study 
German Riding Pony Metzger et al. 2013 
Gypsy Vanner Doan et al. 2012a 
Hanoverian Doan et al. 2012a, Metzger et al. 2013 
Hegu Wang et al. 2014 
Holsteiner Metzger et al. 2013 
Hungarian Doan et al. 2012a 
Kasakh Wang et al. 2014 
Lucitano Doan et al. 2012a, Metzger et al. 2013 
Maremanno Metzger et al. 2013 
Mongolian Native Wang et al. 2014, this study 
Oldenburg Metzger et al. 2013 
Paso Fino Doan et al. 2012a 
Percheron This study 
Peruvian Paso Doan et al. 2012a 
Rhinelander Metzger et al. 2013 
Rhenish-German Cold Blood Metzger et al. 2013 
Selle Francais Metzger et al. 2013 
Shire Doan et al. 2012a 
Sorraia This study 
Standardbred This study 
Swiss Warmblood This study 
Thoroughbred Doan et al. 2012a, Dupuis et al. 2012, Metzger et al. 
2013, Wang et al. 2014, this study 
Trakehner Metzger et al. 2013 
Welsh-Arabian pony Doan et al. 2012a 
Westphalian Metzger et al. 2013 
Zweibrücker Metzger et al. 2013 
Przewalski horse Metzger et al. 2013, this study 
*No individual breeds were specified by Dupuis and colleagues (2012) where horses 
were classified as ponies, trotters, warmblood or draft breeds. 
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Figure 15. Genetic relationships of the horse breeds studied for CNVs. 
Phylogenetic analysis done by Maximum Likelihood. 
* New breeds added in this study (except Swiss Warmblood); 
** Breeds involved in 2 or more studies. Numbers denote bootstrap values.  
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In summary, this study contributes to CNV research in horses by analyzing 
genomes of 16 horse breeds of which 11 were studied for CNVs for the first time. We 
took an important step towards the discovery of variants of biomedical importantce by 
carrying out a comparative analysis and integration of all available CNV data for the 
horse. We generated an integarted datset of 1476 equine CNVRs which is a necessary 
resource for the study of sequence properties and functional profiles of equine CNVs, as 
well as for the discovery of new variants, particularly those with possible pathogenic 
effects. We conclude that despite progress, the majority of the CNVs reported for the 
horse require further validation by invloving more diverse breeds and individual 
animals, and using comparable methodological platforms.  
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CHAPTER III 
ANALYSIS OF GENOMIC COPY NUMBER VARIATION IN EQUINE 
RECURRENT AIRWAY OBSTRUCTION 
 
Introduction 
 
Respiratory disorders directly affect the health, well-being, and performance of 
horses and have a major economic burden on the owners. Affected horses cannot 
compete for key events and require constant treatment or prevention that is expensive 
and has limited efficacy. That is why the equine industry and practitioners have listed 
respiratory ailments as disorders of the highest research priority in the horse (Oke 2013).  
Recurrent airway obstruction (RAO) is a common chronic pulmonary disease 
that affects the respiratory system of adult horses of diverse breeds’ worldwide 
(Robinson et al. 1996). The condition has two forms. One form, usually referred to as 
just RAO or chronic obstructive pulmonary disease (COPD-RAO) (Venugopal et al. 
2010), affects horses living in poorly ventilated stalls in cold climate. Continuous 
inhalation of organic dusts and endotoxins causes hypersensitivity reaction of the lower 
respiratory tract and results in inflammation, airway-blockage, bronchial muscle 
contraction, and difficulty in breathing during resting (Derksen et al. 1988; McGorum et 
al. 1993; Pirie et al. 2003). The other form is summer pasture associated obstructive 
pulmonary disease (SPAOPD) which is caused by air born allergens in pasture-living 
horses in warm and humid climates (Seahorn et al. 1994). Clinical signs of SPAOPD 
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include recurrent nasal discharge, cough, labored expiratory effort, and crackles and 
wheezes on auscultation (Seahorn and Beadle 1993). Overall, the pathophysiologic 
changes for COPD-RAO and SPAOPD-RAO are similar, characterized by mucus 
production, neutrophil accumulation in the airway, bronchial hyperactivity, and 
bronchospasm (Venugopal et al. 2010). In literature, the cold climate form is typically 
referred to as RAO, and the Southern form as SPAOPD-RAO (Venugopal et al. 2010). 
Notably, many of the clinical symptoms observed in RAO are indicative of human 
asthma due to which this equine condition has been proposed to serve as a natural model 
for asthma in humans (Swinburne et al. 2009; Scharrenberg et al. 2010).  
Being a complex disease, etiology of RAO involves both an environmental and a 
genetic component. The latter is thought to be polygenic (Schaeper 1939) with a 
complex inheritance mode (Schaeper 1939; Gerber et al. 2009), variable expressivity and 
genetic heterogeneity across equine populations (Swinburne et al. 2009). Due to this 
complexity, the current knowledge of RAO genetics is limited. The condition has been 
studied using a combination of genomics approaches, such as microsatellite- and SNP-
based whole-genome association studies (Swinburne et al. 2009; Shakhsi-Niaei et al. 
2010; Shakhsi-Niaei et al. 2012), candidate gene and whole genome gene expression 
profiling (Kachroo et al. 2010; Venugopal et al. 2010; Cote et al. 2012; Klukowska-
Rotzler et al. 2012b; Lanz et al. 2013) and pathway analysis of candidate genes 
combined with proteomic data (Racine et al. 2011). While the findings provide some 
insight into the multi-genic and complex nature of the condition and show the likely 
involvement of interleukins and other innate immunity related genes (Shakhsi-Niaei et 
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al. 2010; Klukowska-Rotzler et al. 2012a; Shakhsi-Niaei et al. 2012; Lanz et al. 2013), 
still very little is known about the genetic predisposition of horses to RAO, and 
molecular genetic mechanisms modulating pathogenesis of the disease. 
So far, candidate gene and association studies of RAO in horses have primarily 
focused on SNPs, and not considered possible role of another form of common genetic 
polymorphism – copy number variation (CNVs). This involves deletions, duplications, 
and complex rearrangements typically larger than 50 base-pairs that contribute to 
phenotypic plasticity and adaptations, but can also be pathogenic and associated with 
diseases and disorders (Conrad et al. 2010b; Weischenfeldt et al. 2013). For example, 
recent studies show that over 20% of asthma candidate genes are located near or within 
CNVs, suggesting possible role of CNVs in the susceptibility and/or pathogenesis of 
human asthma (Rogers et al. 2013; Ceroni et al. 2014). 
Building upon these findings in humans, the aim of this study is to investigate 
potential involvement of CNVs in equine RAO. Using a custom-made whole-genome 
tiling array, we identify CNVs in the genomes of severely RAO affected horses and 
matching controls. The findings add to our insights about the genetic component of this 
respiratory disorder and the role of CNVs in equine complex traits.  
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Material and methods 
 
Horses and phenotypes 
 
The study population (n=63) comprised of severely RAO affected (n=39) and 
age- and/or breed-matched healthy control horses (n=24) of various breeds (Table 13). 
The horses originated from three different study populations and were phenotyped as 
follows: i) RAO affected (n=20) and control (n=19) Swiss Warmblood horses were 
phenotyped at the University of Bern, Switzerland (Dr. Gerber) by measured exposure to 
agents that trigger RAO, followed by detailed clinical examination using the Horse 
Owner Assessed Respiratory Signs Index (HOARSI) (Laumen et al. 2010)(Lanz et al. 
2013). All RAO affected horses in this group categorized as HOARSI-4 and the controls 
as HOARSI-1; ii) RAO affected horses (n=13) of different breeds from The University 
of Montreal, Canada (Dr. Lavoie) were phenotyped by exposure to moldy hay to induce 
airway obstruction, followed by full clinical exam which included tests for airway 
reactivity, mucus accumulation, and transpulmonary pressure, and cytological analysis 
of tracheo-bronchial and bronchio-alveolar fluids (Lavoie-Lamoureux et al. 2012; de 
LAGARDE et al. 2014), and iii) SPAOPD-RAO (n=6) and matched control horses (n=5) 
of different breeds were phenotyped according to HOARSI (Laumen et al. 2010) at the 
Mississippi State University (Dr. Swiderski) as HOARSI-4 (RAO affected) and 
HOARSI-1 (controls). Twenty-two horses (16 RAO affected and 6 controls, Table 13) 
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were studied by array CGH, while all 63 animals were analyzed by quantitative PCR 
(qPCR). 
 
 
Table 13:  Details about the RAO study cohort.  
H4 – HOARSI4; H1 – HOARSI1; SPA – SPAOPD; * - horses used for array CGH 
 
Horse ID Breed Gender Sample origin 
RAO affected 
horses  
 
 
*H4-1912 Swiss-Warmblood Female University of Bern, Switzerland 
H4-1883 Swiss-Warmblood Male University of Bern, Switzerland 
*H4-1892 Swiss-Warmblood Female University of Bern, Switzerland 
*H4-1943 Swiss-Warmblood Male University of Bern, Switzerland 
H4-1970 Swiss-Warmblood Female University of Bern, Switzerland 
*H4-1987 Swiss-Warmblood Male University of Bern, Switzerland 
H4-1996 Swiss-Warmblood Male University of Bern, Switzerland 
H4-2004 Swiss-Warmblood Female University of Bern, Switzerland 
H4-2015 Swiss-Warmblood Male University of Bern, Switzerland 
H4-2021 Swiss-Warmblood Female University of Bern, Switzerland 
*H4-1998 Swiss-Warmblood Male University of Bern, Switzerland 
*H4-1999 Swiss-Warmblood Male University of Bern, Switzerland 
H4-2007 Swiss-Warmblood Male University of Bern, Switzerland 
H4-2017 Swiss-Warmblood Female University of Bern, Switzerland 
*H4-2029 Swiss-Warmblood Male University of Bern, Switzerland 
H4-2035 Swiss-Warmblood Male University of Bern, Switzerland 
*H4-2109 Swiss-Warmblood Male University of Bern, Switzerland 
H4-2134 Swiss-Warmblood Male University of Bern, Switzerland 
H4-2139 Swiss-Warmblood Male University of Bern, Switzerland 
H4-2147 Swiss-Warmblood Female University of Bern, Switzerland 
SPA-H4-1 Appaloosa Male Mississippi State University, USA  
*SPA-H4-2 Quarter Horse Male Mississippi State University, USA  
*SPA-H4-3 Tennessee Walking Male Mississippi State University, USA  
*SPA-H4-4 Missouri Foxtrotter Female Mississippi State University, USA  
*SPA-H4-5 Tennessee Walking Male Mississippi State University, USA  
SPA-H4-6 Mustang Male Mississippi State University, USA  
*RAO-40 Standardbred Female University of Montreal, Canada  
*RAO-354 Appaloosa Male University of Montreal, Canada  
*RAO-361 Thoroughbred Female University of Montreal, Canada  
RAO-363 Quarter Horse Female University of Montreal, Canada  
*RAO-372 Belgian draft Female University of Montreal, Canada  
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Table 13 continued 
Horse ID Breed Gender Sample origin 
RAO affected 
horses  
 
 
RAO-378 
Flea-bitten Grey 
Horse 
Female 
University of Montreal, Canada  
RAO-379 Canadian Female University of Montreal, Canada  
RAO-380 Standardbred Male University of Montreal, Canada  
RAO-382 Paint Male University of Montreal, Canada  
RAO-383 Arabian Female University of Montreal, Canada  
RAO-384 Quarter Horse Female University of Montreal, Canada  
RAO-391 Appaloosa Female University of Montreal, Canada  
RAO-392 Quarter Horse Female University of Montreal, Canada  
Control horses    
*H1-126* Swiss-Warmblood Female University of Bern, Switzerland 
*H1-140 Swiss-Warmblood Female University of Bern, Switzerland 
*H1-146 Swiss-Warmblood Female University of Bern, Switzerland 
*H1-154 Swiss-Warmblood Male University of Bern, Switzerland 
H1-160 Swiss-Warmblood Male University of Bern, Switzerland 
H1-191 Swiss-Warmblood Male University of Bern, Switzerland 
H1-225 Swiss-Warmblood Female University of Bern, Switzerland 
H1-1502 Swiss-Warmblood Male University of Bern, Switzerland 
H1-1864 Swiss-Warmblood Female University of Bern, Switzerland 
H1-192 Swiss-Warmblood Male University of Bern, Switzerland 
H1-1145 Swiss-Warmblood Female University of Bern, Switzerland 
H1-1460 Swiss-Warmblood Female University of Bern, Switzerland 
H1-1509 Swiss-Warmblood Male University of Bern, Switzerland 
H1-1511 Swiss-Warmblood Male University of Bern, Switzerland 
H1-1519 Swiss-Warmblood Male University of Bern, Switzerland 
H1-1605 Swiss-Warmblood Male University of Bern, Switzerland 
H1-1610 Swiss-Warmblood Female University of Bern, Switzerland 
H1-1941 Swiss-Warmblood Female University of Bern, Switzerland 
H1-2008 Swiss-Warmblood Male University of Bern, Switzerland 
SPA-Hl-1 Quarter Horse 
Male Mississippi State University, 
USA  
SPA-Hl-2 Quarter Horse 
Male Mississippi State University, 
USA  
*SPA-Hl-3 Quarter Horse 
Male Mississippi State University, 
USA  
SPA-Hl-4 Quarter Horse 
Female Mississippi State University, 
USA  
*SPA-Hl-5 Thoroughbred 
Female Mississippi State University, 
USA  
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DNA isolation & quality control 
 
DNA was isolated from peripheral blood and/or hair using standard PCI (Phenol/ 
Chloroform/ Isoamyl alcohol) method (Sambrook et al. 1989) or Gentra Puregene Blood 
Kit (QIAGEN, USA) according to manufacturer’s protocol. The latter was modified to 
adjust it for DNA isolation from hair follicles. Briefly, hair follicles were incubated in 
cell lysis solution for at least 72 hrs. After isopropanol treatment to precipitate DNA 
pellet, the sample was centrifuged at 16,000 x g for 20-30 minutes, instead of 3 minutes 
at 2000 x g, according to the original protocol. The same applied after treatment with 
70% ethanol. The DNA was cleaned with DNeasy Blood and Tissue kit (Qiagen) with 
the following modifications to the manufacturer’s protocol: during DNA purification, 
80% ethanol was used instead of solution AW2, and the final DNA pellet was eluted in 
water instead of solution AE. The final quality and quantity of the DNA samples were 
checked by gel electrophoresis on a 1% agarose gel and by Nanodrop spectrophotometry 
(Thermo Scientific).  
 
Array comparative genomic hybridization 
 
Array CGH experimental procedures 
Probe labeling and array CGH experiments were performed according to Agilent 
Technologies Protocol Version 6.2.1. All hybridizations comprised of a pair of 
differently labeled probes, one of which was always the reference DNA (Thoroughbred). 
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Briefly, 1µg of purified genomic DNA was digested with restriction enzymes RsaI and 
AluI for 2 hours at 37C and 20 minutes at 65C to produce 200-500 bp fragments. 
Cleaved samples were labeled with fluorescence dyes Cy3 (for the reference DNA) or 
Cy5 (for sample DNA) by random priming using Genomic DNA Enzymatic Labeling 
Kit (Agilent Technologies). The final labeling reaction contained random primer (5µl), 
1X dNTP (5µl) mix, 1X reaction buffer (10µl), Exo-Klenow enzyme (1µl) and Cy3- or 
Cy5-dUTP (3µl), and was conducted for 2 hours at 37C, 10 minutes at 65C. The 
products were cleaned with 30 kDa filters (Amicon) and the yield and specific activity of 
labeled DNA was determined with a Nanodrop spectrophotometer. Typical yield for 1 
µg of starting DNA was 6-8 µg; specific activity for Cy3 was 25-40 pmol/µg and for 
Cy5 20-35 pmol/µg. The hybridization mixture was prepared using Agilent Oligo aCGH 
Hybridization Kit and contained equal quantity of Cy3 and Cy5 labeled probes, 1 µg/µL 
horse Cot1 DNA, 10X blocking agent, and 2X Hi-RPM buffer. Denatured and pre-
annealed probe mixture was applied onto gasket slide, placed in Agilent SureHyb 
hybridization chamber, ‘sandwiched’ with an array slide and incubated in Agilent 
hybridization oven at 65C for 40 hours. The array slides were washed with Agilent 
aCGH Wash Buffers 1 and 2, 10 min in each, and dried with Acetonitrile and Agilent 
Stabilization and Drying Solutions.  
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Array data analysis 
The array slides were scanned with Agilent SureScan DNA Microarray Scanner 
and Agilent Scanner Control software v8.3. The data were extracted and normalized 
with Agilent Feature Extraction software v11.0.1.1 and saved in .fep format. The Feature 
Extraction software checks the quality of aCGH by measuring Derivative Log2 Ratio 
Standard Deviation (DLRSD), Signal-To-Noise Ratio (SNR) and Background Noise 
(BGNoise). The data were further analyzed with Agilent Genomic Workbench 5.0 
software. In each array spot log2 ratios of Cy3 versus Cy5 were computed with the 
default P-value threshold 0.05 and overlap threshold value 0.9. The CNVs were 
represented by gains and losses of normalized fluorescence intensities relative to the 
reference and called by conservative criteria which required alternations of >0.5 log2 
ratios over 5 neighboring probes. Homozygous losses were called when signal log2 ratio 
was <-2.0. Copy number variable regions (CNVRs) were determined by ADM-2 
algorithm (Lipson et al. 2006) by combining overlapping CNVs in all samples across the 
CGH experiments. Parameters used in this analysis were as follows: Threshold of ADM-
2: 6.0; Centralization: ON (Threshold: 6.0, Bin Size: 10); Fuzzy Zero: ON; Aberration 
Filters: ON (minProbes = 5 & minAvgAbsLogRatio = 0.5 & maxAberrations = 10000 
AND percentPenetrance = 0); Feature Level Filters: ON, IntraArray: ON). Output files 
were generated with genomic coordinates and cytoband locations for all CNVs. The raw 
data will be submitted to NCBI Gene Expression Omnibus (GEO). 
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Quantitative PCR (qPCR) 
 
Genomic copy number changes in horse genes SPI2 and SERPINA1 in chr24, as 
detected by aCGH, were validated and further analyzed by qualitative and quantitative 
PCR. Primers for array probes, genomic segments and gene exons and introns (Table 14) 
were designed using horse whole genome sequence information (EquCab2), UCSC 
Genome Browser, and Primer3 software. Optimal DNA concentration for qPCR, 25 
ng/µL, was determined by serial dilutions. The qPCR experiments were performed with 
LightCycler® 480 (Roche Diagnostics) in triplicate assays. Each assay was done in 
triplicate 20 µL reactions containing 50 ng of template DNA, 10 μM primers, and the 
SYBR Green PCR kit (Roche). Relative copy numbers of the selected regions were 
determined in comparison to the reference sample (Thoroughbred) and normalized to an 
autosomal reference gene GAPDH. The cycling conditions were 1 cycle 5 min at 95°C; 
45 cycles 10 sec at 95°C, 5 sec at 58°C, and 10 sec at 72°C; 1 cycle for melting curve 30 
sec 95°C, 30 sec 65°C and final cooling 20 sec at 50°C. Quantification of the copy 
number was carried out using the comparative CT method (2
ΔΔ
Ct) (Livak and 
Schmittgen 2001; Bodin et al. 2005) with p<0.05 as a cut-off threshold for statistical 
significance. Qualitative PCR results were analyzed by agarose gel electrophoresis. 
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Table 14: Primers for qualitative and qPCR to analyze a CNVR in chr24. 
 (see also Figure 3.1 for explanations) 
 
 
 
 
No Primer 
Locatio
n 
Forward 5'-3' Reverse 5'-3' Product 
size, bp 
1 SPI2 3’ TCGGAGCCTCAGTTTCTTCT ACATGAGGGATGACGGTGA 133 
2 SPI2 3’ GTTATGCGGAGTTGCACACA ATCACCGCCTAAGCCACTC 100 
3 SPI2 3’ TTCAGGAAGCTGTGGGTTTC CCTTGCCTGTGTCCACTGTA 157 
4 Exon GTGCCAGGTCAACCATTCTT ACCACGATGTGGGAAATCAT 216 
5 Exon TGCCCAAACTGTCCATTTCT GTCAAGGGCACTTCCTCAGT 121 
6 Intron GTCAGGCCAGTAGGTTGGAA AGCCTGAGTGGTGCTACCTG 135 
7 Intron AGAGGCTTTGCAGGACAAGA TCTCCCACTTAGCCCCCTAT 113 
8 Exon TCGAGCCTGAGTCTACGACA GTCGGGCAGGATGAAGAAG 105 
9 Intron TGCACAACCAACCTGAGCTA CCTTCTTTGCTGGTGGAAAC 103 
10 Intron TACAAAGAACACGGGACTCG ACAGGTTCCCGACAGTTTCA 115 
11 Intron TTAGCCCCGTTTACAGATGG GGAGAGAAGGGAAGGTGGAC 159 
12 Array 
probe 
GCAAAGCCCTCATCTTCTTG GTGGGTTTCAGCCAACATTT 167 
13 Exon TTCCTTGGGTTCCCTTTTCT GCTTCCAGCATCTCCTGAAC 219 
14 Array 
probe 
AGAATATCCCAAGCCACCAG CCTCACCTTCCCCATCTGTA 199 
15 Array 
probe 
GTGCTGACCATTGACGAGAA TTAAGACGAAGGGCCTGTTG 109 
16 Array 
probe 
CAAATATCCCAAGCCACCAG GACGGATTTTGCGAGGATAA 148 
17 Array 
probe 
GCTCCTGAACCACAGAGTCC GGTAGCTCTTGCTCCTCGTG 134 
18 Array 
probe 
TAACGACAGGCCATTCTTCC AAGAAGAGCTTCCCCTGAGC 194 
19 Exon TGGGGAGAAGAAGATGTTGG CTGAGGATCTGCAGGGAGAC 173 
20 Exon TCGAGCCTGAGTCTACGACA GTCGGGCAGGATGAAGAAG 176 
21 Array 
probe 
GTGCTGACCATTGACGAGAA TTAAGACGAAGGGCCTGTTG 109 
22 Exon GTTTGCCCAAACTGTCCATT ACACTGTCAGGGACGTTTCC 129 
23 Array 
probe 
AGAACCGTCACCTGACAAGG CCATCTGGCTGTGCAGAGTA 153 
24 Exon GCTGAACCAGAGAGGCAGTT GACGAGAAAGGCACTGAAGC 183 
25 Array 
probe 
GTGTCCCAGGTCTTCTCGTC CTGAACCACACACAGGAAGC 155 
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Gene content analysis of CNVs 
 
Ensembl gene list (Ensembl Genebuild 73.2) along with their position in the 
horse genome was added to Agilent Genomic Workbench as a custom track to determine 
the genic and intergenic CNVs. Gene Ontology analysis (GO) and Kyoto Encyclopedia 
of Genes and Genomes (KEGG) pathway analysis of the genes present in CNVs were 
performed using DAVID (The Database for Annotation, Visualization and Integrated 
Discovery) bioinformatics tool with default settings (Huang da et al. 2009b; Huang da et 
al. 2009a). TheGO annotations used were: BP (Biological Process), MF (Molecular 
Function) and CC (Cellular Component). Because only a limited number of genes in the 
horse genome have been annotated, horse gene IDs were converted to orthologous 
human Ensembl gene IDs by BioMart, followed by GO and pathway analyses, as 
described above. Biological functions of the genes in CNVRs were further analyzed 
manually by data mining in Ensembl (Stalker et al. 2004), UCSC (Karolchik et al. 2003) 
and NCBI (Sayers et al. 2010) Genome Browsers searching for data for equine orthologs 
in other mammalian species. CNVs present in intergenic regions were analyzed in UCSC 
genome browser and NCBI and GeneCards for similarities to known mammalian genes. 
Genes present within equine CNVRs were also aligned with the human genome variant 
database (HGVD) and Online Mendelian Inheritance databases for Man (OMIM) and 
Animals (OMIA). 
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Results 
 
CNV discovery and analysis 
 
Array CGH experiments in 22 horses, 16 RAO cases and 6 controls, resulted in 
760 CNV calls (Table 15; Appendix 3.1) with an average of 35.9 calls per individual. 
This number is slightly higher than the 26.4 calls per individual as reported by us for 
normal horse populations in Chapter II. Among individual horses, the number of CNV 
calls was the highest (69) in a SPAOPD affected Quarter Horse SPA-H4-2 and the 
lowest (10) in an RAO-affected Standardbred RAO-40 (Table 15). While there were no 
significant differences between the numbers of CNV calls between RAO cases and 
controls, a clear tendency for fewer calls was observed for experiments using DNA 
isolated from hair follicles compared to blood DNA (Table 15).  
Losses clearly dominated over gains which is a typical feature for aCGH 
experiments and reported by us (Chapter II) and others (Doan et al. 2012a; Wang et al. 
2012; Wang et al. 2014b) before. Completely and partially overlapping CNV calls were 
merged into 245 CNV regions (CNVRs) (Appendix 3.2). 
Next, in order to find CNVs specific to RAO cases, we compared the CNVRs 
detected in this study with the composite dataset of 1476 CNVs/CNVRs for the horse 
(Chapter II) and with the CNVRs detected in horses with disorders of sexual 
development (Chapter III). Comparison revealed that the majority (197) of CNVRs 
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found in this study were shared with other equine populations, thus validating those as 
common CNVRs in the horse genome.  
Importantly, 48 CNVRs (Appendix 3.3) were found only in the RAO study 
cohort (16 cases, 6 controls) and, thus, represented novel CNVRs for the horse. Among 
these, 18 were present in both RAO cases and controls, or controls only, and contributed 
mainly to the horse CNV dataset. However, 30 variants were exclusive to RAO cases 
and subjected for further analysis.  
 
Novel CNVRs in RAO affected horses 
 
After the initial analysis of all CNVRs, we focused on the 30 novel CNVRs that 
were found only in RAO affected horses (Table 16; Appendix 3.4) and were tentatively 
referred to as ‘RAO-specific’. Such CNVRs regions were detected in 9 out of 16 RAO 
affected horses and the majority were private, thus present in only one individual (Table 
16; Appendix 3.4). One novel CNVR, a 36 kb loss in chr10 involving an immunity-
related FUT9 gene (Comelli et al. 2006), was shared by a Swiss Warmblood H4-1998 
and a Quarter Horse SPA-H4-2. No RAO specific CNVRs were found in six affected 
horses, viz., RAO-40, RAO-354, RAO-361, RAO-372, H4-1892, H4-2109, and SPA-
H4-3. Chromosome-wise, the RAO specific CNVRs were distributed on 15 autosomes 
(chr1, 3, 5, 6, 8, 10, 11, 14, 15, 16, 20, 21, 23, 24, 29, and chrUn. The average size of 
these CNVRs was 37 kb which is smaller than the 110 kb average for the horse genome 
(Chapter II).   
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Table 15: Summary of CNV calls in RAO cases and controls. 
 H1 – controls; H4 –cases; @ - horses used in breed CNV study in Chapter II. 
 
Horse ID & 
phenotype 
#CNVs  Gains Losses Novel DNA 
source 
RAO affected horses  
*H4-1912 43 11 32 1 blood 
*H4-1892 39 12 27 0 blood 
*H4-1943 42 4 38 1 blood 
*H4-1987 60 10 50 5 blood 
*H4-1998 59 6 53 3 blood 
*H4-1999 61 3 58 4 blood 
*H4-2029 23 0 23 1 blood 
*H4-2109 30 3 27 0 blood 
*SPA-H4-2 69 15 54 12 blood 
*SPA-H4-3 39 14 25 0 blood 
*SPA-H4-4 21 11 10 2 blood 
*SPA-H4-5 24 9 15 1 blood 
*RAO-40 10 4 6 0 hair 
*RAO-354 18 1 17 0 hair 
*RAO-361 11 4 7 0 hair 
*RAO-372 13 3 10 0 hair 
Control horses  
*H1-126 30 8 22 0 blood 
*H1-140@ 29 9 20 1 blood 
*H1-146@ 30 6 24 1 blood 
*H1-154@ 23 1 22 0 blood 
*SPA-H1-3 24 7 17 0 blood 
*SPA-H1-5 62 18 44 0 blood 
Total 760 159 601 32  
Average 35.9     
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Altogether, 24 of the 30 RAO specific CNVRs (80%) involved transcribed 
genes: 19 protein coding genes and 9 known human or horse mRNA/cDNA sequences 
(Table 16, Appendix 3.4). Six CNVRs were located in intergenic regions or in chrUn. 
Functional relevance of the genes to RAO was further analyzed by mining human and 
animal genome databases (NCBI, Ensembl, GeneCards, GO, HGVD, OMIM, OMIA) 
and published literature. 
Among the CNV genes, several posed interest due their involvement in acquired 
and innate immunity (BTNL2 MHC class III; FUT9; RNASE9), infections (FUT9; 
KRT23), disease susceptibility (BTNL2), respiratory disorders (BTNL2, LINGO2, SPI2, 
SERPINA1) and tuberculosis (BTNL2, Morais et al. 2012; RDH16, SIRT4), autoimmune 
disorders (BTNL2 rheumatoid arthritis; Mitsunaga et al. 2013) and drug metabolism 
(ELTD1, RDH16). However, none of the RAO specific CNVRs involved genes which 
have been previously associated with RAO, such as interleukins or interleukin receptors, 
(Klukowska-Rotzler et al. 2012b; Shakhsi-Niaei et al. 2012). Likewise, no CNVRs were 
detected in horse chromosome 11 which is homeologous to HSA17q21 (Raudsepp et al. 
1996, Raudsepp et al. 2008) – the strongest candidate region for human asthma by 
GWAS (Akhabir & Sandford 2011). Even although a CNVR in chr15 at 79 Mb in a 
Swiss Warmblood H4-1999 fell into one of the RAO candidate regions according to 
GWAS (Swinburne et al. 2009), the functions of the NBAS gene in the CNVR were not 
related to autoimmunity or inflammation (Table 16). 
Eighteen equine RAO specific genic CNVRs had a homeologous CNVR in The 
Human Genome Variant Database (HGVD) (Table 16) - an indication that these 
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genomic regions tend to be copy number variable in diverse mammalian genomes. The 
search of OMIM and OMIA databases revealed that 6 RAO-specific CNVRs involved 
genes associated with 6 known Mendelian disorders in humans, and one in dogs (Table 
16).  
Of particular interest was a CNVR in chr24 at 37 Mb in a Swiss Warmblood 
horse H4-1987 (Table 16). This was the only RAO specific CNVR which corresponded 
to entries in all three databases analysed: the HDGV, OMIM and OMIA. Most 
importantly, the region involved two genes, SPI2 and SERPINA1, which encode for 
alpha-antitrypsin. Deficiency of alpha-antitrypsin causes lung and liver malfunctioning, 
and human SERPINA1 is a known candidate gene for Chronic Pulmonary Obstructive 
Disease (COPD) (Zorzetto et al. 2008; Denden et al. 2010; Papatheodorou et al. 2010; 
Carroll et al. 2011; Quint et al. 2011; Serapinas et al. 2012; Linja-aho et al. 2013). 
Furthermore, this CNVR is located less than 40 kb upstream of a cluster of at least 5 
other serpin-family genes (Figure 16), including SERPINA3 which has been associated 
with human asthma (Rogers et al. 2012). Due to these reasons, this CNVR was analyzed 
in more detail (see below). 
Besides the analysis of putative RAO specific CNVRs, we sorted the CNV data 
for highly negative aberration values (log2 < -2 ) and identified 15 putative homozygous 
deletions (appendix 3.5). However, as the majority involved clusters of olfactory 
receptor genes, no further analysis followed. 
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Table 16: Summary information for the 30 “RAO specific” CNVRs. 
 
 
Position, 
Mb 
CNV 
Type 
Horse ID 
and 
phenotype 
Gene 
symbol 
Associated 
phenotype/processes 
Human 
DGV ID 
OMIM ID, 
description 
OMIA ID, 
description 
chr1:22.5 Loss SPA-H4-2 JL635247 n/a n/a n/a n/a 
chr1:43.8 Loss SPA-H4-2 intergenic n/a n/a n/a n/a 
chr1:99.1 Loss SPA-H4-2 human 
cDNA 
n/a n/a n/a n/a 
chr1:149.1 Loss H4-1999 AK127847 n/a esv274524
8 
n/a n/a 
chr1:157.4 Loss H4-2029 RNASE9 Epididymitis, pancreatitis nsv901468 n/a n/a 
chr1:185.8 Gain H4-1912 JL637766, 
JL629243 
n/a n/a n/a n/a 
chr3:105.5 Loss SPA-H4-2 JL640154 n/a n/a n/a n/a 
chr5:5.6 Loss H4-1998 NME7 Primary ciliary dyskinesia 
and situs inversus 
nsv872531 n/a n/a 
chr5:83.9 Loss SPA-H4-2 ELTD1  Drug metabolism. Cannabis 
dependence and nicotine 
addiction 
nsv871835 n/a n/a 
chr6:16.3 Loss SPA-H4-2 intergenic n/a n/a n/a n/a 
chr6:74.6 Gain SPA-H4-4 RDH16 Cytochrome p450, 
tuberculosis. Metabolism 
and Drug metabolism 
esv24053 612712, leber 
congenital 
amaurosis 13, 
RDH12 
n/a 
 
  
 139 
 
Table 16 continued. 
Position, 
Mb 
CNV 
Type 
Horse ID 
and 
phenotype 
Gene 
symbol 
Associated 
phenotype/processes 
Human DGV 
ID 
OMIM ID, 
description 
OMIA ID, 
descriptio
n 
chr6:78.7 Loss H4-1999 USP15  Spinocerebellar ataxia n/a n/a n/a 
chr8:13.8 Loss SPA-H4-2 SIRT4, U4  Down-regulates insulin 
secretion. Hyperinsulinism 
and tuberculosis 
nsv899555 n/a n/a 
chr8:89.2 Gain H4-1987 ZNF407 Ectodermal dysplasia nsv909919 n/a n/a 
chr10:47.7 Loss SPA-H4-2 , 
H4-1998 
FUT9, 
pseudogene 
Malaria, and 
cytomegalovirus infection 
esv2422431 n/a n/a 
chr10:53.7 Loss SPA-H4-2 AK125948 n/a nsv912634 n/a n/a 
chr11:21.7 Loss H4-1998 KRT23 Aggressive periodontitis 
and periodontitis 
nsv9550 n/a n/a 
chr14:75.4 Loss H4-1999 intergenic n/a n/a n/a n/a 
chr15:79.0 Loss H4-1999 NBAS Short stature, optic nerve 
atrophy, Pelger–Huët 
anomaly and 
neuroblastoma 
nsv515567 614800, short 
stature, optic 
nerve 
atrophy, and 
Pelger–Huët 
anomaly 
n/a 
chr16:13.1 Loss SPA-H4-2 CNTN4 Autism spectrum disorders 
and atrioventricular septal 
defect 
esv2422274 612540, 
myopathy, 
congenital, 
compton-
north, 
CNTN1 
n/a 
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Table 16 continued. 
 
Position, 
Mb 
CNV 
Type 
Horse ID 
and 
phenotype 
Gene 
symbol 
Associated 
phenotype/processes 
Human DGV 
ID 
OMIM ID, 
description 
OMIA ID, 
descriptio
n 
chr16:67.8 Loss SPA-H4-2 CPNE4 Infertility Variation_4354 n/a n/a 
chr20:32.6 Loss SPA-H4-2 BTNL2 Pulmonary sarcoidosis nsv830630 181000, 
sarcoidosis, 
susceptibility  
n/a 
chr21:39.7 Loss SPA-H4-5 CDH12 Meconium aspiration 
syndrome and congenital 
diaphragmatic hernia 
nsv428115 137215, 
gastric 
cancer, 
hereditary 
diffuse; 
CDH1 
n/a 
chr23:45.6 Loss SPA-H4-4 LINGO2 Neuronitis and essential 
tremor 
esv270849 n/a n/a 
chr24:37.0 Loss H4-1987 SPI2, 
SERPINA1 
Alpha 1-antitrypsin 
deficiency, and liver 
disease, chronic 
pulmonary obstructive 
disease (COPD) 
nsv470662 611489, 
corticosteroid
-binding 
globulin 
deficiency 
SERPINA6 
000032-
9615 
UID:102, 
Alpha-1-
antitrypsin 
deficiency 
in dogs 
chr29:23.3 Gain H4-1987 CELF2, 
Non-Horse 
Ref Gene  
Neuroblastoma, and 
childhood epilepsy 
nsv5798 n/a n/a 
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Table 16 continued. 
 
Position, 
Mb 
CNV 
Type 
Horse ID 
and 
phenotype 
Gene 
symbol 
Associated 
phenotype/processes 
Human DGV 
ID 
OMIM ID, 
description 
OMIA ID, 
descriptio
n 
chrUn:0.11 Gain SPA-H4-5 intergenic n/a n/a n/a n/a 
chrUn:0.47 Loss H4-1987 intergenic n/a n/a n/a n/a 
chrUn:0.04 Loss H4-1987 intergenic n/a n/a n/a n/a 
chrUn:0.08 Loss H4-1943 JL631917 n/a n/a n/a n/a 
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Analysis of a CNVR in SERPIN genes in chr 24 
 
The CNVR in chr24: 37,051,746-37,077,730 was a 26 kb size deletion involving 
the entire SERPINA1 gene and SPI2 exon 1 (Figure 16). The CNVR was demarcated by 
9 array probes which were located as follows: probe #12 (Ec_24_37051895) in SPI2 
exon 1; probes #21 and #23 (Eic_24_37070988, Eic_24_37071086,) in SERPINA1 
introns 2 and 3; probe #25 (G_24_37077530) in the 5’ region of SERPINA1, and probes 
#14-18 (Eic_24_37054678, G_24_37061721, G_24_37066083, Eic_24_37068005, 
Ec_24_37068288) between SPI2 and SERPINA1 (Figure 16B, C; note that both genes 
are transcribed from the reverse strand (Ensembl). The deletion aberration values were 
moderate (-log2average -0.5; log2max -0.8) and the CNVR was detected in one RAO affected 
Swiss Warmblood male horse (H4-1987).  
As a first step, we confirmed the deletion by qPCR using primers for four CNVR 
specific probes (#15, #18, #21, #23; Figure 17) and showed significant difference (p < 
0.05) in copy numbers between H4-1987 and the Thoroughbred reference.  
Next, the copy numbers were compared between 38 RAO cases and 23 controls 
(Table 13; note that DNA for one RAO case and one control was finished) using primers 
for 8 array probes. While clear differences were observed between individual horses in 
both groups, there was no significant difference in copy numbers between cases and 
controls (Figure 18). 
 
 
 143 
 
 
 
Figure 16: Schematic diagram of a region in chr24.  
The region flanking the CNVR and serpin gene cluster A. Cytogenetic location of the 
region (grey line) in Chr24; B. Arrows showing the location of PCR primers #1-#25 
(Table 3.2; open arrows correspond to tiling array probes); brackets denote the span of a 
25,984 bp RAO specific CNVR; C. Schematic of the genomic structure of SPI2 and 
SERPINA1 (Ensembl). 
 
 
 
 
Figure 17: Validation of the deletion in chr24 by qPCR. 
qPCR was performed in RAO affected Swiss Warmblood H4-1987 and the 
Thoroughbred reference.  
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Figure 18: CNV analysis in chr24 by qPCR using array probe specific primers.  
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The array probes in chr24 region of interest were mainly intergenic or intronic 
(Figure 16), thus we designed primers for all SERPINA1 and SPI2 exons, all SPI2 
introns and flanking regions (Figure 16). While optimizing the primers by regular 
qualitative PCR, we noticed that primer #13 from SPI2 exon 1 
(ENSECAE00000074130; Figure 16) amplified differently from individual horses. This 
difference was expressed as a very strong, medium, or weak band in gel electrophoresis 
(Figure 19). We conducted the analysis twice on the entire study cohort and confirmed 
that these differences were consistent and repeatable, although the CNV was present in 
cases and controls. No similar variability by qualitative PCR was observed for any other 
SPI2 or SERPINA1 exons. 
 
 
 
 
Figure 19: Regular (qualitative) PCR with SPI2 exon 1 primers. 
(primer #13; (ENSECAE00000073450) showing CNV in both cases and controls. Each 
horse was tested in duplicate (2 adjacent lanes per horse). 
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Copy number variation in SPI2 exon 1 was further refined by qPCR (Figure 20) 
showing outstanding differences between individual horses but, again, the variation was 
present in both RAO cases and controls. 
 
 
 
Figure 20: Analysis of CNV in SPI2 exon 1.  
(primer #13; ENSECAE00000073450) by qPCR in all RAO cases and controls 
 
 
Finally, all SPI2 and SERPINA1 exon specific primers were tested by qPCR in 
the study cohort and no significant differences between the two groups were found 
(Figure 21). We conclude that the region in chr24 containing serpin genes is copy 
number variable in horses but this variation is not associated with the RAO phenotype. 
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Figure 21: Quantitative PCR with SPI2 and SERPINA1 exon primers. 
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Discussion 
 
Substantial advances have been made in recent years in the discovery and 
analysis of CNVs in the horse genome by studying populations of normal horses ((Doan 
et al. 2012a; Doan et al. 2012b; Dupuis et al. 2013; Metzger et al. 2013a; Wang et al. 
2014b) and Chapter II). Altogether, over 1400 CNVRs have been identified in 41 diverse 
breeds (Chapter II). This dataset was effectively used in this study for the analysis of 
CNVs in RAO affected and control horses, and the detection of CNVs that were present 
only in RAO affected horses. Furthermore, as the CNVs in RAO control group largely 
overlapped with those already known for the horse, array CGH for similar studies in the 
future can be conducted in cases only and compared with the composite dataset. 
Despite this progress, very little is known about CNVs that might influence 
complex equine traits or susceptibility to complex diseases. Recently, CNVs were 
studied in recurrent laryngeal neuropathy (RLN), common upper airway pathology in the 
horse (Dupuis et al. 2012). The authors used SNP genotyping data for CNV discovery 
but found no association between CNVs and RLN, although GWAS on the same data 
had previously identified chr 21 and 31 as candidate regions for RLN (Dupuis et al. 
2011).  
The present study is, to our best knowledge, the second attempt to detect CNVs 
that might influence the risk to complex diseases in horses, and the first systematic 
evaluation of CNVs in equine RAO. Although this study and the one for RLN (Dupuis et 
al. 2012) differ regarding the phenotype, CNV detection methodology and the size of 
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study cohorts, a few similarities are worth mentioning. Both phenotypes were equine 
complex respiratory disorders and both studies detected a few functionally relevant 
candidate CNVs, but no association to the disease. In RLN the candidate regions by 
GWAS did not overlap with candidate CNVs (Dupuis et al. 2011, 2012). Likewise, the 
30 putative RAO specific CNVRs in this study (Table 16) did not overlap with the 
known RAO associated regions in chr13 and 15 as revealed by GWAS (Swinburne et al. 
2009; Shakhsi-Niaei et al. 2012). Horse chr13 showed no study specific (Appendix 3.3) 
or RAO specific (Table 16, Appendix 3.4) CNVRs, although a quantitative trait locus 
(QTL) including the interleukin 4 receptor (IL4R) gene, one of the candidate regions for 
RAO, maps to this chromosome (Shakhsi-Niaei et al. 2012). The only CNVR in chr15 
was a small deletion in one RAO affected horse and located at 79 Mb, thus outside the 
candidate region at 40-60 Mb as detected by Swinburne and colleagues (2009).  
The absence of overlap or close proximity between SNPs and CNVs in RLN 
(Dupuis et al. 2011, 2012) likely signifies the known limitations of using SNP arrays to 
tag multiallelic and complex CNVs (Redon et al. 2006, Beckman et al. 2007). Due to 
this, it has been recommended to combine GWAS with array CGH (Beckman et al. 
2007). However, in the case of RAO, different platforms were applied for GWAS 
(Swinburne et al. 2009; Shakhsi-Niaei et al. 2012) and for CNV discovery (this study). 
No intersection between SNP and CNV data might indicate that different mechanisms 
regulate the many genomic loci contributing to RAO.  
Here we identified 30 CNVRs that were exclusive to RAO affected horses, 
although these CNVRs were predominantly private (present in one animal) and could 
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not be associated with the disease phenotype (Table 16). Prevalence of private CNVRs 
can have several explanations. First, these might be just novel CNVRs for the horse 
genome and not related to RAO. Indeed, 18 out of 30 RAO specific CNVRs were found 
in breeds that are poorly (Swiss Warmblood) or not at all (Missouri Foxtrotters, 
Tennessee Walking horses) represented in the composite CNVR dataset of 41 horse 
breeds (Chapter II, Table 12). However, 11 (37%) RAO specific CNVRs were found in 
an affected Quarter Horse SPA-H4-2 (Table 13, Table 16) – a breed well represented in 
the CNVR dataset. This suggests that at least some of the RAO specific CNVRs might 
be related to the condition and were found in single individuals due to the heterogeneous 
nature of RAO (Swinburne et al. 2009), or because of a small study cohort, or both. 
Finally, it is also possible that a few of these CNVRs are false positives. Therefore, all 
RAO specific CNVRs will be validated by qPCR and/or FISH in the nearest future. 
Although we did not identify CNV association with equine RAO, recent findings 
in humans (Rogers et al. 2013) do not exclude CNVs as factors modulating susceptibility 
to complex diseases, such as asthma. It is just not yet clear how. Similarly to our study, 
the vast majority of CNVs in human asthma candidate genes were rare (< 5%) and not 
statistically significant - this despite the involvement of 1212 subjects. Also, there was 
no intersection between CNVs and previously detected asthma-associated SNPs 
(reviewed by Akhabir et al. 2011) – a situation similar to RLN (Dupuis et al. 2011, 
2012) and RAO (this study, Swinburne et al. 2009, Shakhsi-Niaei et al. 2012) in horses.  
On the other hand, analysis of over 270 asthma candidate genes showed that 69 
CNVs mapped to within 50 kb of 58 (21%) asthma genes, whereas in six cases the 
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candidate genes resided within the CNVR boundaries, and modest association was found 
with two genes – NOS1 and SERPINA3 (Rogers et al. 2013). The latter was of interest 
regarding RAO because a CNVR in one affected Swiss Warmblood horse involved two 
SERPIN genes - SPI2 and SERPINA1 (Table 16), whereas several other serpin family 
members including SERPINA3 were in close vicinity (Figure 16). These genes are 
appealing candidates for RAO because of the known association of SERPINA1 with 
pulmonary health in asthma (Thun et al. 2013) and COPD (Denden et al. 2010; Saunders 
et al. 2012; Thun et al. 2013). The gene encodes for alpha1-antitrypsin which is a highly 
polymorphic protein, and its deficiency predisposes human adults to lung emphysema 
and chronic liver disease (Denden et al. 2010). Although we were not able to associate 
SERPINA1 with RAO, we showed that the equine genes for alpha1-antitrypsin are highly 
copy number variable. It is therefore surprising that the CNVR in horse chr24 involving 
SPI2 and SERPINA1 was not detected by any of the previous CNV studies in the horse 
(Doan et al. 2012a; Doan et al. 2012b; Dupuis et al. 2013; Metzger et al. 2013a; Wang et 
al. 2014b), including ours (Chapter II). Partially, this can be explained by difficulties to 
design array probes in a region containing a cluster of genes that share sequence 
similarity. Indeed, only one array probe was designed in SPI2 (Figure 16). However, this 
does not explain why NGS (Doan et al. 2012b) or SNP beachips (Metzger et al. 2013, 
Dupuis et al. 2012) did not detect the CNVRs, or why we found it now and not before. It 
is plausible that the region is variable in particular breeds, like Swiss Warmblood, which 
has been used in only one previous study (Chapter II). 
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Besides the serpins, the other genes of most functional interest among the RAO 
specific CNVRs were probably BTNL2 and FUT9 (Table 16). Butyrophilin-like 2 
(BTNL2) belongs to MHC class III, is functionally associated with class II genes in 
regulating T-cell proliferation, and is involved in immunity disorders such as sarcoidosis 
related lung inflammation and rheumatoid arthritis (Morais et al. 2012; Aigner et al. 
2013; Mitsunaga et al. 2013; Wennerstrom et al. 2013). Fucosyltransferase 9 (FUT9) is 
needed for terminal fucosylation of important molecules (KID, BRN) in innate and 
acquired immunity (Comelli et al. 2006) and was the only CNV gene that showed up in 
two RAO affected horses (Table 16). Detailed analysis of the two genes in the entire 
RAO study cohort of 63 horses is underway. It would also be worth to explore the 
possibility of somatic mosaicism (Pham et al. 2014) and check whether the CNVRs of 
interest in this study are present in tissues other than blood. Maybe this answers also 
why so few CNVRs were found in DNA isolated from hair follicles (Table 15). Future 
studies should also investigate whether copy number differences in functionally relevant 
genes to RAO are correlated with different gene expression. Last but not least: the search 
for CNVs in RAO identified 48 new CNVRs in the horse, thus contributing to the 
composite horse CNV dataset and to better understanding the role of these variants in 
equine biology. 
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CHAPTER IV 
IDENTIFICATION OF CNVS IN EQUINE DISORDERS OF SEXUAL 
DEVELOPMENT (DSDS) – CRYPTORCHIDISM AND XY SRY-POSITIVE SEX 
REVERSAL 
 
Introduction 
 
Disorders of sexual development (DSDs) and reproduction are not uncommon in 
horses and involve a broad variety of conditions that affect sex determination, sexual 
differentiation, the development and function of gonads, and fertility (Lear and Bailey 
2008; Villagomez and Pinton 2008; Villagomez et al. 2009). Among these, probably the 
most common are cryptorchidism and sex reversal syndromes (Villagomez and Pinton 
2008; Villagomez et al. 2009; Raudsepp et al. 2010; Raudsepp et al. 2013). Both are 
complex disorders involving non-genetic and genetic factors and both negatively affect 
the fertility and performance of horses. While etiology of DSDs largely remains unclear, 
contribution of a genetic component is acknowledged for all (Villagomez and Pinton 
2008; Villagomez et al. 2009; Raudsepp et al. 2013). Therefore, molecular genetic 
research is needed to better understand the etiology of the conditions and devise tests for 
diagnostics and prevention. 
Cryptorchidism affects about 8% of full term male foals (Hayes 1986; Amann 
and Veeramachaneni 2006; Amann and Veeramachaneni 2007; Arighi 2011; Russell and 
Pollock 2011) and manifests in the failure of one (unilateral) or both (bilateral) testes to 
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descend into the scrotum. Because undescended testis is typically dysfunctional, bilateral 
cryptorchids are sterile (Foster and Ladds 2007; Russell and Pollock 2011), while 
unilateral cryptorchids are usually fertile because of normal spermatogenesis in the 
descended testis. Nevertheless, surgical removal of a retained testis is indicated, because 
of increased risk for the development of primary testicular neoplasms (Pratt et al. 2003; 
Foster and Ladds 2007; Arighi 2011) and because it continues the production of 
testosterone and induction of stallion behavior (Arighi 2011; Russell and Pollock 2011). 
Thus, while cryptorchidism may or may not affect stallion fertility, it poses risk on 
health and performance. At the same time, very little is known about the genetic 
component of cryptorchidism. It is thought to be heterogeneous and polygenic, although 
candidate gene studies in humans (Massart and Saggese 2009; Massart and Saggese 
2010), mice (Agoulnik and Feng 2007; Agoulnik et al. 2012), pigs (Rothschild et al. 
1988), dogs (Pathirana et al. 2010; Zhao et al. 2010; Zhao et al. 2013) and horses 
(Diribarne et al. 2009) have not revealed any consistent and significant associations with 
cryptorchidism. 
Sex reversal is a situation where the genetic sex (the karyotype, sex 
chromosomes) disagrees with the gonadal and/or the phenotypic sex. In horses, male-to-
female 64,XY sex reversal syndrome is the second most frequent sex chromosome 
abnormality after X chromosome monosomy (Raudsepp et al. 2010; Das et al. 2012). 
The affected individuals are genetically male with female-like external genitalia. 
Gonadal phenotypes vary from underdeveloped and retained testes (like in bilateral 
cryptorchidism) to underdeveloped ovaries and ambiguous forms in between. One form 
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of XY sex reversal is associated with various deletions in the Y chromosome, all 
involving the SRY gene (Raudsepp et al. 2010). Another form is SRY-positive and is 
genetically heterogeneous (Switonski et al. 2005; Raudsepp et al. 2010; Lear and McGee 
2012; Pujar and Meyers-Wallen 2012). A point mutation in the androgen receptor (AR) 
gene is to date the only known causative mutation for this form, although found only in 
one affected Quarter Horse family (Revay et al. 2012). Genetic causes of the majority of 
SRY-positive cases of XY sex reversal remain, as yet, undefined. 
Recent studies in human DSDs, including sex reversal, hypospadias and 
cryptorchidism, suggest critical involvement of dosage sensitive genes and genomic 
copy number variants (CNVs) (Smyk et al. 2007; Ledig et al. 2010b; Li et al. 2010; 
Tannour-Louet et al. 2010; Tuttelmann et al. 2011; White et al. 2011) encouraging the 
initiation of similar research in horses.  
The aim of this study is to investigate the possible involvement of CNVs in 
equine cryptorchidism and SRY-positive XY sex reversal. Whole genomes of affected 
horses are studied for CNVs by array comparative genomic hybridization (CGH). The 
findings are compared with a composite CNV database for normal horse populations 
(Chapter II), so that variants specific to DSDs can be identified and analyzed.  
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Material and methods 
 
Horses and phenotypes 
 
The study involved 12 bilateral cryptorchid horses of various breeds (Table 17). 
Eight of these had testes retained in abdomen, one in inguinal canal and no information 
about the position of testes was available for 3 horses. The horses were phenotyped and 
samples procured with owner’s consent at Texas A&M Large Animal Clinic by Dr. 
Carolyn Arnold.  
 
 
Table 17: List of bilateral cryptorchid horses used for the study. 
 
Horse ID Breed Karyotype SRY-PCR Cryptorchid 
phenotype 
H291 Mixed breed 64,XY pos Bilateral, inguinal 
H304 N/A 64,XY pos Bilateral, abdominal 
H324 Appaloosa 64,XY pos Bilateral, abdominal 
H349 Lipizzaner 64,XY pos Bilateral, abdominal 
H354 Pony 64,XY pos Bilateral, abdominal 
H361 Mustang 64,XY pos Bilateral, abdominal 
H365 N/A 64,XY pos Bilateral, abdominal 
H390 American Quarter 
Horse 
64,XY pos Bilateral, abdominal 
H397 Mixed breed 64,XY pos Bilateral, position n/a 
H441 American Quarter 
Horse 
64,XY pos Bilateral, position n/a 
H451 American Quarter 
Horse 
64,XY pos Bilateral, abdominal 
H614 American Quarter 
Horse 
64,XY pos Bilateral, position n/a 
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The study also involved 8 SRY-positive sex reversal horses (Table 18) whose 
phenotypes and karyotypes were available at the depository of The Molecular 
Cytogenetics and Genomics Laboratory at Texas A&M University, or supplied by 
collaborators Dr. Teri Lear (The University of Kentucky) and Dr. Sue McDonnell (The 
University of Pennsylvania). As a rule, the identity of horses remained confidential. The 
exceptions were Standardbreds H369 (Martha) and H348 (Helen) (Table 18), two elite 
racers whose problematic sexual identity has been released in press making headlines in 
New York Times (Finely 2009) and Horse.com (Lear and McGee 2012). 
 
DNA isolation & quality control 
 
DNA was isolated from peripheral blood using standard PCI (Phenol/ 
Chloroform/ Isoamyl alcohol) method (Sambrook et al. 1989) or Gentra Puregene Blood 
Kit (QIAGEN, USA) according to manufacturer’s protocol. The DNA was cleaned with 
DNeasy Blood and Tissue kit (Qiagen) with the following modifications to the 
manufacturer’s protocol: during DNA purification, 80% ethanol was used instead of 
solution AW2, and the final DNA pellet was eluted in water instead of solution AE. The 
final quality and quantity of the DNA samples were checked by gel electrophoresis on a 
1% agarose gel and by Nanodrop spectrophotometry (Thermo Scientific).  
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Table 18: List of SRY-positive sex- reversal horses used for array CGH. 
 
Horse ID Breed Karyotype SRY-
PCR 
Phenotype of gonads and 
external genitalia 
H369 American 
Standardbred 
(Martha) 
64,XY pos Male pseudohermaphrodite: 
rudimentary abdominal testicles 
and abnormal female external 
genitalia 
H348 American 
Standardbred 
(Helen) 
64,XY pos Male pseudohermaphrodite: 
rudimentary abdominal testicles 
and abnormal female external 
genitalia 
H169 Appaloosa 64,XY pos Normal female external 
genitalia 
H252 Mixed breed 64,XY pos Abnormal female external 
genitalia 
H543 American 
Standardbred  
64,XY pos Female-like sexual behavior; 
gelding-like external genitalia 
with penis and sheath  
H544 Tennessee Walking 
Horse  
64,XY pos Abnormal female external 
genitalia 
H545 American 
Standardbred  
64,XY pos Female-like sexual behavior; 
gelding-like external genitalia 
with penis and sheath 
H546 Thoroughbred 64,XY pos Hypoplastic testes with 
abnormal female external 
genitalia 
 
 
Array comparative genomic hybridization and data analysis 
 
Probe labeling and array CGH experiments were performed according to Agilent 
Technologies Protocol Version 6.2.1. All hybridizations comprised of a pair of 
differently labeled probes, one of which was always the reference DNA – a 
Thoroughbred mare Twilight for females and a Thoroughbred stallion Bravo for males. 
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Briefly, 1µg of purified genomic DNA was digested with restriction enzymes RsaI and 
AluI for 2 hours at 37C and 20 minutes at 65C to produce 200-500 bp fragments. 
Cleaved samples were labeled with fluorescence dyes Cy3 (for the reference DNA) or 
Cy5 (for sample DNA) by random priming using Genomic DNA Enzymatic Labeling 
Kit (Agilent Technologies). The final labeling reaction contained random primer (5 µl), 
1X dNTP mix (5µl), 1X reaction buffer (10 µl), Exo-Klenow enzyme (1 µl), and Cy3- or 
Cy5-dUTP (3 µl) and was conducted for 2 hours at 37C, 10 minutes at 65C. The 
products were cleaned with 30 kDa filters (Amicon) and the yield and specific activity of 
labeled DNA was determined with a Nanodrop spectrophotometer. Typical yield for 1 
µg of starting DNA was 6-8 µg; specific activity for Cy3 was 25-40 pmol/µg and for 
Cy5 20-35 pmol/µg. The hybridization mixture was prepared using Agilent Oligo aCGH 
Hybridization Kit and contained equal quantity of Cy3 and Cy5 labeled probes, 1 µg/µL 
horse Cot1 DNA, 10X blocking agent, and 2X Hi-RPM buffer. Denatured and pre-
annealed probe mixture was applied onto gasket slide, placed in Agilent SureHyb 
hybridization chamber, ‘sandwiched’ with an array slide and incubated in Agilent 
hybridization oven at 65C for 40 hours. The array slides were washed with Agilent 
aCGH Wash Buffers 1 and 2, and dried with Acetonitrile and Stabilization and Drying 
Solutions. Washing in Wash Buffer 1 was done for 10 minutes instead of the 5 minutes 
recommended by the Agilent protocol. 
Data analysis was done using the Agilent Genomic Workbench software (v5.0). 
The CNVs were represented by gains and losses of normalized fluorescence intensities 
relative to the reference and identified using the ADM-2 aberration algorithm (Lipson et 
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al. 2006). Parameters used in this analysis were as follows: Threshold of ADM-2: 6.0; 
Centralization: ON (Threshold: 6.0, Bin Size: 10); Fuzzy Zero: ON; Aberration Filters: 
ON (minProbes = 5 & minAvgAbsLogRatio = 0.5 & maxAberrations = 10000 AND 
percentPenetrance = 0); Feature Level Filters: ON, IntraArray: ON). The CNVs were 
called with an average log2 ratio 0.5 over 5 neighboring probes (Chapter II). Output files 
of CNVs were generated with genomic coordinates, cytoband chromosomal locations, 
and sequence description showing whether the CNV was present in a gene, intergenic 
segment, and subtelomeric region or in the Y chromosome. Signal log2 ratio less than -
2.0 was considered an indication of a homozygous deletion.  
 
Qualitative and Quantitative PCR 
 
Quantitative PCR on the genomic DNA of cases and controls was used for 
demarcating breakpoints for deletions discovered by array CGH. Primers for regular 
PCR were designed using Primer3 software (Table 19) (Koressaar and Remm 2007; 
Untergasser et al. 2012).  
Quantitative PCR (qPCR) was performed to validate selected CNVs. Primers 
were designed using horse whole genome sequence information (EquCab2), UCSC 
Genome Browser (Karolchik et al. 2003) and Primer3 software (Koressaar and Remm 
2007; Untergasser et al. 2012). The criteria for qPCR primer design were as follows: GC 
content > 50%; complementarity = 4; product size 100-200 bp, and annealing 
temperature 55°C - 60°C (Table 19).  
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The DNA concentration was optimized by serial dilutions and qPCR reactions 
were carried out with 25 ng/µL of DNA using the SYBR Green PCR kit (Roche) and a 
Roche LightCycler® 480 (Roche Applied Sciences) according to the manufacturer's 
instructions. The CNVs were tested in respective cases with the controls in triplicate 
reactions in duplicate experiments, and normalized to reference gene GAPDH 
(representing autosome with no CNVs in a ~ 1 kb window). Quantification of the copy 
number was carried out using the comparative Ct method (2
ΔΔ
Ct) (Livak and Schmittgen 
2001). Cut-off threshold for statistical significance was set at p<0.05. 
 
Fluorescence in situ Hybridization (FISH)  
 
Selected CNVs were validated by fluorescence in situ hybridization (FISH). The 
CHORI-241 equine BAC library (CHORI-241) was screened by PCR using CNV-
specific primers. The corresponding BAC clones were identified and their DNA isolated 
as described elsewhere (Gustafson et al. 2003). The BAC DNA was labeled with biotin-
16-dUTP or digoxigenin-11-dUTP using Biotin- or DIG-Nick Translation Mix (Roche) 
and hybridized to metaphase and interphase chromosomes. Images for a minimum of 10 
metaphase spreads and 20 interphase cells were captured for each experiment and 
analyzed with a Zeiss Axioplan2 fluorescent microscope equipped with Isis V5.2 
(MetaSystems GmbH) software. Cell cultures, chromosome preparations, BAC library 
screening, BAC DNA isolation, FISH, microscopy and image analysis were carried out 
according to our standard protocols (Raudsepp and Chowdhary 2008a).  
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Table 19: Primers for qualitative and quantitative PCR. 
 
Primer/ 
Probe 
Name 
Forward 5'-3' Reverse 5'-3' Product size, 
bp 
Primers for Chr29 deletion 
Start of deletion 
S1 GTAAGCCTGGGACCGATGTA TGCTCCCCAAAGTCATTTTC 789 
S2 TGGTCTGTCTTCCCTCAACC GGAAGATGGGGTAGGAGAGG 808 
S3 CAGGTGCTTCTGTGTCTCCA TAGTGGCAGCCCTCAGAGAC 718 
S4 GTTTCAGGTAGCTGCCCAAG TGAGTCTCTGTGGCCCTCTT 760 
S5 GCAAGGTCAGGAGCAGTAGG TGAAGAAAGCCTGCCTGTTT 831 
S6 GCTGTGATGCAGGAAGAACA CATCGCTCATTCAGGAGACA 732 
S7 GTAACCACAGGTGGGTGGAC TGTGGTGAGTTAGGGGGAAA 711 
S8 CAGCATCGAGCACTGAAGAA GGGGTCTGGCATACATGAAC 761 
S9 GAAGACTGCAGTGCCAGTGA TGCACGTCCCTGTAGAAGTC 705 
S10 CACCCCCAGTTAGAGAGCTG GCAGGGTGGATGGGTTAGT 863 
S11 TATGTGAAGCCCTCCCTGAC CAAGCCCCCAGTACACAGTT 705 
End of deletion 
E1 TGAGACAGGGATTGGAAAGG TGAGCCCTCTCTTTCCTTCA 727 
E2 TGTCACCCCCATATGGAATC GCCACATAAAAATCGAGTGC 709 
E3 TGGAGACAAAAGCACCATTG AGTCCCTGCCAAGAACTCAA 779 
E4 CTGGTTGCTTTCTTGACAGAAG CTGGATATGGAATCTGCCTTT 182 
E5 ACATCAGCATGGGTTCCTTC TGTCCAGGGTGATTTGTTCA 773 
E6 AGCAGCTCAGGGGATCACTA TGGGCCATTATTGTGTCAAA 736 
E7 GTTGTAACCACTGGGCCTTC AATTAGCGAACGCCAAGAAT 701 
E8 CAAATCACCCTGGACATTGA TCCTGTGTCAGAGGCAGCTA 923 
E9 GGCAACCTAAGACAGGCATC AGCGTCCCATTAACAAACCA 814 
E10 TTTGGGGAGCTCTCAATCAG GGAGCAGTAGGCAAGACAGG 806 
E11 TTAACGACTTGGGGAACAGC AACATTCCATTTGCCTCAGC 750 
E12 AAAGCCGCCTTCTAAACCAT CGGGAGAGTCTTTCCACAAA 871 
qPCR primers for Chr29 deletion 
G_29_287
03419 
TAGGTTCGTTTGGGCTTCAC ACAGGCTGGTCTGGATGACT 159 
G_29_287
11378 
CATCTCCTTCATTAAGCTGTGA
AC 
ATTCTATGGGGCGGGACTT 84 
G_29_287
30858 
CTCTCCCTTCGTTTTCATCG TTCCTGTGGACAGCCTTTCT 77 
Ei_29_28
791319 
CTTGTGGTCAATCCCAGACA TTCCTGTGGACAGCCTTTCT 166 
qPCR Primers for CNVR in PAR region 
AKAP17
A- Exon1 
GCTTCTCCGACATCCTCAAG TCCCCAAACTTCTCGAACAC 235 
AKAP17
A- Exon4 
GAAACCTGAACGGGAGTGTG GGTTGCACTTGTCTTGCTCA 213 
ASMT- 
Ex 2 
GAGCTGGGGGTGTTCGAC TTCCTCTCCTCGTGTCCACT 154 
ASMT- 
Ex 8 
CGTCCTGGTGGTCGAAGG CAGGACGGCGTGGTACAG 193 
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Table 19 continued. 
Primer/ 
Probe 
Name 
Forward 5'-3' Reverse 5'-3' Product size, 
bp 
qPCR Primers for CNVR in PAR region 
ZBED1- 
Ex A 
GACAACCAGAACCGCTCCTA CGAACACCTTGTTGCTGATG 190 
ZBED1- 
Ex B 
CGAGATCGACATGTTCCTCA TAGCTGCCGTCCTTGATCTT 150 
XG- Ex 9 CGATCTTGCTTTTCGACTCC ACAATTCCTCCTCCTGTTGC 129 
GYG2- 
Ex 1 
CAGTGTCTGACCAGGCCTTT GTGATCAGCACCACCAGCTT 121 
Gs_X_55
441 
CTTTTGATGAGGTGGGCAAC ATTCAGAGCCCGAGATGAGA 174 
Gs_X_66
198 
GAACGGAATGTCGCTCTTTC TGAGTTTCCAGATGGCTCCT 168 
Gs_X_72
077 
GGAATCAGCCAGGTGAGTGT TAGAGGCACGGCTGTTATGA 167 
G_X_133
651 
ACGGGGACCGAAAAATCTAC GGAGGGAATTCACACCTTGA 188 
Gs_X_14
7232 
GTCAGGTTGTGGGGAGAAAA AATCCAAGAGGAACCCAACC 176 
qPCR Primers for sex-reversal and cryptorchid specific common CNVRs 
Eic_8_13
132401 
ACAGCTTGGCTCTTGGTCAT CACCCAGAAAAGGGAACAAA 159 
Eic_28_1
8836887 
TCATCTTACGGCCTGCTACC GTTCAAGATCTCCCAATTACAG
G 
75 
 
 
Gene content analysis of CNVs 
 
The Ensembl annotated horse gene list with their genomic coordinates in 
Ensembl-73 was added to Agilent Genomic Workbench as a custom track to identify 
CNVs involving genes. Regions that did not contain Ensembl horse genes were 
manually analyzed in UCSC genome browser and NCBI to find similarity to known 
mammalian genes, mRNAs or cDNAs. Gene Ontology analysis (GO) and Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the genes present in 
CNVs were performed using DAVID bioinformatics tool with default settings (Huang da 
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et al. 2009b; Huang da et al. 2009a) to determine enrichment for particular biological 
processes. Additional search for gene functions was conducted with NCBI Gene and 
GeneCards. 
 
Results 
 
CNVs in bilateral-cryptorchid horses 
 
Array CGH analysis in 12 bilateral cryptorchid horses resulted in 330 CNV calls 
(Appendix 4.1.1) with an average of 27.5 calls per individual (Table 20). Overlapping 
and adjacent calls were arranged into 130 CNVRs located across all autosomes, the X 
chromosome, and chrUn (Appendix 4.1.2). In order to identify CNVRs present 
specifically in cryptorchid horses, the 130 CNVRs were aligned with the composite 
dataset of 1476 CNVRs (Chapter II) and the CNVRs identified in RAO affected horses 
(Chapter III). Ultimately, 16 CNVRs were present in bilateral cryptorchid horses only, 
and were considered as novel and putatively cryptorchid specific (Table 21., Appendix 
4.1.3). However, only one small gain in chrUn was shared between two cryptorchid 
Quarter Horses (H441 and H614), while the remaining cryptorchid specific CNVRs 
were private, i.e., present in one horse only (Tables 20, 21; Appendix 4.1.3). 
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Table 20: Summary of CNVs in the 12 bilateral cryptorchid horses. 
 
Horse 
ID Breed CNVs Gains Losses 
Novel 
CNVRs 
H291 Mixed breed 40 20 20 none 
H304 N/A 33 19 14 2 
H324 Appaloosa 24 11 13 none 
H349 Lipizzaner 45 23 22 3 
H354 Pony 43 16 27 4 
H361 Mustang 31 9 22 none 
H365 N/A 31 11 20 2 
H390 
American 
Quarter 
Horse 8 1 7 
none 
H397 Mixed breed 10 4 6 1 
H441 
American 
Quarter 
Horse 21 3 18 
1; shared 
with H614 
H451 
American 
Quarter 
Horse 17 2 15 
none 
H614 
American 
Quarter 
Horse 27 9 18 
2; 1 shared 
with H441 
Total  330 128 202 16 
Average  27.5    
Median  29    
 
 
Analysis of the 16 cryptorchid specific CNVRs for gene content and functions 
showed that all CNVRs, except those located in chrUn, involved known genes, cDNAs 
or mRNAs (Table 21). Functions of the genes were variable and related to cell-cell 
interactions, cell defense, and various cellular functions, such as transcription, DNA 
repair, and apoptosis. Two CNVRs harbored genes that could be very conditionally 
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related to reproduction: a loss in chr31 containing STXBP5 which is involved in 
membrane fusions and calcium-dependent exocytosis, thus possibly in sperm acrosome 
reaction, and a loss in chr11 involving ZNF599 – a transcription factor which mutations 
have been associated with hypospadias (Table 21).  
Seven CNVRs that were found only in cryptochid horses had orthologous 
variable sequences in the human genome (human genome variant database), suggesting 
that these variants are a normal part of mammalian genomes and might be more 
prevalent in horses as well. Four CNV genes corresponded to Mendelian disorders in 
man and one in dogs, although the disorders were related to nervous sytem and anemia 
(Table 21).  
Taken together, there was no associaotion between the bilateral cryptochid 
phenotype and the CNVRs, and none of the CNVRs specifically found in cryptorchid 
horses involved genes with known functions in development or reproduction.
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Table 21: Novel CNVRs in bilateral cryptorchid horses. 
 
 
Position, 
chr:Mb 
Type Horse ID Gene 
symbol 
Description DGV OMIM OMIA 
1:24.0 Loss H354_bi crypt Pseudogene N/A N/A N/A N/A 
4:0.9 Loss H614_bi crypt GNAO1 Increase or decrease in cAMP levels  nsv833242 615473. Epileptic encephalopathy, early 
infantile, 17; EIEE17 
N/A 
4:56.6 Gain H304_bi crypt JL632581 Horse mRNA N/A N/A N/A 
8:74.4 Loss H354_bi crypt WDR7 Amelogenesis imperfecta, and alcohol 
dependence. 
nsv527474 N/A N/A 
8:88.0 Gain H304_bi crypt JT478681 non-Horse mRNA N/A N/A N/A 
11:172 bp Loss H365_bi crypt ZNF599 Transcriptional regulation. Diseases: 
Hypospadias, and mental retardation 
dgv1074e1 606937. Spinocerebellar ataxia, autosomal 
recessive 5; SCAR5, ZNF592  
N/A 
20:9.7 Gain H349_bi crypt JL631755 Horse mRNA N/A N/A N/A 
20:19.7 Loss H397_bi crypt RPL5 Diseases: Diamond-Blackfan anemia, and 
Diamond-Blackfan anemia. 
esv32853 615550. Diamond-Blackfan anemia 12; 
RPL15 
OMIA 000041-9615 
UID:119 
Diamond-Blackfan 
anaemia. 
Phenotype in dog 
(Canis lupus 
familiaris). 
29:15.4 Loss H614_bi crypt PLXDC2 May play a role in tumor angiogenesis. 
Diseases: Sotos syndrome, and endothelitis.  
dgv131n67 N/A N/A 
31:19.1 Loss H614_bi crypt STXBP5 Regulatory role in calcium-dependent 
exocytosis and neurotransmitter release. 
Diseases: type 1 von Willebrand disease, 
and von Willebrand's disease. 
nsv886752 612164, epileptic encephalopathy, early 
infantile, 4; Stxbp1 
N/A 
Un:0.01 Gain H349_bi crypt N/A N/A N/A N/A N/A 
Un:0.05 Gain H441_bi crypt, 
H614_bi crypt 
N/A N/A N/A N/A N/A 
Un:0.2 Loss H365_bi crypt N/A N/A N/A N/A N/A 
Un:0.4 Loss H349_bi crypt N/A N/A N/A N/A N/A 
X:85.1 Gain H354_bi crypt TSC22D3 Protects T-cells from IL2 deprivation-
induced apoptosis. Diseases: vascular 
dementia, and brain edema 
N/A N/A N/A 
X:118.4 Loss H354_bi crypt EIF2S1  Initiation of protein synthesis. Diseases: 
brain ischemia, and Newcastle disease. 
esv2751285 N/A N/A 
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CNVs in XY SRY-positive sex reversal horses 
 
A total of 345 CNV calls were made in the 8 sex reversal horses (Table 22; 
Appendix 4.2.1). The lowest number of CNVs were detected in H252 (17) and the 
highest in H543 (88) with a median of 32.5 CNVs per horse. Based on the overlaps, the 
CNVs were arranged into 172 CNVRs that were distributed on all chromosomes except 
the Y (Appendix 4.2.2). After comparison of this data with the composite dataset of 
1476 horse CNVRs (Chapter II) and with the CNVRs identified in the RAO study cohort 
(Chapter III), 41 CNVRs were confined to sex reversal horses only and considered novel 
(Table 23, Appendix 4.2.3). All DSD horses, except H348, had novel CNVRs (Table 22, 
23) of which 8 were shared between two or more horses and the remaining 33 were 
private (Table 23, Appendix 4.2.3). 
Notably, all 41 novel CNVRs involved genes, pseudogenes, or expressed 
sequences such as mRNAs, cDNAs or ESTs (Table 23), and 15 CNVRs shared genes 
with the human variation database (Table 23 and Appendix 4.2.3). Analysis of OMIM 
and OMIA databases showed that 9 novel CNVRs contained genes corresponding to 
Mendelian conditions in man and one in animals. The latter was a CNVR in chr1 
involving the PTEN gene which is associated with hydrocephalus in cattle and dogs. 
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Table 22: Summary of CNVs in the 8 sex reversal horses. 
 
Horse ID Breed CNVs Gains Losses Novel CNVRs 
H169 Appaloosa 26 13 13 1 
H252 Mixed breed 17 5 12 1 
H348 
American Standardbred 
(Arizona Helen) 31 9 22 0 
H369 
American Standardbred 
(Martha Maxine) 34 9 25 1 
H543 American Standardbred  88 4 84 20 
H544 Tennessee Walking Horse  29 1 28 6 
H545 American Standardbred  78 5 73 17 
H546 Thoroughbred 42 3 39 6 
Total  345 49 296 31 
Average  43.1    
Median  32.5    
 
 
The known protein coding genes in novel CNVRs were analyzed for possible 
functional significance in DSDs with the primary focus on the 8 CNVRs that were 
shared between affected horses. The majority was involved in functions typical to CNV 
genes in general population of horses and other mammals (Redon et al. 2006). These 
include G-protein coupled receptors or olfactory receptors (4), signal transduction (4), 
cell-cycle regulation (4), and transcription factors (5). Three CNV genes (BCL2L11, 
DMTN and PTEN) were involved in tumor suppression and apoptosis. Interestingly, a 
CNVR involving an X-linked stromal antigen STAG2, was found in three sex reversal 
horses. Although the gene has important functions in sister chromatid separation, cell 
cycle and development, no DSD phenotypes have been as yet associated with STAG2 
mutations. 
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Table 23: Summary of genes involved in the 41 novel CNVRs in sex reversal horses. 
 
Position Type Horse ID Gene symbol Function, description 
1:40.51 Loss H543_SEX REV PTEN Tumor suppressor by negatively regulating AKT/PKB signaling pathway. 
3:57.38 Loss H169_SEX REV ETF1 Termination of mRNA translation.  
3:72.25 Loss H543_SEX REV, H545_SEX REV LPHN3 G-protein coupled receptors (GPCR), cell adhesion and signal 
transduction. 
4:44.10 Loss H545_SEX REV PHF14 N/A 
4:68.08 Loss H545_SEX REV JL626060 horse mRNA 
4:76.49 Loss H543_SEX REV AK154362 mouse mRNA 
4:81.74 Loss H545_SEX REV AK190472 mouse mRNA 
4:95.02 Loss H546_SEX REV PRSS2 T cell receptor  
5:22.27 Loss H545_SEX REV pseudogene N/A 
5:77.99 Loss H543_SEX REV COL24A1 Fibrillogenesis at specific anatomical locations during fetal development 
7:27.96 Loss H545_SEX REV ARHGEF12 G protein-coupled receptors. 
7:72.35 Loss H543_SEX REV OR52I1, pseudogene, 
OR52I1 
Olfactory receptors 
7:72.76 Loss H543_SEX REV OR51F2, OR52R1 Olfactory receptors 
8:54.75 Loss H543_SEX REV NOL4 This gene clusters with an RNA gene, lncRNA 
9:36.38 Loss H543_SEX REV, H545_SEX REV JV181555 mRNA, Junco hyemalis (Aves) 
9:53.30 Loss H543_SEX REV BX647886 Human mRNA 
9:77.98 Loss H543_SEX REV FAM135B N/A 
10:35.77 Loss H543_SEX REV JL628991 horse mRNA 
12:0.62 Loss H545_SEX REV CSTF3 Alternative splicing results in multiple transcript variants encoding 
different isoforms. 
14:29.41 Loss H544_SEX REV TET2 Defects in this gene have been associated with several myeloproliferative 
disorders. Associated with anemia, myeloid leukemia 
14:66.39 Loss H543_SEX REV JL627555, DMTN Tumor suppressor and inhibits malignant cell transformation 
15:14.24 Loss H369_SEX REV BCL2L11 Programmed cell death or apoptosis.  
16:19.96 Loss H543_SEX REV KF274565 human mRNA 
17:34.06 Loss H545_SEX REV BC034915 human mRNA 
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Table 23 continued. 
Position Type Horse ID Gene symbol Function, description 
18:14.06 Loss H543_SEX REV, H544_SEX REV JU909423 bison mRNA 
18:60.93 Loss H546_SEX REV DUSP19 Congenital cataracts, facial dysmorphism, and neuropathy, and Lafora 
disease. 
19:41.02 Loss H543_SEX REV JU918700 bison mRNA 
20:18.92 Gain H252_SEX REV E2F3 Transcription factors. Diseases associated with E2F3 include 
retinoblastoma, and Wilms tumor 
20:36.50 Loss H546_SEX REV SRSF3 Affiliated with the lncRNA class. Diseases  include open-angle glaucoma, 
and primary open angle glaucoma 
20:52.04 Loss H543_SEX REV JU726520 bison mRNA 
23:27.81 Gain H546_SEX REV, H545_SEX REV GLDC Electron carrier activity and lyase activity. 
23:41.23 Loss H543_SEX REV, H545_SEX REV CX600759 N/A 
23:46.90 Loss H544_SEX REV JO239254 non-Horse mRNA 
25:7.30 Loss H545_SEX REV Processed pseudogenes N/A 
25:15.79 Loss H543_SEX REV MUSK Transmembrane receptor protein. Diseases include musk-related 
congenital myasthenic syndrome, and progressive bulbar palsy 
25:22.61 Loss H543_SEX REV, H544_SEX 
REV, H545_SEX REV 
JO239254 non-Horse mRNA 
26:5.80 Loss H544_SEX REV, H543_SEX REV TIGD1 DNA binding.  
26:17.64 Loss H545_SEX REV JL641040 horse mRNA 
X:57.61 Loss H545_SEX REV ATRX Diseases include thalassemia, Juberg Marsidi syndrome, and sex reversal. 
Involved in mammalian sexual development, development of gonads. 
X:72.17 Loss H545_SEX REV PCDH11X Diseases include schizoaffective disorder, and Cornelia de Lange 
syndrome. 
X:98.51 Loss H546_SEX REV, H544_SEX 
REV, H545_SEX REV 
STAG2 Regulates the separation of sister chromatids during cell division. 
Diseases include tracheitis and laryngotracheitis 
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Functionally the most interesting and relevant among novel CNV genes was the 
X-linked ATRX. Although the gene has mainly been associated with several human X-
linked mental retardation syndromes (Picketts et al. 1996), recent studies show that 
ATRX has a critical and evolutionarily conserved role in normal development of testes 
and ovary (Huyhn et al. 2011). In humans, deletions or mutations in ATRX display 
varying degrees of sex reversal, implicating ATRX in the development of the human 
testis (Biason-Lauber 2010). Therefore, and despite being present in only one sex 
reversal horse (American Standardbred H545), this CNVR will be subject for further 
studies. 
Besides novel CNVRs, of particular interest was a large, over 360 kb deletion in 
the pseudoautosomal region (PAR; chrX: 203-366,729) of a mixed breed sex reversal 
horse H252 (Appendix 4.2.2). A small 35 kb intergenic gain within this region was 
previously detected in a Caspian pony (chrX: 34,725-70,176; Chapter II) and that is why 
this CNVR was not included as novel. However, deletion of this magnitude in the PAR 
was found in horses for the first time. The deletions was probably heterozygous (log = -
0.5; Appendix 4.2.1) and included 4 PAR genes tel-AKAP17A-ASMT-ZBED1-XG as 
ordered starting from the telomere, with GYG2 being immediately proximal to the 
CNVR (Fig 22).  
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Figure 22: Ensembl output for chrX:2 03-366,729. 
Showing the gene content of the deletion (red frame) in H252 sex reversal mixed breed 
horse. 
 
 
The deletion was validated by qPCR using primers for 5 array probes and the 
involved genes (Table 19 for primers). Comparison of copy numbers between H252 and 
Bravo, the male reference for aCGH, showed statistical significance for two array probes 
(GsX_147232, GsX_55441), ASMT exon8 and ZBED1 exon A (Figure 23). Further, 
copy numbers were compared between H252 and Twilight, the female reference, and 
significant or highly significant copy number differences were observed for three array 
probes (GsX_72077, GX_133651, and GsX_66198) and AKAP17A, ASMT, and ZBED1.  
Significant differences were also present between the two reference horses 
(Figure 23). We concluded that the CNVR in the PAR of H252 is true and heterozygous. 
We also concluded that the region is probably more variable among horses than revealed 
by aCGH and requires further analysis by qPCR, FISH, and/or NGS. The significance of 
the deletion with regards the sex reversal phenotype, however, remained as yet unclear. 
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Figure 23: Validation of the CNVR in the PAR of H252 by qPCR.  
A. ArrayCGH probe specific qPCR and B. Gene exon specific qPCR. p-values in blue 
relate H252 to Thoroughbred male reference Bravo and those in red, to Thoroughbred 
female reference Twilight. The p-values in black relate the two reference genome 
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Novel CNVRs shared between bilateral cryptorchid and XY sex reversal horses 
 
Two novel CNVRs, Chr8:13,128,936-13,134,708 and Chr28:18,833,995-
18,846,757, were shared between two or more XY sex-reversal and bilateral cryptorchid 
horses. The CNVRs included 3 genes, all involved at different stages of cell cycle 
regulation and transcription (Table 24). Validation by qPCR confirmed a statistically 
significant loss in chr28 in all 5 affected horses (Figure 24B). A significant copy number 
change was confirmed also for chr8, although qPCR showed a gain and not a loss as 
aCGH (Figure 24A).  
 
 
Table 24: Novel CNVRs present in sex-reversal and bilateral cryptorchid horses. 
 
Position,
chr:Mb 
Type Horse ID Gene symbol Gene name General description 
8:13.12 Loss; 
5.7 kb 
H390_bi crypt, 
H451_bi crypt, 
H369_SEX REV 
MZT2B, 
TUBA3D 
mitotic spindle 
organizing protein 2B, 
tubulin, alpha 3d 
Maintain cellular structure, 
function in intracellular 
transport; spindle formation 
during mitosis. 
28:18.83  Loss; 
12.7 kb 
H390_bi crypt, 
H369_SEX REV 
H544_SEX REV, 
H545_SEX REV, 
H546_SEX REV,  
UBE2N Ubiquitin-Conjugating 
Enzyme E2N 
Mediates transcriptional 
activation of target genes; 
control of progress through the 
cell cycle and differentiation; 
error-free DNA repair pathway; 
contributes to the survival of 
cells after DNA damage. 
Diseases include Riddle 
syndrome, and Machado-Joseph 
disease.  
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Thus, further research is needed to elucidate the CNV profile of this genomic 
region. It is possible that primers for qPCR recognize sequences in other parts of the 
genome and confound the results. Overall, because the involved genes regulate cell cycle 
and transcription, their contribution to DSDs is possible but remains elusive at the 
current status of knowledge about gene functions. 
 
 
 
Figure 24: Quantitative PCR to validate shared CNVRs.  
A. CNVR in chr8; B. CNVR in chr 28 shared between cryptorchid and sex reversal 
horses.. Note: as DNA for H544 and H546 was finished, DNA from H543 was used 
instead; this horse has a very similar phenotype to H544 and H546 (Table 4. 2).  
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A homozygous deletion in chromosome 29 involving AKR1C genes 
 
In addition to detailed analysis of novel CNVRs, all 130 CNVRs in bilateral 
cryptorchid horses and the 172 CNVRs in XY sex reversal horses were studied for log2 
aberration values to identify putative homozygous deletions of functional significance 
(Appendices 4.1.4 & 4.2.4). Of particular interest was an approximately 200 kb loss in 
Chr29:28.6-28.8 Mb showing deeply negative log2 values in one bilateral cryptorchid 
Pony H354 (log2average = -3.8) and in two XY sex reversal (male pseudohermaphrodites) 
Standardbreds H348(log2average = -3.5) and H369 (log2average = -3.1). These aberration 
values were significantly lower than those for normal horses (log2average =-0.7), 
suggesting that the deletion is homozygous. Most importantly, the deletion involved 
members of the AKR1C aldo-keto reductase gene family, known to be critical in the 
backdoor pathway of dihydrotestosterone (DHT) synthesis and sexual development 
(Biason-Lauber et al. 2013; Fukami et al. 2013). A schematic overview of the CNVR, 
including the aberration profiles of all array probes in this region, is presented in Figure 
25.  
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Figure 25: Schematic of the homozygous deletion in chr29 in DSD horses.  
A. chr29 ideogram showing the location of AKR1C gene cluster and a control gene 
CREM; B. Four BAC clones spanning the deletion CNVR (28,640,862-28,835,337); C. 
Detailed map of the CNVR showing the location of genes (black horizontal bars) and 
signal log2 values for 47 array probes in DSD and reference horses; D. FISH results with 
a CHORI-241 BAC 23N13 spanning the deletion (green signal) and a control BAC 
76H13 for CREM gene from a non-CNVR (red signal); E. PCR with CNVR-specific 
primers in the DSD and control horses; F. qPCR with CNVR-specific primers in the 
DSD and control horses. 
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Homozygosity of the deletion was confirmed by qualitative and quantitative PCR 
and by FISH. The genomic DNA of the three DSD horses did not amplify with primers 
designed inside the deletion (Figure 25D, E), although normal amplification was 
obtained with primers outside the CNVR. Homozygosity of the deletion was further 
confirmed by FISH with a BAC clone 23N13 spanning the deletion (Figure 25C). The 
BAC hybridized to chr29 only in control animals but not in the three DSD horses, 
whereas a control BAC with CREM gene from a non-CNVR in chr29 hybridized equally 
to chr29 in the DSD horses and controls. The known involvement of AKR1C genes in 
sexual development suggested a causative relationship between the homozygous deletion 
of this region and the abnormal sexual phenotype. 
Because of the likelihood of a causative deletion, it is important to devise tools 
for the detection of homozygous carriers. Therefore, we designed 23 sets of primers for 
PCR-walking into the deletion from the left (primers S1-S11) and right (primers E1-
E12) to precisely determine the deletion start and end sites (Table 19, Figure 26). 
According to PCR, putative deletion breakpoints were identified between primers S7 and 
S8 at the left (Start) and between primers E8 and E9 at the right (End) of the deletion.  
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Figure 26: Breakpoint analysis for the homozygous deletion in chr29.  
A. Schematic of the region showing the deletion (red solid line) as defined by aCGH; 
green solid bars show the genes involved; grey filled arrowheads S1-S11 and E1-E12 
denote the location of PCR primers; arrowhead with red dots denote overlaps of PCR 
primers with array probes; red arrows indicate the location of deletion breakpoints 1 and 
2 as determined by PCR; B. Gel images showing the results of PCR-walking that 
determined breakpoint-1 between segments S7 and S8, and breakpoint-2 between 
segments E8 and E9; products of the underlined primers are shown. 
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This suggested that primers immediately outside the deletion from left and right, 
viz., S7-forward and E9-reverse, will amplify a small PCR product in the three deletion 
carriers H348, H369, H354. However, we were not able to amplify any products with 
these or other primers flanking the deletion (Figure 26B), suggesting that the deletion 
landscape is more complex, and/or the genome sequence assembly in this region is not 
accurate. These might also be the reasons why primers E4 did not amplify from any of 
the affected or control horses (Figure 26B), and why primers E9 amplified a different 
product in H441 (Figure 26B).  
 
Discussion 
 
Here we conducted a genome-wide CNV analysis in horses with two defined 
disorders of sexual development – bilateral abdominal cryptorchidism and male-to-
female XY SRY-positive sex reversal syndrome. To our best knowledge, this is the first 
global analysis of CNVs in XY DSDs in horses and domestic animals, even although 
cryptorcidism and XY sex reversal have been amply described in several species 
(Amann and Veeramachaneni 2006; Amann and Veeramachaneni 2007; Villagomez et 
al. 2009; Raudsepp et al. 2010; Pujar and Meyers-Wallen 2012). Hitherto, contribution 
of CNVs to various forms of XY DSDs has been to some extent explored only in 
humans, and clinically relevant gains and losses have been found in known (DAX1, 
SOX9, GATA4) and novel (FGFR2, KANK1, ADCY2, ZEB2) candidate genes for gonadal 
development (Ledig et al. 2010a; Tannour-Louet et al. 2010; White et al. 2011).  
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An important foundation for the present study was provided by the previous 
genome-wide CNV discoveries in diverse horse breeds and populations (Chapters II and 
III, and (Doan et al. 2012a; Doan et al. 2012b; Dupuis et al. 2013; Metzger et al. 2013a; 
Wang et al. 2014b)). The resulting composite dataset of over 1400 CNVRs for the horse 
(Chapter II) was a critical resource for evaluating the known CNVRs and identifying 
those that are novel. In the present study we analyzed the genomes of 20 horses - 12 
bilateral cryptorchids and 8 XY SRY-positive sex reversals, and identified altogether 302 
CNVRs (130 in cryptorchids and 172 in sex reversals (Appendices 4.1.2, 4.2.2 ). Of 
these, over 80% were shared with previous studies, thus essentially confirming that these 
genomic regions are CNV in horses. This is important because many of the reported 
CNVs have been discovered in just a single individual ((Doan et al. 2012a; Wang et al. 
2014b), see Chapter II) and require additional supporting evidence. 
With regards equine XY DSDs, our primary interest in this study were the 
remaining 20% of CNVRs that were unique to cryptorchid and/or sex reversal horses 
and not described in horses before. Such CNVRs were found in both groups of DSD 
horses, although it was noteworthy that only 16 novel CNVRs were detected in the 12 
bilateral cryptorchids (Table 17) compared to 41 in 8 sex reversal horses (Table 18). 
Furthermore, in cryptorchids only one CNVR was shared between two affected horses 
while the degree of sharing was 20% in the sex reversal group (Tables 21, 23). Since the 
cryptorchid cohort comprised 7 breeds and the sex reversals 5 breeds (Tables 17, 18), 
these differences cannot be explained by breed diversity. It is also noteworthy that the 
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cryptorchids shared two novel CNVRs with the sex reversal group but only one among 
themselves.  
The two shared CNVRs between the groups involved genes required for protein 
turnaround and DNA repair (UBE2N) and for cell division (MZT2B, TUBA3D) (Table 
24). These are universal biological processes and likely signify normal variants for the 
horse, particularly because no DSD phenotypes have been associated with these genes in 
mice or humans (Safran et al. 2010; Blake et al. 2014). Likewise, the analysis of other 
novel CNV genes in cryptorchids did not reveal any with functional coherence to male 
sexual development and testis descent, and none included genes which mutations or 
CNVs have been associated with cryptorchidism in humans (Tannour-Louet et al. 2010). 
It is therefore conceivable that CNVs do not contribute to cryptorcidism in this particular 
study cohort. It is also possible that our limited knowledge about the functions of these 
CNV genes combined with the genetic heterogeneity of cryptorchidism, counfounded 
the analysis. 
The situation was different in SRY-positive sex reversal horses. Despite being 
phenotypically much more diverse (Table 18) than bilateral abdominal cryptorchidism, 
more novel CNVRs (8 out of 41, 19.5%) were shared between individuals. Functional 
relevance of the majority of CNV genes, however, remained unclear, partly because 
many were transcribed sequences with hitherto uncharacterized functions (Table 23).  
Probably the most interesting novel CNVR gene was the transcriptional regulator 
ATRX. Mutations of this gene in humans cause the ATRX-syndrome which is 
characterized by complex developmental disorders including genital and gonadal 
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abnormalities (Picketts et al. 1996; Huyhn et al. 2011). Due to ATRX mutations or 
deletions, genetically males (XY) display varying degrees of sex reversal, implicating 
ATRX in the development of the human testis (Biason-Lauber 2010). These observations 
are further supported by studies in mice and marsupials showing that ATRX is an 
evolutionarily conserved regulator of gonadal development in therian mammals and acts 
downstream of SRY and SOX9 in the differentiation of testes (Huyhn et al. 2011). It is 
therefore plausible that ATRX mutations or deletions, as found in this study, affect 
normal sexual development also in horses. Detailed analysis of this gene in XY DSD 
horses should be subject for the future studies. 
Of interest was also the large deletion found in the PAR of one XY horse with 
almost normal female external phenotype. The functions of the 4 genes involved 
(AKAP17A, ASMT, ZBED1 and XG) are not well understood, although it is known that 
the PAR genes are dosage sensitive and possibly regulating very early stages of 
development (Raudsepp et al. 2012; Das et al. 2013b; Bellott et al. 2014). Thus, 
deletions in the PAR will cause haploinsufficiency for the genes involved like it happens 
on a larger scale in X-monosomy. However, as the regions showed significant variation 
by qPCR also in reference horses, the findings must be taken with caution and require 
further investigation.  
However, the most functionally relevant CNVR was not a novel but a common 
complex variant present in chr29 at 28.6-28.8 Mb (Figs. 25, 26), previously found in 
normal individuals of at least 10 different breeds as a gain (Doan et al. 2012a) or a loss 
(Chapter II). In the current study, this region was homozygously deleted in one bilateral 
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cryptorchid and two sex reversal horses. The deletion involved at least 4 members of the 
aldo-keto reductase gene family (AKR1C), which function in the biochemical pathway 
that leads to dihydrotestosterone (DHT) synthesis without testosterone intermediate. As 
opposed to the ‘classical’ DHT synthesis from cholesterol and testosterone, this pathway 
is known as ‘the backdoor pathway’ and was originally discovered in marsupials 
(Wilson et al. 2003) and thereafter in eutherian mammals (Auchus 2004; Fluck et al. 
2011; Biason-Lauber et al. 2013; Fukami et al. 2013). The importance of the ‘backdoor 
pathway’ and AKR1C genes in male sexual development was recently demonstrated by a 
study in humans showing that mutations in AKR1C2 and AKR1C4 genes are associated 
with various disorders of sexual development (DSDs) including cryptorchidism and sex 
reversal (Fluck et al. 2011; Biason-Lauber et al. 2013). Furthermore, CNV studies in 
human cryptorchidism have found genomic imbalances and one clinically significant de 
novo CNV in HSA10p14 - a region next to the AKR1C gene cluster.  
Therefore, it is tempting to speculate that the CNVR in chr29 in the horse is a 
causative or a risk factor for some forms of equine XY DSDs. It is noteworthy that the 
three horses with the deletion had remarkably similar gonadal phenotypes: the two sex 
reversal horses (H348, H369, Table 18) were male pseudohermaphrodites with 
underdeveloped abdominal testes like it is in bilateral abdominal cryptorchidism. Thus, it 
is possible that some forms of cryptorchidism and sex reversal are due to the same 
genetic alterations in testis development pathways. However, apparent differences in the 
external phenotypes of the three horses suggest the involvement of additional genetic 
and non-genetic factors. Nevertheless, the region in chr29 requires detailed research by 
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re-sequencing, so that diagnostic tests could be developed for the detection of 
heterozygous carriers. 
Taken together, this is the first attempt to investigate the contribution of CNVs in 
equine XY DSDs. The findings confirm genetic heterogeneity of the conditions, suggest 
likely involvement of CNVs in some, and indicate possible overlap in pathways leading 
to cryptorchidism and male pseudo hermaphroditism. 
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CHAPTER V 
CONCLUSIONS AND FUTURE WORK 
 
During just the past two years, several studies have addressed the phenomenon of 
copy number variation in the horse genome contributing to our knowledge about the 
genomic landscape of CNVs and their role in inter-individual variation in horses. 
Despite the progress, efficient biomedical application of this information requires 
addition of data from many more populations and individuals, as well as validation and 
analysis of the existing CNVs.  
The overall goal of this dissertation was to advance CNV studies in horses by i) 
constructing a new, efficient and high-density whole genome CNV analysis platform; ii) 
discovering CNVs in the genomes of diverse horse breeds including those that have not 
been analyzed before; iii) generating a composite CNV dataset for the horse genome by 
integrating all hitherto available CNV information, and iv) discovering CNVs potentially 
contributing to complex equine diseases and congenital disorders. 
In Chapter II, a tiling array was designed for the discovery of CNVs in the horse 
genome. The 400,000 array probes represented the majority of equine autosomal and X-
linked genes, had a good representation of intergenic regions, and, as a unique feature, 
included sequences from the Y chromosome and sub-telomeric regions. The efficiency 
of the array was illustrated by its use for the discovery of over 100 novel CNVRs, not 
reported in horses before, and by detecting CNVRs in chrX and Un – the chromosomes 
largely ignored by previous studies. Importantly, this platform has a prospective use in 
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many future studies because the array design can easily accommodate the improvements 
in the horse genome sequence assembly. 
The array was successfully applied for CNV discovery in 38 horses representing 
16 diverse breeds of which 11 breeds, mainly ponies and draft horses, were analyzed for 
CNVs for the first time. Of the 258 CNVRs that were identified, 45% were novel and 
55% overlapped with those reported previously. Thus, the findings added new 
information but also validated the existing CNV data for horses. 
Probably one of the most important outcomes of this study was the integration of 
all CNVs and CNVRs from this and previous studies into a composite dataset of 1476 
CNVRs for the horse genome. The integrated dataset is a critical resource for in depth 
analysis of known CNVRs and for new discoveries.  
The utility of the tiling array and the integrated dataset was demonstrated in 
Chapters III and IV by studying CNVs in complex equine conditions: recurrent airway 
obstruction and disorders of sexual development. Cumulatively, these studies identified 
500 CNVRs of which 87 were novel additions to the composite CNVRs dataset. Most 
importantly, these studies identified copy number variable genes and regions that are 
likely contributing or risk factors to complex equine disorders and diseases, such as 
RAO, cryptorchidism and XY sex reversal syndrome. As these studies are the first of 
their kind in horses, the findings are subject for further research.  
One of the immediate future tasks is to properly validate all the novel CNVRs 
reported in this study. Also, novel variants of functional relevance should be analyzed in 
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larger cohorts of affected and control horses to determine possible associations with the 
phenotypes.  
Regarding the overall CNV research in horses, many more individuals of diverse 
breeds should be studied, so that a comprehensive CNV catalogue can be generated for 
the horse genome. Ideally, this information should be incorporated and available in all 
main genome browsers, like it is for humans.  
With the advances of NGS and the availability of whole genome sequence data 
for hundreds of individual horses, it is anticipated that array based CNV analysis will 
soon be replaced by whole genome sequence analysis, although, at the moment it is still 
cheaper to analyze multiple individuals on array platforms than carrying out high-
coverage (40X) NGS and assembly in the same number of individuals. Furthermore, due 
to the very nature of CNVs, these regions are likely to have short-read NGS assemblies 
not as accurate as non-variable regions. Thus, the known CNVRs also identify potential 
targets for genome re-sequencing and –assembly using long-read NGS technologies, 
such as Pacific Biosciences and other single molecule platforms.  
Taken together, exploration of CNVs in the horse genome has started and is 
promising, although, much more research is needed to properly understand the role of 
these variants in equine biology – in phenotypic variation, adaptations, and complex 
traits, in genetic diseases and congenital disorders. 
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APPENDIX 
 
Appendix 2 contains supplemental material (CNV details, gene function, gene ontology 
analysis, database of genome variant analysis, comparative study with other horse CNV 
datasets, CNVs with high/low log values, and qPCR primer list) for Chapter II 
 Appendix 2_Chapter II.xlsx 
Appendix 3 contains supplemental material (CNV details, gene function details, and 
CNVs with high/low log value of RAO study) for Chapter III 
 Appendix 3_Chapter III.xlsx,  
Appendix 4 contains supplemental material (CNV details, gene function details, and 
CNVs with high/low log value of DSD study) for Chapter IV 
 Appendix 4.1 _Chapter IV.xlsx 
 Appendix 4.2_Chapter IV.xlsx 
 
 
